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Scope of this thesis
Faithful transcription of our genome is essential to maintain proper cell function. 
Therefore, transcription is tightly regulated at the different steps of the transcription 
cycle. Transcription is threatened by DNA lesions caused by endogenous and exogenous 
factors. These so-called transcription-blocking lesions (TBLs) can partially or completely 
block transcription or may result in the onset of mutant transcripts. Impaired transcription 
can severely reduce cell function and eventually may result in senescence or cell death. 
Luckily, cells have a dedicated repair pathway called transcription-coupled nucleotide 
excision repair (TC-NER) that removes TBLs. TC-NER is initiated upon stalling of RNA 
polymerase II (Pol II) upon a TBL and promotes the recruitment of downstream TC-NER 
factors. These repair factors help to recognize the TBL, verify the lesion and excise the 
damaged DNA after which the resulting single strand gap is filled by DNA synthesis. After 
damage removal, transcription has to be resumed to maintain cell function. In addition 
to this direct (in cis) consequence of Pol II stalling, transcription is also regulated in a 
genome-wide manner (in trans). This includes a block in transcription initiation, release 
of promoter-paused Pol II and alternative splicing. Together, these mechanisms attempt 
to diminish the severe consequences of TBL-induced transcriptional interference and 
promote lesion-recognition and repair to maintain genome integrity. The direct and 
indirect consequences of TBLs are called the transcription stress response to DNA 
damage and this response is evaluated in detail in Chapter 1. 
Although the TC-NER pathway has been discovered decades ago and most key factors 
have been studied extensively, the exact molecular mechanism is not yet known. For 
example, Pol II is a tightly regulated protein that needs to be resolved upon stalling 
to allow repair factors to access the TBL. However, the exact factors regulating Pol II 
upon DNA damage have yet to be determined. Therefore, in Chapter 2, we described 
different SILAC-based Pol II interaction proteomics experiments to systematically 
identify, potentially novel, UV-specific interacting proteins. We used different isolation 
and extraction methods to extract Pol II and its interactors from the chromatin, immuno-
precipate the Pol II complex and identified its interactors. Moreover, we used proximity 
labeling to covalently tag proteins that are located in close proximity of Pol II in response 
to UV irradiation. Combining the analysis of the different isolation methods identified 
new UV-specific Pol II interactors that need to be further evaluated to provide insight 
whether and how they regulate Pol II during the transcription stress response. Our study 
compared different methods that could be used to identify Pol II-interacting proteins 
and could be used to study its interactors at different time points after UV. 
Additionally, we have used a different approach to identify factors involved in the 
transcription stress response based on their sensitivity to TBLs, by using a genome-wide 
CRISPR/Cas9 sgRNA-based genetic screen (Chapter 3). We used UV irradiation as a 
selective pressure to identify genes involved in the transcription stress response. Analysis 
of the guide RNAs that were lost upon UV irradiation identified transcription elongation 
factor 1 homolog (ELOF1) as a new UV-sensitive gene, amongst many other UV-sensitive 
genes. In this study, we further investigated the role of ELOF1 and identified this protein 
as a component of the Pol II complex where it functioned as an elongation factor. We 
showed that ELOF1 depletion resulted in hypersensitivity to different types of TBLs and 
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that it was an important factor for the TC-NER pathway as repair was severely impaired 
due to improper recruitment of UVSSA and other downstream repair factors. Moreover, 
we showed that the function of ELOF1 in the transcription stress response was highly 
evolutionary conserved. Furthermore, we uncovered a role for ELOF1 in preventing 
transcription-replication conflicts in addition to its function in TC-NER. 
So far, we mainly focused on proteins involved in repairing DNA and regulating the 
transcription stress response to DNA damage. However, transcription, replication and 
DNA damage repair take place at the chromatin, in which the DNA is tightly wrapped 
around nucleosomes, which consists of histone octamers. To regulate the access for 
DNA transacting processes to the DNA, the chromatin can be remodeled. This can be 
regulated by for example post-translational modifications (PTMs) of histones, that can 
directly regulate chromatin compaction or provide a binding platform for chromatin 
remodelers. One of the first PTMs that was shown to regulate chromatin compaction 
during transcription and DNA damage repair was histone acetylation. This was proposed 
to be involved in increasing the accessibility of repair factors to DNA lesions and to restore 
compaction after repair. However, a complete overview of the dynamic acetylation 
events after UV-induced DNA damage is lacking.
Therefore, in Chapter 4, we focused on chromatin reorganization via post-transla-
tional modifications and specifically focused on acetylation levels in response to 
UV-induced DNA damage. We used SILAC-based interaction proteomics and identified 
a genome-wide histone deacetylation in response to UV irradiation. This deacetlyation 
was independent of transcription but dependent on replication. Interestingly, we 
showed that the replication stress-induced deacetylation was a result of degradation 
of acetylated histones. The degradation was independent of ubiquitin and functioned 
via the PA200 proteasome complex. Degradation of acetylated histones likely inhibited 
replication to prevent transcription-replication conflicts and safeguard genome stability.
Finally, in Chapter 5, we evaluate the main findings obtained in the experimental 
work described in this thesis and discuss their implications on the transcription stress 
response. Moreover, some future experiments are proposed that will help to further 
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Abstract
Unperturbed transcription of eukaryotic genes by RNA polymerase II (Pol II) is crucial 
for proper cell function and tissue homeostasis. However, the DNA template of Pol II is 
continuously challenged by damaging agents that can result in transcription impediment. 
Stalling of Pol II on transcription-blocking lesions triggers a highly orchestrated cellular 
response to cope with these cytotoxic lesions. One of the first lines of defense is the 
transcription-coupled nucleotide excision repair (TC-NER) pathway that specifically 
removes transcription-blocking lesions thereby safeguarding unperturbed gene 
expression. In this perspective, we outline recent data on how lesion-stalled Pol II 
initiates TC-NER and we discuss new mechanistic insights in the TC-NER reaction, which 
have resulted in a better understanding of the causative-linked Cockayne syndrome and 
UV sensitive syndrome. In addition to these direct effects on lesion-stalled Pol II (effects 
in cis), accumulating evidence shows that transcription, and particularly Pol II, is also 
affected in a genome-wide manner (effects in trans). We will summarize the diverse 
consequences of DNA damage on transcription, including transcription inhibition, 
induction of specific transcriptional programs and regulation of alternative splicing. 
Finally, we will discuss the function of these diverse cellular responses to transcrip-
tion-blocking lesions and their consequences on the process of transcription restart. 
This resumption of transcription, which takes place either directly at the lesion or is 
reinitiated from the transcription start site, is crucial to maintain proper gene expression 
following removal of the DNA damage. 
Keywords
Transcription-coupled nucleotide excision repair, RNA polymerase II, DNA damage, 
Transcription inhibition, Transcription restart.
Abbreviations
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The eukaryotic genome is transcribed by different RNA polymerases. These polymerases 
consist of multiple subunits, are structurally alike and function in a similar manner 
although they all transcribe a different part of the genome1. In this perspective, we will 
focus on RNA polymerase II (Pol II), the RNA polymerase responsible for transcription of 
protein-coding genes and synthesis of most non-coding snRNAs and miRNAs1. Correct 
temporal and spatial regulation of gene expression is crucial for proper cell function and 
homeostasis. To safeguard this, transcription is tightly controlled at almost each step 
of the dynamic transcription cycle, ranging from initiation, promoter proximal pausing, 
productive elongation to transcription termination2,3. However, the DNA template 
transcribed by Pol II is compromised on a daily basis by numerous types of DNA damaging 
factors. Several types of these DNA lesions can block or strongly impede progression of 
Pol II and are therefore referred to as transcription-blocking lesions (TBLs). If TBLs are 
not resolved properly, prolonged stalling of Pol II can lead to severely disrupted cellular 
homeostasis due to absence of newly synthesized RNA molecules or the appearance of 
mutant RNA molecules4,5. In addition, prolonged stalled Pol II induces R-loops and may 
result in collisions with advancing replication forks6. Altogether, these TBLs may result in 
genome instability, severe cellular dysfunction, premature cell death and senescence7,8 
which finally may result in DNA damage-induced, accelerated aging9.
The effects of different transcription blocking lesions on Pol II
TBLs can originate from both endogenous and exogenous sources. The main examples 
of DNA damage of endogenous origin are by-products of metabolic processes in 
mitochondria. These reactive oxygen species can for example generate 8,5′-Cyclopu-
rine-2’-deoxynucleosides or 8-oxo-7,8-dihydroguanine (8-oxo-G) lesions10-12. Damage 
from exogenous sources which cause TBLs include clinically used chemotherapeutics 
like cisplatin which causes inter- and intrastrand crosslinks, or ultraviolet (UV) radiation 
mainly causing 6-4 pyrimidine-pyrimidone photoproducts (6-4PPs) and cyclobutane- 
pyrimidine dimers (CPDs)13. While all these structurally different types of damage can 
interfere with elongating Pol II9,14, the stalling is mechanistically different for these 
diverse types of lesions15. For example, Pol II most likely does not stall at 8-oxo-G lesions 
itself but is affected by base excision repair intermediates after the action of lesion-spe-
cific DNA glycosylase, such as OGG116-18. Cisplatin-induced interstrand crosslinks do not 
pass through the so-called Pol II translocation barrier. This impairs delivery of this bulky 
lesion to the active site of Pol II and stalls Pol II in front of the lesion19. In contrast, 
UV-induced CPD lesions can pass the translocation barrier and therefore enter the active 
site of Pol II. This results in direct stalling of Pol II, thereby completely covering the lesion 
with a 35-nucleotide footprint; 10 nucleotides downstream and 25 nucleotides upstream 
of the CPD lesion13,20,21. These UV-induced CPDs form a stable road block for Pol II, as 
shown by extreme stability of CPD-stalled Pol II complexes, with half-lives of approx-
imately 20 hours in vitro22. As a consequence of the different effects on elongating 
Pol II, the diverse types of lesions also trigger different response mechanisms such as 
transcriptional bypass for cyclopurines or transcription-coupled nucleotide excision 




In this perspective we will give an overview on how cells cope with TBLs and provide 
insight in the cell-wide consequences of DNA damage on Pol II and transcription. First we 
will discuss how cells can efficiently remove TBLs by using the dedicated TC-NER pathway. 
Furthermore, we will discuss new insights on the consequences of TBLs in trans. These 
effects include both TBL-induced signaling events but also effects of DNA damage on 
non-lesion stalled Pol II by regulating the transcription cycle or affecting splicing. Finally, 
we will discuss factors and mechanisms involved in the last crucial step of overcoming 
the cytotoxic effects of TBLs; restart of transcription. 
Transcription-coupled nucleotide excision repair
The concept of TC-NER was discovered almost three decades ago by the observation that 
UV-induced DNA damage in an actively transcribed gene was removed faster compared 
to damage in a non-transcribed genomic region25,26. Follow-up studies showed that 
preferential repair of active genes was specifically observed in the transcribed strand25,27. 
Since the discovery of TC-NER, many factors have been identified that play an important 
role in removal of TBLs and their discovery resulted in a better understanding of the 
molecular mechanism of TC-NER. 
Figure 1. CSB probes Pol II for lesion recognition. (1) During productive elongation Pol II may run into DNA 
damage or natural occurring pause sequences that consequently impede Pol II forward translocation. (2) 
CSB recognizes and binds stalled Pol II. (3) Binding of CSB will result in an 80 degree bending of the DNA. 
Consequently, the ATPase activity of CSB is suggested to pull on the template DNA thereby mediating Pol II 
forward translocation. (3, left and middle panel) Translocation can be successful in case of natural occurring 
pause sites and less bulky DNA lesions, including oxidative damage, resulting in continuation of productive 
elongation or transcriptional bypass respectively. After the CSB-mediated forward movement, CSB might 
be released from Pol II. (3, right panel) Pol II cannot be translocated over bulky, transcription-blocking DNA 
lesions like UV-induced CPDs. This unsuccessful forward translocation of Pol II likely increases the residence 




CSB senses lesion-stalled Pol II and initiates repair
TC-NER is initiated by recognition of lesion-stalled Pol II by the three main TC-NER 
factors: cockayne syndrome protein A and B (CSA and CSB) and UV-stimulated scaffold 
protein A (UVSSA) (figure 2)28-30. CSB is considered to be a master regulator of TC-NER as 
it plays a key role in recruitment of several proteins to the TC-NER complex. For example, 
CSB is essential for translocation of CSA to the nuclear matrix31,32 and recruitment to 
the TC-NER complex33. In addition, CSB, together with CSA, recruits other factors to the 
TC-NER complex including the pre-mRNA splicing involved protein XAB2, nucleosome 
binding protein HMGN1 and p300 histone-acetyl transferase33. However, the exact 
mechanism of how this 1493 amino acid long multifunctional CSB protein contributes 
to the repair of TBLs remained elusive for a long period. While the C-terminal domain 
of CSB is required for its interaction with Pol II and translocation of CSA to the nuclear 
matrix34, the SWI2/SNF2 DNA-dependent ATPase activity located in the central region 
of CSB was expected to play a crucial role during TC-NER-mediated TBL removal35 and 
was shown to mediate chromatin remodeling after UV-induced DNA damage35-37. 
Interestingly, its key function during TC-NER was only recently disclosed by unraveling 
the structure of the yeast homolog of CSB, Rad26, in complex with lesion-stalled Pol II 
using cryo-EM studies38.
This lesion-stalled structure showed that Rad26 binds to DNA upstream of Pol II and 
the TBL, causing a CSB-mediated 80 degree bending of the extruding DNA. Importantly, 
the 3’-5’ ATP-dependent translocase activity of RAD26 pulls the DNA away from Pol II 
in a similar manner as Snf2, another member of the SWI2/SNF2 ATPase family, pulls 
DNA from nucleosomes39. This “DNA Pulling” is suggested to stimulate forward translo-
cation of Pol II over for example naturally occurring pause sites or small blocking lesions 
(figure 1). However, Rad26 cannot translocate Pol II over bulky DNA lesions that lead to 
a transcription block, like CPDs38. This study provides important new insights in the long 
lasting question how TC-NER, and CSB specifically, could discriminate between normal 
paused Pol II and TBL-stalled Pol II in such a way that TC-NER is only initiated when 
needed. Since Rad26 is highly homologous to mammalian CSB, a similar key role for CSB 
in sensing damage-paused Pol II in mammalian cells is proposed. Interestingly, this model 
suggests that CSB is constantly probing Pol II to sense for an obstruction, indicating that 
CSB interacts both with lesion-stalled as well as unperturbed elongating Pol II. In line 
with this, it was observed that CSB transiently interacts with chromatin in a transcrip-
tion-dependent manner in non-damaged conditions, most likely by binding to Pol II. A 
larger fraction of CSB was bound when cells were challenged with Pol II-stalling agents 
including UV-induced DNA damage or actinomycin D40. Interestingly, the binding affinity 
of Rad26 to Pol II upon stalling at TBLs was not increased in vitro38. This suggests that 
the observed increased CSB binding in cells might be caused by its prolonged binding 
to lesion-stalled Pol II, which could be the trigger for TC-NER complex assembly and 
subsequent repair of the TBL (figure 1)22,38. 
The role of CSA and UVSSA in TC-NER 
A key protein which is recruited by CSB to the TC-NER complex is DDB1- and Cul4- 
associated factor (DCAF) CSA33 which forms the CRL4CSA E3 ligase complex together with 
DDB1, Cul4A and Roc141. In this CRL4CSA complex, CSA is a dedicated substrate receptor, 







WD40 propeller and binds via its helix-loop-helix motif to DDB128,42-44. A recent study 
uncovered that the chaperonin TCP-1 ring complex (TRiC) interacts with CSA, especially 
those CSA proteins that are not incorporated in CRL4CSA complexes. TRiC interaction is 
important for stability of CSA and most likely mediates CSA handover to DDB1 to form 
properly functioning CRL4CSA45. In unperturbed conditions, the ligase activity of CRL4CSA 
is inhibited by binding of the COP9 signalosome41,46. However, upon DNA damage, 
the COP9 signalosome dissociates, resulting in activation of CRL4CSA ligase activity. 
Consequently, CSB, the substrate of the CRL4CSA ligase, is ubiquitylated and targeted for 
proteasomal degradation (figure 2)47,48. However, also other, yet unknown, targets of 
the CRL4CSA complex may exist and function during TC-NER. 
The third main factor in TC-NER initiation is UVSSA, which interacts with both CSA and 
Pol II30,49. One of the roles of UVSSA during the TC-NER reaction is to specifically recruit 
ubiquitin-specific protease 7 (USP7) (figure 2)30,49,50. USP7 was, just as UVSSA, shown 
to be crucial for TC-NER30. The deubiquitylating activity of USP7 plays an important role 
in several different pathways following DNA damage. For example, Mdm2, XPC, p53, 
ALKBH351-54 but also many factors outside the DNA damage response are described 
as USP7 substrates55. In a large number of these processes, USP7 is recruited to its 
substrate as part of a relatively stable complex. This seems to be a common mode 
of action for USP7 and might be essential to specifically target this abundant and 
pleiotropic deubiquitylating enzyme to its substrate56,57. In addition, complex formation 
of USP7 stimulates its deubiquitylating activity. This can be facilitated by remodelling its 
structure to a more competent state mediated by its binding partner56,58-60. Strikingly, 
in contrast to stimulation of USP7 activity following complex formation, the UVSSA-USP7 
interaction was reported to inhibit the deubiquitylating activity of USP761. Following 
induction of TBLs, USP7 is specifically recruited via UVSSA to the TC-NER complex, where 
it counteracts CRL4CSA-mediated CSB ubiquitylation, thereby most likely increasing the 
half-life of CSB in the TC-NER complex (figure 2)30,50. In addition, recently it was shown 
that USP7 also deubiquitylates UVSSA, which is important for efficient TC-NER62. 
	Figure 2. A model how transcription-coupled nucleotide excision repair (TC-NER) removes transcrip-
tion-blocking lesions (TBLs). Step 1, UV-induced TBLs result in stalling of Pol II and the inability of CSB to 
forward translocate Pol II. This results in an increased residence time for CSB on Pol II and most likely results 
in recruitment of the TC-NER factors CSA, UVSSA and USP7. Step 2, CSA is part of the CRL4CSA E3 ligase 
complex and is recruited to the stalled Pol II complex via CSB resulting in polyubiquitylation of CSB. The 
deubiquitylating enzyme USP7 is recruited to the TC-NER complex by UVSSA and stabilizes CSB via deubiq-
uitylation. Step 3, subsequently, TFIIH is recruited, most likely via a direct interaction with UVSSA. As USP7 
and TFIIH bind the same domain of UVSSA, TFIIH binding might compete with USP7, resulting in the loss of 
USP7 activity in the TC-NER complex. Step 4, the forward translocating activity of CSB might counteract the 
reverse translocating helicase activity of the XPB and XPD subunits of TFIIH. To overcome these counter-
acting forces, either the ATPase activity of CSB needs to be inhibited, or CSB can be degraded or evicted from 
the TC-NER complex. Increased CSB ubiquitylation due to absence of USP7 might contribute to one of these 
processes. Step 5, due to the loss of CSB or its ATPase activity, TFIIH is able to efficiently reverse translocate 
(backtrack) Pol II, while at the same time the TFIIH complex verifies the DNA lesion. Step 6, following 
successful Pol II backtracking and damage verification, the DNA lesion is efficiently removed by dual incision 
of the damaged strand by the ERCC1/XPF and XPG nucleases. RPA binds the undamaged strand. Step 7, 
the ssDNA gap is filled by DNA synthesis and ligated to finalize repair. Subsequently, transcription has to 
be restarted. This can be initiated either directly at the lesion or by new Pol II initiation at the transcription 
start site when lesion-stalled Pol II is removed from the template DNA during the repair reaction.
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Even though UVSSA has high affinity for USP7, it also has functions during TC-NER 
for which thus far no role of USP7 is observed. For example, the largest subunit of 
Pol II, RPB1, was shown to be ubiquitylated in a UVSSA-dependent manner but this 
modification does not lead to proteasomal degradation of Pol II63. However, thus far it 
remains unclear whether this is a direct or indirect consequence of UVSSA. In line with 
previously observed interactions between UVSSA and subunits of transcription factor II H 
(TFIIH)63, it was recently shown that UVSSA directly interacts with the PH domain of TFIIH 
subunit p62, via a short, highly conserved, acidic region in the central part of UVSSA64. 
Interestingly, this acidic region in UVSSA was identified as it was highly similar to the p62 
PH-binding region of global genome nucleotide excision repair (GG-NER) DNA damage 
sensor XPC64,65 (figure 2). This observation suggests that TFIIH is recruited to TBLs by 
UVSSA following TC-NER initiation via a similar mechanism as used by XPC to recruit 
TFIIH during GG-NER initiation63,64. TFIIH, which is normally involved in transcription 
initiation, is a stable complex of ten subunits, including the helicases XPB and XPD66. The 
ATPase activity of XPB was suggested to recruit TFIIH to damage and initiate opening of 
DNA around the lesion. The helicase activity of XPD helps to extend unwinding of the 
DNA in a 5’ to 3’ direction and is thought to verify the lesion with help of the weaker 
helicase activity of XPB67-71. XPB is suggested to co-translocate with XPD and helps to 
scan the non-damaged complementary DNA strand since it has opposite directionality 
of XPD and thereby stimulates unwinding and lesion verification (figure 2)68,70. XPA 
promotes lesion recognition by enhancing stalling of XPB and XPD and helps to detect 
chemically altered nucleotides68,72. After proper lesion verification, TFIIH together with 
replication protein A (RPA) recruits the structure-specific endonucleases ERCC1/XPF and 
XPG in the correct orientation to excise the damaged strand73,74. Repair is finished by 
refilling the gap with DNA synthesis and ligation (figure 2)75,76. 
New insights in the TC-NER pathway
The recently acquired insights in the mode of action of these TC-NER initiation factors 
have implications for current TC-NER models. One of the most important findings is 
that CSB, mediated by its ATP-dependent translocase activity, can discriminate between 
Pol II stalled at a DNA lesion or at pause sites by constantly probing the Pol II complex 
for its ability to forward translocate38. This indirect recognition of lesion-stalled Pol II 
instead of detection of the DNA lesion itself allows detection of a large spectrum of 
structurally different types of DNA damage. However, at the same time this mechanism 
may result in different outcomes for lesion-stalled Pol II, depending on the type of DNA 
damage. For example, CSB forward translocation of Pol II could promote transcriptional 
bypass of less bulky, oxidative damage like 8-oxo-G lesions (figure 1)24,38,77. In contrast, 
upon stalling at bulky lesions like CPDs, Pol II cannot be translocated by CSB, resulting 
in a longer residence time of Pol II and CSB at the lesion, which eventually results in 
initiation of TC-NER (figure 1)38. The increased residence time of CSB suggests that CSB 
has to be stabilized, since it is normally targeted for proteasomal degradation by the 
CRL4CSA complex following UV-induced DNA damage48. Protection from degradation 
could be mediated by concerted action of UVSSA and deubiquitylating enzyme USP7 





UVSSA was recently suggested to be involved in recruitment of TFIIH to Pol II63,64. TFIIH, 
with its XPD 5’-3’ and XPB 3’-5’ helicase activity68, is hypothesized to bind downstream 
of Pol II for DNA damage verification. This not only suggests that UVSSA and CSB bind 
to opposite sides of Pol II, but also suggests that the helicase activity of TFIIH might be 
involved in reverse translocation (backtracking) of Pol II38,70. This would indicate that 
proofreading of the lesion and backtracking of Pol II is mediated by the exact same 
complex, namely TFIIH, assuring efficient subsequent removal of the TBL by excision. 
Of note, in this model TFIIH-mediated backtracking of Pol II is counteracted by the Pol 
II forward translocating property of CSB (figure 2). It is therefore tempting to speculate 
that after TFIIH recruitment, CSB needs to be removed in order for Pol II to be efficiently 
backtracked by TFIIH. Eviction of CSB from the TC-NER complex might be mediated by 
ubiquitylation, as CSB was shown to be degraded following CRL4CSA-mediated ubiqui-
tylation48. However, this may also be mediated by other E3 ligases like BRCA1-BARD1 
as this heterodimer was previously implicated to ubiquitylate CSB and target it for 
proteasomal degradation79. Interestingly, USP7 and TFIIH are described to bind a similar 
region of UVSSA61,64, which might suggest competitive binding of these proteins. This 
putative mutual exclusive binding of either TFIIH or USP7 to UVSSA might suggest that 
USP7-mediated CSB deubiquitylation activity is lost following TFIIH recruitment. This will 
result in increased CSB polyubiquitylation, which subsequently might result in removal 
of CSB from the TC-NER complex by proteasomal degradation. This may enable TFIIH to 
reverse translocate Pol II and verify the DNA damage68,70. 
Although it is tempting to speculate that CSB needs to be degraded in order to allow 
Pol II backtracking and damage verification by TFIIH, it cannot be excluded that the 
ATPase activity of CSB is inhibited, or that CSB is evicted from the chromatin without 
being degraded. In line with this last possibility, the C-terminal ubiquitin-associated 
(UBA) domain of CSB, which interacts with ubiquitin chains, plays a role in eviction of 
CSB from the TC-NER complex. CSB mutants lacking this UBA domain remain trapped 
at TC-NER complexes, resulting in increased UV-sensitivity and reduced transcription 
restart, indicating that removal of CSB is a crucial step during TC-NER34,80,81. In line with 
a specific role in eviction of CSB at later stages in the TC-NER reaction, deletion of the 
UBA domain does not interfere with TC-NER complex assembly or ATPase activity of 
CSB80,81, although CSA translocation to the nuclear matrix was affected34. However, 
thus far the exact mechanism of CSB eviction and the ubiquitylated substrates which are 
recognized by the UBA domain of CSB remain elusive. Future experiments are necessary 
to test the above described model. 
Pol II degradation 
In addition to backtracking and lesion bypass, cells have evolved an additional mechanism 
to ensure clearance of lesion-stalled Pol II. The largest Pol II subunit, RPB1, was shown 
to be degraded by the proteasome following UV-induced DNA damage. This degradation 
is hypothesized to be a ‘last resort’ pathway, which only happens in conditions where 
TC-NER fails or when the damage load is too high82-84. Pol II degradation is a highly 
inefficient process, as cells have to generate new elongating Pol II complexes to restart 
transcription. In addition, degradation may result in a global decrease of the total Pol 
II pool that will likely influence transcription in general. However, degradation of Pol II 
prevents severe cytotoxic effects caused by persistent Pol II-stalling at DNA damage which 
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forms genomic roadblocks for advancing replication forks and other chromatin involved 
processes and may induce the formation of R-loops6-9,85. In addition, degradation of 
Pol II will make the DNA lesion accessible for another round of TC-NER or for additional 
repair pathways to remove the TBL, for example by GG-NER. 
During the last resort pathway, RPB1 is polyubiquitylated by the E3 ubiquitin ligase NEDD4, 
which generates lysine 63-linked polyubiquitin chains86. These chains are subsequently 
trimmed down by deubiquitylating enzymes until a monoubiquitin modification 
remains on RPB1. This monoubiquitin can be extended with lysine 48-linked polyubi-
quitin chains by the Elc1/Cul3 ligase complex. Next, this chromatin bound, ubiquitylated 
RPB1 is recognized by the ubiquitin-selective segregase valosin-containing protein 
(VCP/p97) which removes RPB1 from the stalled complex and results in its proteasomal 
degradation46,82,87. 
Clinical consequences and phenotypical differences
The above described new insights in TC-NER may also have implications for understanding 
TC-NER-linked disorders. The importance of functional TC-NER is clearly illustrated by 
the Cockayne syndrome (CS), a human disorder with defective TC-NER, caused predom-
inantly by mutations in CSA and CSB88. CS is characterized by sensitivity to UV light, 
progressive neurodevelopmental symptoms, growth and developmental problems, 
mental retardation and severe premature aging89-91. Strikingly, UV-sensitive syndrome 
(UVSS), which is mainly caused by mutations in UVSSA, is also characterized by absence 
of TC-NER-mediated removal of UV-induced TBLs92, but displays only mild cutaneous 
UV-sensitivity in sharp contrast to the premature and developmental features observed 
in CS74,78,93. The phenotypical differences between these two syndromes may partially 
be explained by additional functions of CS proteins compared to UVSSA. For example, 
CS proteins were proposed to be implicated in specific transcriptional programs94, 
transcription initiation95, redox balance96, repair of double strand breaks97,98 and 
maintenance of mitochondrial DNA stability99,100, while thus far no such roles are 
described for UVSSA. Importantly, it was also suggested that the additional CS features 
may be derived from a defect in repair of (endogenously produced) oxidative DNA damage 
interfering with transcription25,101 as it was shown that CS cells but not UVSS cells are 
sensitive to oxidative DNA damage (figure 3)102,103. CSB deficient cells lack the ability to 
forward translocate Pol II, which in case of an oxidative lesion will result in the inability 
to bypass this lesion38. This might result in persistent stalling of Pol II, thereby preventing 
access for base excision repair proteins to remove the lesion (figure 3). On top of that, 
persistent stalling of Pol II can eventually lead to collisions with replication forks or result 
in onset of R-loops7,104 which may contribute to the CS phenotype. Recently, it was 
indicated that also UVSSA is involved in repair of oxidative lesions105. However, in absence 
of UVSSA, CSB is expected to still induce transcriptional bypass of oxidative lesions which 
might suggest that the reduced repair rate of oxidative lesions due to loss of UVSSA might 
be less cytotoxic than persistently stalled Pol II complexes (figure 3)24,38,77,78,90. It has to 
be noted that mutations in CSA and CSB result in similar phenotypes90, however thus 
far no role for CSA in lesion bypass of oxidative damage has been reported. In addition, 
loss of UVSSA might result in destabilization of CSB, due to impaired recruitment 
of USP7 to the TC-NER complex. Stabilization of CSB by UVSSA/USP7 might only be 





Figure 3. Differential processing of TBLs may explain differences in Cockayne Syndrome and UV sensitive 
syndrome. Less bulky lesions like oxidative damage (top row) and transcription-blocking damage including 
UV-induced CPDs (middle row) will lead to stalling of Pol II. In wildtype cells, CSB will bind TBL-stalled 
Pol II and induce its forward translocation. In case of oxidative lesions, translocation of Pol II by CSB can 
successfully bypass the lesion making it accessible for alternative repair, e.g. by BER. In contrast, CSB cannot 
translocate Pol II over TBLs and this will initiate TC-NER to remove the lesion and restart transcription. In 
absence of CSB, TBL-stalled Pol II cannot be forward translocated. Therefore, Pol II may not be able to 
bypass oxidative damage nor trigger TC-NER and will most likely remain stalled on the lesion. Persistent 
stalling can lead to transcriptional interference, cause replication-transcription collisions and form R-loops. 
CSB-deficient cells are sensitive to both oxidative damage as well as TBLs most likely causing the severe 
Cockayne Syndrome phenotype. In absence of UVSSA, CSB is still able to bind the DNA and probe Pol II for 
translocation. This will lead to successful bypass of oxidative damage similar as in wildtype cells. However, 
most likely due to absence of UVSSA, CSB will be degraded more rapidly. However, as CSB-induced lesion 
bypass of oxidative damage might be a swift process, it is therefore not expected to be influenced by the 
decreased CSB half-life. Since there is still CSA and CSB present in absence of UVSSA, lesion-stalled Pol II 
might be degraded or displaced from the lesion. This will prevent persistent stalling of Pol II and makes 
the lesion accessible for repair by alternative repair pathways like GG-NER. As a consequence, UVSSA- 
deficient cells are sensitive for TBLs but not oxidative damage, which might result in the milder UV-sensitive 
syndrome.
on UV-induced lesions to initiate TC-NER38,78. However this stabilization might not be 
essential during the most likely more rapid lesion bypass of oxidative lesions (figure 3). 
A different but not mutually exclusive explanation for observed phenotypical differences 
between the TC-NER disorders might be that CSA and CSB are involved in degradation 
or removal of Pol II106. Absence of CS proteins might lead to persistent stalling of Pol II 
with the lesion trapped in the active site thereby completely covering the lesion and 
preventing repair. In contrast, UVSS cells might still be able to remove Pol II from the lesion 
and repair UV-induced transcription blocking lesions with alternative repair pathways. In 
this scenario, 6-4PP lesions will be quickly repaired by GG-NER. However, CPD lesions are 
less efficiently repaired by GG-NER and their prevalence might explain the UV-sensitivity 
and failure to restart transcription as observed in UVSS cells (figure 3)74.
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To obtain a better understanding of the contribution of TBLs to the phenotypes of 
TC-NER linked disorders, genome instability and DNA damage-induced aging, it is of 
great importance to understand the exact mode of action of the various TC-NER factors 
during the different stages of this repair pathway. New insights in the spatio-temporal 
TC-NER complex composition might give important indications when the different 
activities of TC-NER factors are crucial, or alternatively, when specific factors need to 
be evicted from damaged chromatin to allow progression to subsequent reaction-steps. 
In addition, more in-depth experiments are needed to unravel the exact functions of 
TC-NER factors. For example, even though the E3 ligase activity of the CRL4CSA complex 
is crucial for TC-NER, its exact role and substrates remain elusive. In addition to this 
important ubiquitin-mediated regulation46, other post-translational modifications are 
expected to provide additional layers of control to allow efficient damage recognition 
and removal. For example, SUMOylation has recently been shown to target CSB and 
this modification is essential for efficient TC-NER34. To be able to explain the striking 
differences observed in TC-NER phenotypes74,78,93, it is important to identify putative 
differential activities of TC-NER factors or changes in the TC-NER complex composition 
following exposure to different types of TBLs. For example, recently it was shown that 
CSB is differentially ubiquitylated following UV-induced or oxidative lesions81, indicating 
that depending on the type of lesion, the TC-NER complex is regulated in a different 
manner.
Genome-wide consequences of transcription blocking lesions on transcription
Since TC-NER is initiated via recognition of lesion-stalled Pol II, most research on the 
effects of transcription-blocking DNA damage has been focused on this specific, 
damage-engaged subset of elongating polymerases25,90. However, in addition to direct 
consequences of DNA lesions that impede Pol II forward progression - effects in cis -, 
accumulating evidence shows that several important regulatory mechanisms exist that 
also affect non-lesion stalled Pol II in a genome-wide manner - effects in trans -. Both 
these cis and trans-effects are expected to be vital for cells to cope with the severe 
consequences of TBLs85,107. In this section, we will focus on genome-wide regulation 
of Pol II following DNA damage. We will discuss examples of TBL-induced effects that 
result in specific transcriptional programs, induced by either targeting the transcription 
cycle or by affecting mRNA splicing. Especially the highly regulated process of 
Pol II-mediated transcription offers several important control steps that can be targeted 
to regulate transcription, prevent genome instability and reduce cytotoxicity following 
exposure to TBLs. 
Pol II-mediated transcription is initiated by general transcription factors that facilitate 
recruitment of Pol II and assembly of the preinitiation complex (figure 4)108. During 
initiation, the CDK7 kinase activity of TFIIH phosphorylates serine 5 of the C-terminal 
domain (CTD) of RPB1, the core catalytic subunit of Pol II. This allows Pol II to engage 
the DNA template and start transcribing a short stretch of RNA followed by a transient 
pause ~60 bp downstream of the transcription start site (TSS) (figure 4)3,109. The release 
of Pol II from promoter proximal pause sites into productive elongation is mediated 
by the CDK9 kinase activity of the positive transcription elongation factor b complex 
(p-TEFb). CDK9-mediated phosphorylation converts the DRB sensitivity  inducing 





Figure 4. Effects of transcription blocking lesions in trans. (1) Basal transcription consists of initiation, 
pausing and elongation. General transcription factors help Pol II to initiate transcription from the 
transcription start site (TSS). Pol II pauses on the promoter proximal pause site (orange, PPP) before being 
released into productive elongation. (2) TBLs have different effects on transcription in a genome-wide 
manner. (2, left panel) Upon UV irradiation, transcription initiation is inhibited, decreasing the formation 
of new pre-initiation complexes, resulting in transcription inhibition. (2, middle panel) In addition, p-TEFb 
is activated independent of transcription. Activated p-TEFb stimulates release of Pol II from the PPP into 
productive elongation. This might result in increased sensing of TBLs and increased TC-NER. (2, right 
panel) Following UV-induced DNA damage, transcription switches to expression of shorter mRNA isoforms 
by using alternative last exons. (3) Both increased pause release of Pol II from the PPP into productive 
elongation, in combination with Pol II release from the DNA template following stalling at TBLs, as well 
as spatial restriction of transcription by the expression of shorter isoforms with alternative last exons, 
results in preferential transcription and TC-NER in the 5’ of genes. This might leave the distal part of genes 
accessible for repair by GG-NER.
elongation factor (NELF) complex, and phosphorylates the CTD of RPB1 on serine 23. 
The  different phosphorylation statuses of Pol II also mediate the binding and release 
of  splicing factors as previously reviewed110. The CTD serves as a ‘landing path’ for the 
spliceosome and mediates co-transcriptional splicing110.
Effects on Pol II transcription upon UV damage
One of the first indications of TBL-induced genome-wide effects on transcription was 
the observation that TATA-binding protein (TBP) is sequestered at cisplatin- and UV-
damaged DNA. This results in a reduced availability of TBP to bind at promoter regions, 
subsequently leading to less transcription initiation111. This observation was followed 
by the discovery of another in trans effect, that results in a massive depletion of the 
hypophosphorylated initiating form of Pol II upon UV irradiation, with a concomitant 
increase in the hyperphosphorylated elongating Pol II112. Additional research indicated 
that this shift could be explained by the inhibition of transcription initiation that was 
detected in UV-treated cell extracts using in vitro assays112. Although this indicates 
that DNA damage directly interferes with the transcription cycle, the loss of hypophos-
phorylated Pol II can also partially be explained by stalling of elongating Pol II at TBLs, 
Chapter 1
22
thereby increasing the fraction of hyperphosphorylated Pol II. In line with these early 
observations, more recently published genome-wide Pol II ChIP-seq data showed that 
directly following UV-induced DNA damage, Pol II was cleared from the promoter113. The 
loss of Pol II ChIP-seq reads near the promoter, which most likely represent promoter 
paused Pol II, can be explained in different ways: Either (1) promoter paused Pol II is 
released into the gene body, (2) paused Pol II is specifically evicted from the chromatin 
or (3) transcription initiation is inhibited. 
As this study showed that in addition to the loss of Pol II, TFIIH promoter-binding was 
reduced following UV irradiation, it was concluded that there is less TFIIH available for 
transcription initiation113. Reduced availability of TFIIH during transcription initiation 
might be caused by the involvement of this general transcription factor in the TC-NER 
reaction following DNA damage. In line with this hypothesis, reduced promoter binding 
of TFIIH and Pol II following UV-induced DNA damage could be rescued by depletion of 
CSB113. This is an intriguing finding since the vast majority of repair-associated TFIIH 
is active in GG-NER which makes up the bulk portion of NER114. This may suggest that 
specifically occupation of TC-NER-associated TFIIH is causing inhibition of transcription 
initiation (figure 4). It is interesting to note that, although most of the genes show a 
decrease in promoter bound Pol II as a result of DNA damage, a specific subset is shown 
to be regulated differently. Interestingly, this set of genes is shown to have strongly 
increased binding of Pol II and consists of genes mainly involved in the p53 response, 
DNA damage response and apoptosis113, indicating that this mechanism can stimulate 
the expression of specific genes following TBL induction. 
p-TEFb activation stimulates transcription of the 5’ end of genes
Another genome-wide effect on the transcription cycle following UV-induced DNA 
damage is caused by activation of p-TEFb115. In unperturbed conditions, a pool of p-TEFb 
is kept in an inactive state in the 7SK snRNP complex116-120. Upon UV-irradiation, most 
likely not as a direct effect of DNA damage but via the damage-induced Ca2+/calmodulin 
signaling pathway, p-TEFb is released from its inhibitory complex116,121. It was recently 
shown that a rapid increase of active p-TEFb levels following UV exposure resulted in a 
wave-like release of promoter paused polymerases into productive elongation on almost 
all active genes (figure 4)122. This will increase the likelihood of Pol II encountering a 
lesion, thereby promoting lesion-recognition and initiation of TC-NER. Such a wave-like 
release might also partially explain the loss of promoter bound Pol II directly after UVB 
irradiation as described above113. Interestingly, such a de novo wave-release of Pol II 
into the gene body122 in combination with inhibited transcription initiation111-113 might 
be indicative for a “final” round of transcription to ‘sense’ TBLs and swiftly initiate 
repair. Recently it was suggested that a significant population of lesion-stalled Pol 
II is released from the DNA template during TC-NER123. This suggests that individual 
elongation complexes will not engage in multiple rounds of TC-NER on successive 
lesions and indicates that only the first encountered TBL in a gene will be recognized. 
Such a scenario would result in preferential repair of TBLs close to the transcription 
start site (figure 4). This hypothesis was supported by a meta-analysis of previously 
performed excision repair sequencing (XR-seq) data showing that most TC-NER is 
executed in the beginning of genes122,124. This is an intriguing finding since TBLs 




Preferential repair of the 5’ end of genes might suggest that the genetic information 
encoded in this region is especially important to preserve and might play an important 
role in the DNA damage response. 
The role of gene size in response to DNA damage
The idea that the 5’ end of genes is important is supported by the finding that 
transcription might be spatially restricted to the first 20 to 25 kb of a gene in response 
to UV125. TBL-induced expression of shorter mRNAs is associated with a shift from 
expression of long mRNAs to shorter isoforms, thereby incorporating alternative last 
exons (ALEs) that are located closer to 5’ end of the gene (figure 4). Expression of shorter 
isoforms will therefore result in damage-induced, altered gene expression125. A key 
example of altered gene expression due to switching to short isoforms is the Activating 
Signal Cointegrator 1 Complex Subunit 3 (ASCC3). Following UV-damage, the long ASCC3 
isoform (over 370 kb, 42 exons) is replaced by expression of the short ASCC3 isoform 
(25 kb) which only shares three exons with the long isoform and has a unique terminal 
exon. Interestingly, the long ASCC3 isoform encodes the ASCC3 protein that is involved 
in repression of transcription125,126. In contrast, the short isoform is functioning as a 
non-coding RNA which is essential for proper transcription restart125. These two isoforms 
have opposing effects on transcription and the changed balance upon UV irradiation can 
regulate transcription inhibition and restart. The importance of these shorter transcripts 
following TBL-induction might explain the observed preferential repair near 5’end of 
genes. 
The concept that short genes are less susceptible to DNA damage is more commonly 
observed in the DNA damage response. The human genome consists of over 20.000 
genes which vary greatly in gene size. Assuming that TBLs are genome-wide dispersed in 
a stochastic manner, long genes are more susceptible to gene inactivation due to direct 
stalling of Pol II on a TBL than shorter genes127,128. A higher chance for TBLs in long genes 
compared to short genes, which will be especially relevant under physiologically relevant 
low damage loads, was linked to a shift in gene expression in favor of small genes upon 
DNA damage exposure127,129. Possibly, gene size has been selected during evolution to 
maintain proficient expression of genes that are important for proper cellular responses 
following exposure to transcription-blocking DNA damage129. 
A clear example of a small gene that plays an important role following UV-induced DNA 
damage is the immediate early gene (IEG) activating transcription factor 3 (ATF3)130-133. 
IEGs are in general short genes and their expression can be rapidly induced following 
cellular stress130. In line, also expression of ATF3 is strongly increased following 
UV-induced DNA damage131-133. Upon expression, ATF3 is targeted to CRE/ATF-binding 
sites which are located near promoters of specific genes, thereby inhibiting specifically 
the expression of these genes131,132. Importantly, this ATF3-mediated transcription 
inhibition in trans needs to be resolved to allow proper transcription restart as discussed 
below in the transcription restart section. In addition to ATF3, also BMI1 together with 
the E3 ligase UBR5 was recently shown to repress Pol II elongation and nascent RNA 
synthesis at UV-induced DNA lesions134. Together, the above discussed examples show 
that different factors actively repress transcription in trans following DNA damage, 
either in general or by targeting a specific subset of genes.
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Alternative splicing enhances DNA damage signaling
In addition to the above described selection of alternative last exons, which results in 
expression of smaller mRNAs following TBL induction, also other alternative splicing 
(AS) mechanisms play an important role. Damage-induced effects on splicing can induce 
specific gene expression programs or may contribute to damage-involved signaling. 
AS-induced expression of different isoforms following DNA damage, has thus far been 
attributed to changes either in Pol II elongation rate (kinetic coupling)135,136 or in the 
interaction between Pol II and the core spliceosome or splicing regulators (recruitment 
coupling)104,137,138.
An example of the kinetic coupling model is nicely illustrated by the observed increase 
in phosphorylation of the C-terminal domain (CTD) of Pol II, which slows down 
transcription elongation135. A reduced elongation rate can result in exon inclusion135,136 
or skipping139,140. UV-induced AS is a general mechanism regulating expression of 
many genes, including several genes specifically involved in regulation of survival and 
apoptosis. For example, the ratio between anti-apoptotic Bcl-xL and pro-apoptotic 
Bcl-xS, both isoforms of the Bcl-x gene, is shifted towards the Bcl-xS isoform contributing 
to a higher UV-induced cell death135. Interestingly, it was shown that UV-induced AS 
also happens on non-damaged genes, indicative for an effect in trans on Pol II and 
co-transcriptional splicing135. 
In line with the finding that regulation of AS by kinetic coupling is regulated in trans, 
it was recently shown that ataxia telangiectasia and Rad3-related (ATR) signaling plays 
an important role in UV-induced hyperphosphorylation of the CTD of Pol II141. ATR is 
known to be activated upon UV-irradiation in non-cycling cells, following excision of the 
lesion-containing DNA during the XPF/ERCC1- and XPG-mediated excision step of NER. 
The residual repair-intermediate, containing a 22-35 nucleotide long piece of ssDNA, is 
bound by RPA which is subsequently recognized by ATR interacting protein (ATRIP)/ATR 
complexes thereby triggering ATR signaling74,142,143. Of note, the study on ATR signaling 
used keratinocytes in which the majority of ssDNA intermediates will be generated via 
the much more active GG-NER sub-pathway114. This suggests that stalling of Pol II itself 
may not be the initiating event, but that Pol II is a target of the ATR-induced effect on 
elongation speed141. 
Together these studies show that in addition to direct impediment of the forward 
translocation of elongating Pol II by the lesion13,16-21, the elongation rate of Pol II is also 
affected in trans by ATR. A reduced transcription elongation rate will subsequently lead 
to AS events136, resulting in induction of specific isoforms following DNA damage135,141. 
Whether and how this ATR and DNA damage-induced Pol II hyperphosphorylation is 
different from the canonical hyperphosphorylated (Pol IIO) remains currently unknown. 
Of note, most likely ATR affects Pol II in an indirect manner as there are no target 
sequences known in the CTD for this DNA-damage kinase. Interestingly, in addition to 
reducing Pol II elongation rate, ATR activation may also affect different axillary factors 
involved in AS144-147.
In addition to the above described AS events according to the kinetic coupling model, 




irradiation- or camptothecin-induced TBLs induce co-transcriptional exon skipping of 
for example the MDM2, CHEK2 and MAP4K2 transcripts137,138. This damage-induced 
AS is linked to the loss of interaction between EWS, a member of the TET family of 
RNA and DNA-binding proteins, and its target RNAs137. The loss of interaction between 
these co-transcriptional binding partners might be mediated by the lost interaction 
between EWS and the spliceosome-associated factor YB-1 upon DNA damage138. Also 
in Drosophila cells, camptothecin induces AS which is mediated by ATR activation and 
results in proteasome-mediated degradation of splicing regulator Tra2146. Interestingly, 
in addition to damage-induced AS by targeting splicing regulators, it was recently shown 
that also the core spliceosome is affected following the induction of TBLs. Pol II stalling 
on TBLs promotes chromatin displacement of late-stage spliceosomes104, composed of 
U2, U5 and U6 small nuclear ribonucleoproteins148, and initiate a positive feedback loop 
centered on the signaling kinase ATM. The initial spliceosome displacement results in an 
increased R-loop formation through hybridization of pre-mRNA with template DNA104,149. 
Interestingly, R-loop formation near the TBL leads to a non-canonical activation of 
the protein kinase ATM, which signals to impede core spliceosome organization even 
further, consequently resulting in increased intron retention and altered splicing in a 
genome-wide manner104,150.
Regulation of transcription restart
Even when TBLs are successfully repaired, their induction is expected to remain highly 
cytotoxic if transcription is not properly resumed. Therefore, transcription restart 
is important to assure proper de novo mRNA production and to maintain cellular 
homeostasis85. Transcription restart was thus far mostly assumed to reconvene at the 
lesion where Pol II was stalled, as soon as the TBL is removed by TC-NER25,151. However, 
as discussed above, also a significant part of TBL-induced transcription inhibition is 
caused by effects in trans that have direct consequences for the mode of transcription 
restart. For example, if the TBL-induced block in transcription initiation is reversed111-
113, this will result in transcription restart by new initiation events at the promoter. In 
line with these findings, genome-wide analyses of nascent RNA sequencing data152 
showed that transcription recovery of RNA synthesis occurred as a wave in the 5’-3’ 
direction following UV- or camptothecin-induced TBLs. This indicates that a significant 
part of transcription restarts at the beginning of genes127,128, which could provide time 
for the GG-NER pathway to remove TBLs at the more distal parts of genes before the 
transcription machinery encounters these lesions127. This could result in a smooth 
progression of transcription once restarted. Transcription restart at the promoter might 
be caused by recovery of in trans-mediated transcription initiation blockage but may 
also indicate that transcription does not always resume from the position where it was 
initially stalled (in cis). In line with the latter, it was recently suggested that a significant 
population of lesion-stalled Pol II is released from the DNA template during the TC-NER 
reaction123, indicating that the observed transcription resumption from the 5’ end of 
genes might also be a common mechanism for transcription inhibition in cis. 
Of note, these findings do not exclude that transcription can also be restarted at the 
site of the lesion itself which is in line with several factors suggested to be involved in 
backtracking or 3′-end RNA processing25,107. Furthermore, transcription resumption 
directly at the repaired lesion seems to be the most efficient restart mechanism 
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since the same Pol II complex is able to continue with transcription of the already 
partially synthesized mRNA. 
Factors involved in transcription restart
Thus far, several factors have been suggested to be involved in backtracking of Pol II 
to allow repair. To resume transcription from this backtracked position it is crucial that 
protruding nascent RNA is cleaved so that the 3′ end of the RNA is properly realigned 
with the DNA in the active site of Pol II153. This reaction is mediated by transcription 
factor II S (TFIIS) which is suggested to stimulate the intrinsic 3′–5′ exonuclease activity 
of Pol II21,153-155. TFIIS is recruited in a CSA- and CSB-dependent manner33. The Ccr4-Not 
complex further supports recruitment of TFIIS and enhances its cleaving activity thereby 
suggesting that TFIIS and Ccr4–Not jointly reactivate arrested Pol II156. Absence of TFIIS 
results in significantly decreased, but not completely absent, transcription resumption. 
This can be explained by the fact that remaining intrinsic cleavage activity of Pol II is 
sufficient to cleave the RNA and restart transcription. Even though this restart will 
happen in a less efficient manner, it is most likely sufficient to prevent increased 
UV-sensitivity upon depletion of TFIIS153,157,158. The intrinsic cleavage activity of 
Pol II might also explain the observed differences in the role of TFIIS in transcription 
resumption157,158, but this may also be caused by the presence of the redundant TFIIS 
paralogue TCEA2, which is not solely expressed in the testis as originally described159. In 
addition to its stimulating function on TFIIS, Ccr4-Not was suggested to directly promote 
transcription elongation by binding to the emerging transcript, thereby stimulating Pol 
II to resume transcription after repair of a lesion160. Despite that TFIIS and Ccr4-Not are 
implied in Pol II backtracking to allow resumption of transcription, it cannot be excluded 
that their role in facilitating RNA cleavage of the protruding RNA may also be involved in 
release of Pol II from chromatin following TC-NER initiation123. 
Another factor which was shown to stimulate transcription restart is elongation factor 
ELL which binds to TFIIH via the CDK7 subunit of the CDK-activating kinase (CAK) complex. 
Thus far, the exact function of ELL during transcription restart remains unknown. 
However, it was hypothesized that ELL functions as a docking protein, thereby enabling 
other proteins to bind and stimulate transcription resumption. ELL was shown to be 
specifically involved in transcription resumption since depletion of ELL does not affect 
TC-NER161. This uncoupling of repair and transcription restart might also indicate that 
ELL is involved in transcription restart at the TSS as a consequence of damage-induced 
transcription inhibition in trans161. 
Another important process during transcription restart is resolving ATF3- 
mediated transcription inhibition, which has been shown to affect approximately 5000 
genes131,132. Interestingly, CSB and the CRL4CSA E3 ligase complex, possibly together 
with the E3 ubiquitin ligase Mdm2, were shown to ubiquitylate ATF3131. The subsequent 
proteasomal degradation of ATF3 at CRE/ATF sites relieves the ATF3-mediated transcrip-
tional repression. This finding also suggests that on top of absence of functional TC-NER 
in CSA and CSB-deficient cells, loss of transcription restart might be partially explained 
by maintained transcriptional repression of ATF3-regulated genes and consequently 
contributes to the severe phenotype observed in CS patients131,132. Interestingly, in 




that CSB has an additional function at the promoter. This might be in line earlier with 
observations that CSB is involved in regulating gene expression94.
Chromatin remodeling factors involved in Pol II restart
Histone chaperones and ATP-dependent chromatin remodelers are responsible for 
histone sliding, eviction and insertion to remodel chromatin and facilitate different 
DNA transacting processes. Several remodeling factors were identified to be specifically 
involved in NER-mediated repair162. In addition to their role in repair, several of 
these chromatin involved factors were also shown to play a key role in the restart of 
transcription163,164. For example, nucleosome binding protein HMGN1 and p300 
histone-acetyl transferase were shown to be recruited to the TC-NER complex33. These 
factors are hypothesized to induce sliding of upstream nucleosomes resulting in a more 
open chromatin structure, which might facilitate Pol II backtracking25,165,166.
In addition, the histone chaperones Histone regulator A (HIRA) and Facilitating Chromatin 
Transcription (FACT) were identified to remodel histones following TBL induction, a 
process that was shown to be essential for transcription restart167,168. HIRA is recruited 
to sites of DNA damage where this histone chaperone deposites histone variant H3.3 
near the damage167. Histone 3.3 is normally involved in promoting transcription or 
removing inhibitory factors via specific marks169 and might promote transcription restart 
via this mechanism. The other chaperone, FACT, consists of the SPT16 and SSRP1 subunits 
and was shown to exchange histone H2A and H2B which stimulates Pol II transcription 
along chromatin by destabilizing nucleosomes170. Interestinlgy, only the SPT16 subunit 
of the FACT complex was shown to be important for transcription restart, in line with 
SPT16-dependent accelerated H2A/H2B exchange at the site of damage168. This suggest 
that SPT16 increases plasticity of chromatin via enhanced incorporation of histone 
H2A/H2B171, thereby promoting translocation of Pol II either to enhance repair, reverse 
translocate Pol II from the lesion or restart transcription after repair168. In addition to 
these two histone chaperones, proteins involved in post-translational modifications of 
histones may promote transcriptional restart. For example, the lysine methyltransferase 
DOT1L normally methylates H3K79, a histone mark that regulates transcription172,173. 
DOT1L knock-out cells show increased UV-sensitivity coupled to a deficient recovery of 
transcription restart following TBL induction without affecting TC-NER174. These DOT1L 
effects can be rescued by treatment with Trichostatin A, which relaxes the chromatin 
structure, suggesting that DOT1L promotes transcription initation by opening up 
chromatin of UV-repressed genes and is therefore essential for transcription restart174. 
Interestingly, HIRA and DOT1L are not necessary for transcription restart in response 
to the reversible transcription inhibitor DRB167,174, indicative for a specific regulation 
of transcription restart following removal of TBLs. In line with this additional layer of 
control during the cellular response to TBLs, it was observed that transcription restart 
can be regulated in a gene-specific manner127.
Outlook
The development of new sequencing approaches, including nascent RNA-seq127, XR-seq124 
and ChIP-seq113,122, has resulted in important new insights in the underlying mechanism 
of transcription inhibition in response to UV-induced DNA damage. In addition to the 
direct physical block of Pol II once encountering a TBL (inhibition in cis), accumulating 
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evidence shows that the highly regulated transcription cycle is targeted at different key 
steps to efficiently induce transcription inhibition in a genome-wide manner (inhibition in 
trans). Examples are inhibition of transcription initiation112,113 or induction of immediate 
response genes (IEGs) like ATF3 that inhibit transcription by binding to their response 
elements near promoters131-133. Most likely many more cellular processes that are involved 
in transcription inhibition following TBL induction await their discovery. One of the main 
questions that remains, is why transcripition is inhibited in a genome-wide manner, while 
cells are equiped with a highly efficient TC-NER pathway that can directly resolve lesion-
stalled Pol II. Apparently, additional back-up mechanims are required for proper cell surival 
following DNA damage. It is tempting to speculate that these mechanisms have evolved to 
prevent persistent Pol II stalling, as lesion-stalled Pol II repair intermediates might be more 
toxic for a cell than the actual TBL itself, for example due to the induction of R-loops7,8 or 
transcription-replication collisions6. Importantly, by affecting a specific subset of genes, 
these genome-wide regulatory systems allow cells to regulate transcription of genes 
essential for cells to cope with TBLs. As a consequence, TC-NER activity is focussed on 
repair of these important genes that are not inhibited in trans. 
It has been shown that different types of TBLs have different outcomes on the impedement 
of Pol II in cis15. Therefore, it seems logical that also transcription inhibition in trans could 
be differentially affected depending on the type of damage. In line with this idea, recently 
a rapid accumulation of Pol II near promoters and enhancers was observed following 
oxidative damage175. This is in sharp contrast to rapid release of paused Pol II into 
productive enlongation observed following UV-induced DNA damage122. The differential 
response between these types of DNA damage could be explained by differences in the 
activation mechanisms of these pathways. Some of the in trans effects are induced by 
the initial stalling of Pol II at a lesion, including release of the core spliceosome and 
subsequent ATM activation104. In contrast, UV-induced p-TEFb activation by release 
from its inhibitory complex is a direct consequence of the UV-damage and is thus 
activated independent of transcription122. To obtain a better insight in the biological 
relevance of the mechanism of transcription inhibition, it is important to study whether 
different types of TBLs have different outcomes on transcription inhibition in trans. In 
addition, TBLs may also have strikingly different outcomes in different cell types and 
organs74,176,177. This is clearly illustrated by extreme damage-sensitivity of photoreceptor 
cells in retinas of TC-NER-deficient mice or neurodegeneration in CS patients178,179. These 
differential cellular outcomes to TBLs may be explained by differences in transcription 
levels, replication or activity of DNA-repair pathways. However, also the presence of 
multiple mechanisms to inhibit transcription might explain the differential response and 
sensitivity of different tissues to TBLs.
Improved insights in different modes of transcription inhibition, both in cis and in trans, 
is crucial to understand the molecular mechanism of transcription restart. For example, 
a large contribution of transcription inhibition in trans will most likely result in restart 
from the TSS, while stalling of Pol II in cis might result in transcripiton resumption by 
the same Pol II and RNA molecule that was stalled at the TBL. Even though transcription 
will be restored in both cases, the molecular mechanisms to restart transcription and 
the involved factos will be completely different for restart at the beginning of genes 
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Abstract
Correct transcription is crucial for life. However, DNA damage severely impedes 
elongating RNA Polymerase II (Pol II), causing transcription inhibition and transcrip-
tion-replication conflicts. Cells are equipped with intricate mechanisms to counteract the 
severe consequence of these transcription-blocking lesions (TBLs). However, the exact 
mechanism and factors involved remain largely unknown. Here, using a genome-wide 
CRISPR/cas9 screen, we identified elongation factor ELOF1 as an important new factor 
in the transcription stress response upon DNA damage. We show that ELOF1 has an 
evolutionary conserved role in Transcription-Coupled Nucleotide Excision Repair 
(TC-NER), where it promotes recruitment of the TC-NER factors UVSSA and TFIIH 
to efficiently repair TBLs and resume transcription. Additionally, ELOF1 modulates 
transcription to protect cells from transcription-mediated replication stress, thereby 
preserving genome stability. Thus, ELOF1 protects the transcription machinery from 
DNA damage by two distinct mechanisms.




Faithful transcription is essential for proper cell function. However, transcription is 
continuously threatened by DNA damaging agents, which induce transcription-blocking 
lesions (TBLs) that strongly impede or completely block forward progression of RNA 
polymerase II (Pol II)1,2. Impeded transcription elongation by DNA damage can affect 
transcription fidelity or result in complete absence of newly synthesized mRNA 
transcripts3,4. This can result in severe cellular dysfunction, senescence and cell death, 
consequently contributing to aging5-7. Furthermore, prolonged stalling of Pol II at TBLs 
can form physical road blocks for the replication machinery, thereby giving rise to 
transcription-replication conflicts. These conflicts are detrimental for cells since they can 
lead to genome instability and onset of cancer7-10. Cells are equipped with an intricately 
regulated cellular response to overcome the highly toxic consequences of TBLs. This 
transcription stress response includes repair of TBLs and mechanisms to overcome 
transcription-replication conflicts1,8. 
The main mechanism to remove TBLs is transcription-coupled nucleotide excision repair 
(TC-NER). TC-NER removes a wide spectrum of environmentally or endogenously-in-
duced TBLs, such UV-light-induced lesions or oxidative damage caused by metabolic 
processes1,11. The biological consequences of TBLs and relevance of the TC-NER 
pathway are best illustrated by the fact that inactivating mutations in TC-NER genes can 
cause Cockayne syndrome (CS), which is characterized by photosensitivity, progressive 
neurodegeneration and premature aging12. The TC-NER initiating factor CSB (ERCC6) is 
recruited upon Pol II stalling. CSB uses its forward translocating ability to discriminate 
between lesion-stalled and other forms of paused Pol II13. When lesion-stalled Pol II is 
recognized, TC-NER complex assembly is continued by recruitment of CSA (ERCC8)14-16, 
which is part of a Cullin 4-RING E3 ubiquitin ligase complex (CRL4CSA)17, and UVSSA. 
Interestingly, recently it was shown that also the ubiquitylation of lesion-stalled Pol II 
plays an important role in the transcription stress response18,19. UVSSA subsequently 
promotes the recruitment of TFIIH18,20 which forms the core incision complex with XPA 
and RPA. The incision complex unwinds the DNA, verifies the lesion, and recruits the 
endonucleases ERCC1/XPF and XPG to excise the TBL21. Repair is finalized by refilling and 
ligating the gap22, after which transcription can restart. The repair reaction also resolves 
lesion-stalled Pol II, which helps to lower the frequency of TBL-induced transcription- 
replication conflicts.
Although several key factors have been identified in the cellular response to DNA 
damage-induced transcription stress, the exact molecular mechanism to repair TBLs 
by TC-NER or to avoid collisions of lesion-stalled Pol II with the replication machinery 
remain largely unknown.
Results
To obtain mechanistic insights in the DNA damage-induced transcription stress response, 
we performed a genome-wide CRISPR/Cas9 loss-of-function screen to identify novel 
factors involved in this cellular response. Briefly, fibroblasts were lentivirally transduced 
with an sgRNA library23 at low multiplicity-of-infection (<0.25). The resulting pool of 
gene-edited cells was split into two populations. The control group was mock-treated, 
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while in the other group TBLs were induced by exposure to a daily UV-C dose of 6.8 J/
m2 for 10 consecutive days (Fig. 1A). This UV dose maintained a ~50% cell confluency 
throughout the screen (Suppl. Fig 1A). sgRNA abundance was determined by next 
generation sequencing of PCR-amplified incorporated sgRNAs from the isolated 
genomic DNA of surviving cell pools24. sgRNA counts from UV-exposed cells were 
compared to those from untreated cells and negatively selected genes were identified 
using MAGeCK25 (Fig. 1B, Suppl. Table 1). Gene ontology analysis among the top hits 
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GO biological processes. Top 10 terms of n=49 genes (FDR<0.1)
Pathway description Gene count Adjusted p-value
nucleotide-excision repair 13 out of 112 1.41E-15
cellular response to DNA damage stimulus 22 out of 873 3.12E-14
transcription-coupled nucleotide-excision repair 11 out of 73 4.46E-14
DNA repair 18 out of 563 1.12E-12
response to UV 12 out of 140 1.55E-12
response to radiation 15 out of 447 2.61E-10
cellular response to stress 25 out of 2105 3.11E-09
DNA metabolic process 18 out of 943 7.67E-09
response to light stimulus 12 out of 313 2.36E-08
nucleic acid metabolic process 34 out of 5207 3.02E-07
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(FDR<0.1), identified many genes involved in the UV-induced DNA damage response 
(Fig. 1C). These genes included factors involved in translesion synthesis (TLS), like RAD18 
and POLH26, and many NER genes including the global genome-NER (GG-NER) damage 
sensors DDB2 and XPC21. Especially the identification of key TC-NER factors CSA, CSB and 
UVSSA underscored the potential of this screen to identify factors involved in the DNA 
damage-induced transcription stress response1 (Fig. 1B). 
Interestingly, one of the top hits was Elongation Factor 1 Homolog (ELOF1), an 
 evolutionary-conserved small zinc-finger protein (~10 kDa)27. ELOF1 was identified in 
budding yeast in which disruption of its orthologue, Elf1, was shown to be synthetic 
lethal with mutation of genes encoding elongation factors such as SPT6 and TFIIS28. 
Follow-up studies in yeast revealed that Elf1 interacts with the core Pol II elongation 
complex as shown by proteomics29, Cryo-EM studies30, and by its presence at gene 
bodies as shown by ChIP28,31. In vitro studies showed that Elf1 binds downstream of Pol 
II at the DNA entry tunnel and promotes elongation through nucleosomes32. However, 
its exact function as a transcription elongation factor, especially in mammalian cells, and 
its role in the DNA damage response has thus far remained unknown. 
To validate the sensitivity to UV upon ELOF1 depletion, as determined in our CRISPR/
Cas9 screen, we performed clonogenic survival experiments using two independent 
ELOF1 knockout (KO) cell lines (Suppl. Fig. 1B-F). ELOF1 KO resulted in a severe UV 
hypersensitivity, even slightly higher than observed in TC-NER-deficient CSB KO cells 
(Fig. 1D). Similar results were obtained upon siRNA-mediated depletion of ELOF1 (Fig. 
1E, Suppl. Fig. 1G,H). Re-expression of ELOF1 in ELOF1 KO cells fully rescued their UV 
sensitivity, indicating that the observed effects are specific for ELOF1. Although the 
N-terminal tail of ELOF1 promotes Pol II progression on the nucleosome32, constructs 
without this N-terminal tail could still rescue the UV sensitivity in ELOF1 KO cells 
(Fig. 1F, Suppl. Fig. 1I). However, the conserved zinc-finger domain of ELOF1 was crucial 
for survival upon UV-induced DNA damage. Furthermore, photolyase-mediated reversal 
of UV-induced cyclobutane pyrimidine dimer (CPD) lesions (33) almost completely 
rescued the UV sensitivity of ELOF1 KO cells, showing that this sensitivity is due to 
induction of DNA damage and not RNA or protein damage (Suppl. Fig. 1J). 
	Figure 1. Genome-wide CRISPR/cas9 screen identifies ELOF1 as a novel factor involved in the UV-induced 
DNA damage response. (A) Schematic of the CRISPR/cas9 screen. MRC-5 (SV40) cells infected with a 
lentiviral sgRNA library were mock-treated or irradiated daily with 6.8 J/m2 UV-C for 10 consecutive days. 
sgRNA abundance was determined by sequencing and UV-sensitive genes were identified by comparing 
the abundance in UV-irradiated cells over mock-treated cells. The screen was performed in duplicate. (B) 
UV-sensitive genes were ranked based on the gene-based P-value resulting from MaGecK analysis of the 
change in abundance of sgRNAs in UV-treated over mock-treated. Dotted line indicates FDR=0.1. Genes 
involved in NER or TLS are color-coded. (C) Top 10 enriched GO terms (biological process) identified using 
g:Profiler of UV-sensitive genes with FDR<0.1 (n=49). (D) Relative colony survival of HCT116 wildtype (Wt) 
cells, indicated knock-out cells (-/-) or rescued cells exposed to the indicated doses of UV-C. (E) Relative 
colony survival of MRC-5 cells transfected with indicated siRNAs following exposure to the indicated 
doses of UV-C. (F) Relative colony survival of HCT116 ELOF1 KO cells with expression of the indicated 
ELOF1 mutants following exposure to the indicated doses of UV-C. Zn: zinc-finger mutant, ΔN: deletion of 
N-terminus. Plotted curves represent averages of three independent experiments ± SEM. *P≤0.05.
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We first tested whether ELOF1 is part of the elongating Pol II complex, as previously 
observed for Elf1 in yeast28,29. Since we could not obtain antibodies capable of recognizing 
endogenous ELOF1, we generated homozygous ELOF1-mScarletI-HA knock-in (KI) cells to 
allow detection of endogenously expressed ELOF1 (Suppl. Fig. 2A). In living cells, ELOF1 
was localized strictly to the nucleus, excluded from the nucleoli, and showed high level 
of co-localization with endogenously expressed GFP-tagged RPB133, the largest subunit 
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of Pol II (Fig. 2A and Suppl. Fig. 2B,C). Previous live-cell imaging studies on GFP-RPB1 
mobility showed that fluorescence recovery after photobleaching (FRAP) experiments 
are a sensitive way to study Pol II-mediated transcription, as the different steps of the 
transcription cycle are characterized by kinetically distinct Pol II populations33. Therefore, 
we compared the mobility of ELOF1 to that of Pol II using FRAP, and observed that it 
was almost identical in non-treated conditions (Fig. 2B). The large ELOF1 immobilization, 
which slowly redistributes in time, suggests that the majority of ELOF1 molecules is 
chromatin-bound, most likely engaged in transcription elongation, similar as observed for 
Pol II33. The engagement of ELOF1 in transcription elongation was confirmed by its swift 
chromatin release, as shown by its strong mobilization upon inhibition of transcription 
initiation with the CDK7 inhibitor THZ134, or inhibition of release of promoter-paused Pol 
II into the gene body by the CDK9 inhibitor Flavopiridol35 (Fig 2B). This almost complete 
mobilization upon transcription inhibition suggests that ELOF1 is exclusively involved 
in transcription-related processes. Furthermore, this highly similar dynamic behavior, 
also upon transcription inhibition, suggests that ELOF1 is closely associated with Pol II. 
Interestingly, treatment with the DNA intercalator actinomycin D36 resulted in a severe 
immobilization of Pol II, while ELOF1 was only transiently immobilized. This suggests 
that ELOF1 can still dissociate from actinomycin D-stalled Pol II complexes while RPB1 
remains trapped on the DNA. 
To further investigate whether ELOF1 is part of the elongating Pol II complex we 
immunoprecipitated (IP) ELOF1 and detected its interaction with the RPB1 and RPB3 
subunits of Pol II (Fig. 2C). The interaction of ELOF1 with P-Ser2-modified RPB1, which 
primarily marks productively elongating Pol II, indicates that ELOF1 is present in the 
elongating Pol II complex. The reciprocal IP of P-Ser2-modified Pol II confirmed that 
ELOF1 interacts with elongating Pol II (Suppl. Fig. 2D). Moreover, SILAC-based interaction 
proteomics of endogenously expressed GFP-RPB133 identified ELOF1 as a genuine Pol 
II interactor with similar SILAC ratios as other elongation factors (Suppl. Fig. 2E). To 
obtain a complete overview of ELOF1 protein interactions, we performed SILAC-based 
	Figure 2. ELOF1 is part of the elongating Pol II complex. (A) Co-localization of ELOF1 and Pol II in HCT116 
cells with ELOF1-mScarletI-HA and GFP-RPB1 during live-cell imaging. Scale bar: 10 µm. (B) Fluorescence 
recovery after photobleaching (FRAP) analysis of endogenously expressed ELOF1-mScarletI (Left) and 
GFP-RPB1 (Right). Cells were mock-treated (NT) or inhibited at different steps of the transcription cycle 
using indicated inhibitors. Relative Fluorescence Intensity (RFI) was measured over time, background-cor-
rected, and normalized to pre-bleach fluorescence intensity. n≥20 for ELOF1-KI and n≥8 for RPB1-KI cells. 
(C) Immunoprecipitation of ELOF1 using RFP beads in ELOF1-KI cells followed by immunoblotting for 
indicated proteins. Cells were harvested 1 hour after mock treatment or irradiation with 16 J/m2 UV-C. BC: 
binding control. (D) Interaction heat map of the SILAC ratios of ELOF1-interacting proteins as determined by 
quantitative interaction proteomics following HA-IP of ELOF1. Average SILAC ratios of duplicate experiments 
are plotted and represent ELOF1-interactors relative to empty beads. SILAC ratio >1 indicate increase in 
interaction. * indicates proteins quantified in one experiment. (E) Top panel: Schematic of DRB/TTchem-seq 
to measure Pol II elongation rates. Bottom panel: Metagene profiles of DRB/TTchem-seq in HCT116 Wt or 
indicated KO (-/-) cells, with ELOF1 re-expression where indicated, 10, 20, 30, or 40 minutes after DRB 
release. (F) Average elongation rates as determined by DRB/TTchem-seq. (G) Interaction heat map based on 
the SILAC ratios as determined by quantitative interaction proteomics of P-Ser2-modified Pol II-interacting 
proteins in ELOF1 -/-A cells relative to Wt cells. Average SILAC ratios of duplicate experiments are plotted. 
* indicates proteins quantified in one experiment. SILAC ratios <1 indicate loss of interaction, >1 indicate 
increase in interaction. 
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interaction proteomics for ELOF1, revealing high SILAC ratios for many Pol II subunits 
and elongation factors including TFIIS, SPT6, SPT5 and the PAF complex37,38 (Fig. 2D and 
Suppl. Table 2). Gene ontology analysis of the most enriched ELOF1-interactors showed 
specific involvement in transcription-related processes (Suppl. Fig. 2F). Of note, the 
ELOF1-Pol II interaction did not change upon UV-induced DNA damage, in contrast to 
the interaction with CSB39 (Fig. 2C and Suppl. Fig. 2D). Together, these live-cell imaging 
and interaction data indicated that ELOF1 is an integral component of the transcription 
elongation complex, independent of DNA damage. 
Next, we tested whether ELOF1 acts as a transcription elongation factor by determining 
its effect on Pol II elongation rates. Therefore, we performed DRB/TTchem-seq
40, in 
which nascent RNA is labeled with 4SU to determine the Pol II position in a gene body 
at different time points after its release from the promoter by DRB washout (Fig. 2E). 
Single gene profiles (Suppl. Fig. 3A) and metagene analysis (Fig. 2E) showed that ELOF1 
KO resulted in a clear decrease in elongation rate, while ~6-fold overexpression of ELOF1 
(Suppl. Fig. 1E) resulted in increased elongation rate. Based on metagene analysis, an 
average decrease in elongation speed from 2.6 kb/min to 2.0 kb/min was observed for 
ELOF1 KO cells, while an increase to 3.1 kb/min was observed after ELOF1 overexpression 
(Fig. 2F). In line with this reduced elongation rate, the overall nascent RNA synthesis was 
also reduced upon ELOF1 depletion (Suppl. Fig. 3B-D). In contrast, loss of CSB had no 
obvious effect on Pol II elongation rate. 
To identify the mechanism for the reduction in elongation speed after loss of ELOF1, 
we compared the composition of the elongation complex with and without ELOF1. 
Endogenous P-Ser2-modified Pol II was isolated, and differences in the Pol II interactome 
were detected using SILAC-based proteomics. Absence of ELOF1 did not affect the 
presence of the core Pol II subunits or the majority of elongation factors in the elongation 
complex (Fig. 2G, Suppl. Table 2). For example, presence of the SPT4/5 dimer, which 
interacts genetically and biochemically with yeast ELOF128,32, was not changed in the 
elongation complex. Interestingly, the biggest change in complex composition was found 
for CSA, CSB and TFIIS, each having a 3- to 4-fold increased interaction with Pol II without 
ELOF1 (Fig. 2G). As CSB recognizes stalled and paused Pol II complexes, for example at 
DNA lesions or natural pause sites13, the increase in CSB binding might indicate that the 
forward translocation of Pol II is more frequently perturbed in the absence of ELOF1. 
Such perturbation can induce Pol II backtracking that is recognized by TFIIS to stimulate 
subsequent transcript cleavage41 to allow continued forward translocation. In line with 
such a model, we observed increased TFIIS binding to elongating Pol II in ELOF1 KO cells 
(Fig. 2G). In addition, depletion of TFIIS gave rise to synthetic lethality with ELOF1 KO 
(Suppl. Fig. 3E) as was previously also observed in yeast28.
After having established that ELOF1 is a bona fide elongation factor, we studied its 
role in the DNA damage response. Since ELOF1 was shown to be an integral part of 
the transcription elongation machinery, and ELOF1 KO cells are sensitive for UV-induced 
DNA damage, which is a potent inhibitor of transcription, we tested whether ELOF1 
is needed for recovery of transcription after UV irradiation by quantifying nascent 
transcription levels by EU incorporation42. Transcription was severely reduced 2 hours 
ELOF1 drives TC-NER and prevents genome instability
107
3
after UV damage but fully recovered in Wt cells after 18 hours (Fig. 3A and Suppl. Fig. 
4A). Strikingly, the transcription recovery was completely abolished in ELOF1 KO cells, 
as in TC-NER- deficient CSA KO cells, but could be rescued by re-expression of ELOF1. 
Similar results were obtained using siRNA-mediated ELOF1 knockdown (Suppl. Fig. 4B,C). 
This indicates that ELOF1 either has a function in the removal of TBLs, or in the restart 
of transcription. To distinguish between both possibilities, we measured TC-NER activity 
by quantifying the gap-filling synthesis using EdU incorporation in non-replicating 
GG-NER-deficient cells43. Like CSB depletion, loss of ELOF1 severely inhibited the TC-NER 
activity indicating that ELOF1 has a crucial function in TC-NER (Fig. 3B, Suppl. Fig. 4D-E). 
The function of ELOF1 was restricted to the TC-NER sub-pathway, since the gap-filling 
synthesis in GG-NER-proficient cells was not affected (Fig. 3C, Suppl. Fig. 4F-G). Together, 
this shows that ELOF1 is important for removing UV-induced lesions by TC-NER to 
subsequently promote transcription recovery. 
Next, we tested the sensitivity of ELOF1 KO cells to other types of DNA damage. 
Interestingly, ELOF1 KO, like CSB KO, resulted in a severe sensitivity to a wide spectrum 
of genotoxins that cause TBLs, including Illudin S44, Cisplatin45, Camptothecin46 and 
oxidative lesions47 (Fig. 3D-E and Suppl. Fig. 5A-C). However, ELOF1 KO cells were not 
sensitive to replication stress induced by hydroxyurea (Suppl. Fig. 5D). Importantly, 
sensitivity to TBLs is generally not observed after depletion of elongation factors since 
these were not among the top hits of our CRISPR/Cas9 screen for UV-sensitive genes 
(Suppl. Table 1). In addition, transient knockdown of the core elongation factors SPT4 
and SPT5 did not increase UV sensitivity, although this caused a comparable reduction in 
RNA synthesis, similar as depletion of ELOF1 (Suppl. Fig. 3B-D, 5E). 
As ELOF1 is highly conserved from archaea to mammals27, we tested whether the ELOF1 
orthologues in Saccharomyces cerevisiae and Caenorhabditis elegans are also involved 
in repairing TBLs. Similar to mutations in RAD26, the budding yeast ortholog of CSB, 
inactivation of ELF1 (elf1Δ) had no effect on the UV sensitivity (Suppl. Figure 6A), which 
can be explained by the highly efficient GG-NER machinery in budding yeast48. To 
specifically study the effect of elf1Δ in TC-NER, we tested the effect of its inactivation 
on UV survival in GG-NER-deficient RAD16 mutants (rad16Δ). This showed a clearly 
increased sensitivity to UV for both the elf1Δ and the rad26Δ mutants, suggesting that 
Elf1 is involved in TC-NER (Fig. 3F). 
To determine if the increased UV sensitivity in the elf1Δ mutant is caused by a TC-NER-
defect, we analyzed CPD repair profiles in the transcribed strand (TS) and non-transcribed 
strand (NTS) of yeast genes 2 hours after UV using high-resolution CPD-sequencing49 
(Suppl. Fig. 6B). This analysis showed that in the elf1Δ mutant, GG-NER-mediated repair 
in the NTS was hardly affected. However, TC-NER-mediated repair in the TS was severely 
compromised, as shown by meta-analysis of ~4500 genes (Fig. 3G) and by individual 
genes (Suppl. Fig. 6C). The global repair rate in elf1Δ was hardly affected (Supp. 
Fig. 6D), which is in agreement with a TC-NER-specific effect that only happens in the 
TS of active genes. Although Elf1 was described to stimulate Pol II progression on the 
nucleosome32, no nucleosome-dependent difference in TC-NER efficiency was detected 
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which is involved in transcription processivity at nucleosomes32, had no effect on the 
UV-survival (Fig. 1F). 
Strikingly, the elf1Δ rad26Δ double mutant showed an even higher UV sensitivity than 
the elf1Δ and rad26Δ single mutants in a rad16Δ background, indicating that Elf1 has 
functions in the UV-induced DNA damage response independent of Rad26 (Fig. 3F). 
Close-ups of the CPD sequencing data showed that repair in the elf1∆ mutant is also 
compromised immediately downstream of the transcription start site (TSS) (Fig. 3H). This 
genomic region can be repaired in a Rad26-independent manner50 by a Rpb9-mediated 
transcription-coupled repair mechanism51. This may suggest that Elf1 also functions in 
Rpb9-mediated repair, independent of Rad26 (Fig. 3F). Indeed, elf1∆ enhances the UV 
sensitivity in rad16∆rpb9∆ mutants, but not in a rad16∆rpb9∆rad26 mutant (Fig 3I and 
Suppl Fig. 6F), indicating that Elf1 is involved in both Rad26-dependent and -independent 
repair. This was confirmed by the finding that deletion of ELF1 in both rad16∆rad26∆ 
and rad16∆rpb9∆ mutants resulted in reduced TC-NER (Suppl. Fig. 6G,H).
To study the role of ELOF1 in a multi-cellular model organism, we made use of the 
conservation of ELOF1 in C. elegans. We assayed UV-survival of mutant germ and early 
embryonic cells, which predominantly depends on GG-NER, and of post-mitotic first-stage 
larvae, which mainly depends on TC-NER52. In contrast to inactivation of the GG-NER 
factor xpc-1, did inactivation of elof-1 not increase UV sensitivity of germ and embryonic 
cells (Fig. 3J and Suppl. Fig. 6I). However, elof-1 mutant animals showed a strong UV 
sensitivity in the first larval stage, similar to TC-NER-deficient csb-1 animals (Fig. 3K). 
 Figure 3. ELOF1 is an evolutionary-conserved core TC-NER factor. (A) Transcription restart after UV 
damage as determined by relative EU incorporation in the indicated HCT116 Wt and KO (-/-) cells, with 
ELOF1 re-expression where indicated, at the indicated time points after UV-C (8 J/m2). Relative integrated 
density normalized to mock-treated levels and set to 100%. Red lines indicate average integrated density 
± SEM. n≥300 cells from at least three independent experiments. (B) TC-NER-specific UDS as determined 
by relative EdU incorporation in XP186LV fibroblasts (XP-C) transfected with indicated siRNAs following 
UV-C-irradiation (7 hours, 8 J/m2). n≥100 cells from two independent experiments. (C) Relative levels of 
EdU incorporation in C5RO (hTert) cells transfected with indicated siRNAs, following UV-C-irradiation (3 
hours, 16 J/m2). n≥200 cells from at least two independent experiments (D+E) Relative colony survival of 
the indicated HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where indicated, upon a 24-hour 
exposure to the indicated concentrations of illudinS (D) or Cisplatin (E). Plotted curves represent average 
of at least three independent experiments ± SEM. (F) Indicated mutant yeast strains were serially 10-fold 
diluted, spotted, and exposed to the indicated UV-C doses. (G) CPD-seq analysis of Wt (left) and elf1∆ 
mutant (right) yeast showing the average fraction of unrepaired CPDs remaining on the transcribed strand 
(TS) and non-transcribed strand (NTS) for ~4500 yeast genes following 2-hour repair relative to no repair. 
Each gene was divided in 6 equally-sized bins. Repair in flanking DNA upstream of the transcription start site 
(TSS) and downstream of the transcription termination site (TTS) is also depicted. (H) Close-up of CPD-seq 
repair data near the TSS in Wt (left) and elf1∆ mutant (right) cells. Nucleosome positioning data is shown 
for reference. (I) Indicated mutant yeast strains were serially 10-fold diluted, spotted, and exposed to the 
indicated UV-C doses. (J) C. elegans germ cell and embryo UV survival assay, measuring GG-NER activity, of 
wild type, csb-1, xpc-1, and elof-1 animals. The percentages of hatched eggs (survival) are plotted against 
the applied UV-B doses. The mean survival of two replicate experiments each performed in quintuple is 
depicted. (K) L1 larvae UV survival assay, measuring TC-NER activity, of wildtype, csb-1, xpc-1 and elof-1 
animals. The percentages of animals that developed beyond the L2 stage (survival) are plotted against 
the applied UV-B doses. The mean survival of three replicate experiments each performed in quintuple is 
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Together these data indicate that ELOF1 is an important and highly evolutionary-con-
served repair factor, specifically involved in repair of DNA damage in transcribed strands 
of active genes (Fig. 3). As ELOF1 is an integral part of the elongation complex (Fig. 2), 
its depletion will most likely affect Pol II forward translocation upon encountering TBLs. 
To test this, we used GFP-RPB1 KI cells to study Pol II mobility by FRAP, which provides 
quantitative information on Pol II elongation rates and fraction sizes of elongating and 
promoter-bound Pol II, i.e. initiating and promotor-paused Pol II33. UV-induced DNA 
damage resulted in an increased Pol II immobilization, especially of the long-bound 
fraction, as evident from the reduced slope of the FRAP curve at time points >100 sec 
(Fig. 4A), which mainly represents dynamics of elongating Pol II33. Monte-Carlo-based 
modeling53 of these FRAP data revealed an increase in the fraction size and residence 
time of elongating Pol II. This indicates that UV-exposure resulted in more elongating 
Pol II transcribing with a lower average elongation rate (Fig 4B), most likely caused 
by Pol II-stalling at TBLs54,55. Interestingly, the long-bound Pol II fraction after UV was 
further immobilized upon knockdown of ELOF1, to a similar extent as after depletion of 
CSB. Monte-Carlo-based modeling of these FRAP data showed an approximately 30% 
increase of the average residence time of elongating Pol II, suggesting that Pol II-stalling 
at lesions is prolonged in the absence of ELOF1 (Fig. 4A-B, Suppl. Fig. 7C). Similar results 
were obtained by Pol II ChIP-seq experiments (van der Weegen et al. submitted back-to-
back). ELOF1 knockdown also resulted in an increased residence time of elongating Pol II 
in unperturbed conditions, indicative of a reduced elongation rate (Fig. Suppl. 7A-B), in 
line with our DRB/TTchem-seq data (Fig 2E-F).
Since Pol II elongation was slowed down upon DNA damage induction in the absence 
of ELOF1, we immunoprecipitated elongating Pol II after UV to study whether specific 
 Figure 4. ELOF1 is crucial for proper TC-NER complex assembly. (A) FRAP analysis of Pol II mobility in 
MRC-5 GFP-RPB1 KI cells after depletion of indicated factors in untreated cells (NT) or directly after UV 
induction (UV, 12 J/m2). Relative Fluorescence Intensity (RFI) was measured over time, background-cor-
rected, and normalized to pre-bleach fluorescence intensity. n≥17 cells. (B) Left panel: residence time of 
the elongating Pol II fraction. Right panel: relative fraction sizes of promoter-bound or elongating Pol II as 
determined by Monte-Carlo-based modeling based on the RPB1 mobility shown in (A). (C) Immunoprecipi-
tation of P-Ser2-modified Pol II in Wt and ELOF -/-A cells followed by immunoblotting for indicated proteins. 
Cells were harvested 1 hour after mock treatment or irradiation with 16 J/m2 UV-C. (D) Interaction heat 
map based on the SILAC ratios as determined by quantitative interaction proteomics of UV-specific Pol 
II-interacting proteins in ELOF1 -/-A cells relative to Wt cells. Average SILAC ratios of duplicate experiments 
are plotted. SILAC ratios <1 indicate loss of interaction, >1 indicate increase in interaction. * indicates 
proteins quantified in one experiment. (E) Left panel: Relative immobile fraction of CSB in CSB-mScarletI 
KI cells transfected with indicated siRNAs directly (UV) or 5 hours after UV-C irradiation (5h UV, 4 J/m2) as 
determined by FRAP analysis (Suppl. Fig. S8E). Right panel: Relative fluorescence intensity of CSB-mScarletI 
in CSB-KI cells transfected with indicated siRNAs as determined by live-cell imaging. Plotted values represent 
mean ± SEM and are normalized to mock-treated. n≥9 cells. (F) Immunoprecipitation of P-Ser2-modified Pol 
II in Wt and ELOF -/-A cells 1 hour or 5 hours after UV-C (16 J/m2) irradiation followed by immunoblotting for 
indicated proteins. IgG was used as binding control. *non-specific band. (G) Same as left panel of E but for 
UVSSA-mScarletI KI cells (Suppl. Fig. 8F-G). n≥16 cells. (H) Relative immobile fraction (left panel) or relative 
fluorescence intensity (right panel) of CSB-mScarletI in CSB-KI cells transfected with indicated siRNAs 2 
hours after UV-C irradiation (4 J/m2) as determined by FRAP analysis (Suppl. Fig. 8H). VCPi: treatment with 
VCP inhibitor. Plotted values represent mean ± SEM and are normalized to mock-treated. n≥10 cells. (I) 
Immunoblot of chromatin fraction of indicated HCT116 Wt or ELOF1 KO cells 1 hour after 12 J/m2 UV-C or 
mock treatment. SSRP1 is shown as loading control. 
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reaction steps of TC-NER were compromised. In ELOF1 KO cells, TC-NER initiating 
factors CSA and CSB were still properly bound to lesion-stalled Pol II. However, the 
UV-induced Pol II interaction with TFIIH complex subunits XPD and p62 was strongly 
reduced (Fig. 4C), which was not a consequence of TFIIH degradation (Suppl. Fig. 7D). 
To obtain a more unbiased overview of the effects of ELOF1 KO on the DNA damage-in-
duced Pol II interactome, we performed SILAC-based interaction proteomics on the 
elongation complex after UV-induced DNA damage in presence or absence of ELOF1. 
The interaction of most elongation factors with Pol II was not affected by the absence of 
ELOF1 (Fig.4D and Suppl. Fig.7E). Interestingly, while CSA and CSB could still bind to Pol 
II in the absence of ELOF1, the proteins most affected in their Pol II binding were UVSSA 
and TFIIH subunits. 
Since UVSSA plays a crucial role in the recruitment of TFIIH to lesion-stalled Pol II18,20,56, 
the decreased binding of UVSSA is most likely the cause of reduced TFIIH recruitment, 
and explains the observed TC-NER defects. To confirm these results, we generated 
CSB and UVSSA knock-in cells (Suppl. Fig. 8A,B), expressing mScarletI-tagged CSB and 
UVSSA proteins from their endogenous locus, allowing direct analysis of their quantity 
and mobility in living cells. TBL-induced immobilization of these TC-NER factors, as 
determined by FRAP39,57, is an accurate measure for their involvement in TC-NER, 
as shown by their UV-induced immobilization in a transcription-dependent manner 
(Suppl. Fig. 8C,D). In line with the IP experiments, did ELOF1 depletion not affect the 
CSB immobilization 1 hour after UV. CSB remained immobilized up to at least 5 hours 
after UV (Fig. 4E and Suppl. Fig. 8E). This prolonged binding of CSB to stalled Pol II upon 
UV was confirmed by IP experiments, which also showed prolonged binding of 
CSA (Fig. 4F). These observations are in line with a model in which TBLs cannot be 
removed because of the TC-NER defect caused by ELOF1-deficiency, which will result 
in prolonged binding of CSB and CSA to lesion-stalled Pol II. In contrast, UVSSA immobi-
lization upon UV damage was severely reduced after ELOF1 depletion (Fig. 4G and 
Suppl. Fig. 8F-G), further indicating that ELOF1 plays a crucial role in the recruitment of 
UVSSA to lesion-stalled Pol II. UVSSA recruits the deubiquitylating enzyme USP7, 
which protects CSB from proteasomal degradation mediated by the ubiquitin-selective 
segregase VCP/p9757-59. In line with this, we observed that reduced UVSSA recruitment 
upon ELOF1 depletion, and consequently of USP7, resulted in a UV-induced ~40% 
decrease of overall CSB levels (Fig. 4E) by VCP-mediated proteasomal degradation (Fig. 
4H right panel). Interestingly, FRAP analysis showed an even stronger CSB immobilization 
upon TBL induction and VCP inhibition in ELOF1-depleted cells (Fig. 4H and Suppl. Fig. 
8H), suggesting that chromatin-bound CSB is degraded in the absence of ELOF1, most 
likely when bound to lesion-stalled Pol II. Therefore, the increase in CSB immobilization 
upon UV-exposure confirms that in the absence of ELOF1, a larger Pol II fraction remains 
stalled at the lesion.
Recently, the ubiquitylation of a single lysine mutation in RPB1 (K1268) was described 
to be an important event in the transcription stress response18,19. Therefore, we 
tested whether ELOF1 is involved in the UV-induced ubiquitylation of Pol II by means 
of a slower migrating P-Ser2-modified RPB1 band18. Interestingly, ELOF1 KO almost 
completely abolished the UV-induced RPB1 ubiquitylation (Fig. 4I), to the same extent 
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as CSB KO or inhibiting NEDD8-conjugating enzyme NAE1, which controls the activity of 
CRL complexes18,19 (Suppl. Fig. 8I). Similar results were obtained using siRNA-mediated 
depletion of ELOF1 (Suppl. Fig. 8J). 
Together, our results demonstrate that the presence of ELOF1 in the lesion-stalled Pol 
II complex is an important determinant for proper Pol II ubiquitylation and for correct 
assembly of the TC-NER complex. The observed TC-NER defect explains the severe 
sensitivity of ELOF1 KO cells to different TBLs (Fig. 1D,E, 3D,E and Suppl. Fig. 5A-C). 
Strikingly, while testing the sensitivity of ELOF1 KO cells for a wide spectrum of DNA 
lesions, we observed that ELOF1 KO cells were also sensitive to the DNA crosslinker 
Mitomycin C (MMC) (Fig. 5A). Interestingly, CSB KO cells were not sensitive to MMC 
suggesting that ELOF1 has an additional function in the DNA damage response, besides 
canonical TC-NER. The prolonged transcription block in ELOF1 KO cells upon MMC 
exposure (Suppl. Fig. 9A), which was not observed in CSB KO cells, suggests that this 
additional role for ELOF1 is also linked to transcription. To investigate this additional 
function of ELOF1, we depleted ELOF1 in TC-NER-deficient CSB KO or NER-deficient XPA 
KO cells and strikingly observed that this resulted in increased UV sensitivity (Fig. 5B). 
Interestingly, CSB has also additional functions to ELOF1 in the response to UV-induced 
damage (Suppl. Fig. 9B). The additional role of ELOF1 to TC-NER was further confirmed 
in CS patient cells characterized by inactivating mutations in CSA (CS-A), in which 
knockdown of ELOF1 also resulted in additional UV sensitivity (Fig. 5C). Remarkably, this 
additive effect was completely absent in non-cycling CS-A cells (Fig. 5D), indicating that 
it is dependent on cell proliferation. 
This replication-dependent sensitivity, together with the specific role of ELOF1 in 
transcription (Fig. 2), its additive effect to TC-NER (Fig. 5A and Suppl. Fig. 8A), and the 
prolonged Pol II-stalling upon ELOF1 knockdown (Fig. 4A,B), opened the possibility that 
lesion-stalled Pol II collides with incoming replication forks in the absence of ELOF1, 
thereby causing transcription-replication conflicts. Therefore, we investigated the 
impact of ELOF1 KO on DNA replication by analyzing the progression rates of individual 
replication forks by sequentially labelling cells with CldU and IdU. Tract length analysis 
revealed no significant difference in replication fork progression upon ELOF1 KO in 
unperturbed conditions, indicating that ELOF1 has no role in fork progression (Fig. 5E). 
However, 2 hours after UV, the tract length was significantly decreased in ELOF1 KO cells 
compared to Wt and ELOF1-complemented cells. Also, in CSB KO cells a small effect on 
fork progression was observed, however not to the same extent as in ELOF1 KO cells. 
This suggests that loss of the elongation factor ELOF1 results in replication problems 
upon induction of TBLs, likely due to the transcription-mediated replication blockage. 
Transcription-replication conflicts have previously been shown to result in under- 
replicated DNA, which may cause DSBs upon mitotic progression and subsequently 
give rise to genome instability8,60. In line with this hypothesis, we observed a more 
pronounced increase in 53BP1-foci upon UV irradiation in ELOF1 KO cells compared 
to Wt or CSB KO cells (Fig. 5F, Suppl. Fig. 9C). As replication-interference and under- 
replicated DNA are important drivers of chromosomal aberrations, we assessed this in 
ELOF1 KO cells. This clearly resulted in an increased number of chromosomal aberrations 
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We unveiled an important role for ELOF1 in the cellular response to DNA damage-in-
duced transcription stress by two independent mechanisms: promoting TC-NER and 
reducing transcription-mediated replication hindrance (Fig. 5H). First, ELOF1 is crucial for 
TC-NER. Interestingly, while the interaction of most TC-NER factors with elongating Pol 
II is strongly increased upon DNA damage1,14,39,56-58, ELOF1 is already an intrinsic part 
of the elongating complex in unperturbed conditions where it stimulates transcription 
elongation (Fig. 2). Its dual function as an elongation and repair factor can be the cause 
of the embryonic lethality observed in ELOF1 KO mice61 and may explain why thus far 
no ELOF1 mutations were found in TC-NER related syndromes, something commonly 
observed for other TC-NER factors12. The role of ELOF1 in TC-NER is highly conserved, 
also in yeast in which TC-NER is differently organized. For example, in yeast TBLs can be 
repaired in a Rad26-independent manner50, and no homolog of UVSSA is detected. As 
ELOF1 is an integral part of the elongation complex we speculate that this is the reason 
why ELOF1 is crucial in both Rad26-dependent and -independent repair pathways, since 
its presence in the stalled Pol II complex is not dependent on Rad26.
ELOF1 promoted UVSSA binding to lesion-stalled Pol II, resulting in subsequent TFIIH 
recruitment, which promotes assembly of the full incision complex to excise the TBL and 
restart transcription. In the absence of ELOF1, TC-NER can still be initiated since CSB and 
the CRL4CSA E3 ubiquitin ligase complex are still properly recruited to lesion-stalled Pol II 
(Fig 5H). Interestingly, although UVSSA was previously shown to be incorporated into the 
TC-NER complex through a direct interaction with CSA56,62, we found that in the absence 
of ELOF1, a repair intermediate accumulated that consists of CSA but not of UVSSA. This 
 Figure 5. ELOF1 is important for preventing genome instability in addition to its function in TC-NER. 
(A) Relative colony survival of indicated HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where 
indicated, upon a 1-hour exposure to the indicated concentrations of mitomycin C. Plotted curves 
represent averages of three independent experiments ± SEM. (B) Relative colony survival of MRC-5 Wt or 
indicated KO (-/-) cell lines, transfected with indicated siRNAs following exposure to the indicated doses 
of UV. Plotted curves represent averages of at least two independent experiments ± SEM. *P≤0.05. (C+D) 
Viability of replicating CS-A (SV40, C) or non-replicating primary CS-A cells (hTert, D) following exposure 
to the indicated UV-C doses as determined by AlamarBlue staining. Plotted curves represent averages of 
at least two experiments ± SEM. (E) Top panel: Schematic of experimental conditions for fork progression 
in indicated cell lines labeled with CldU (red) for 15 min followed by IdU (green) for 15 min as indicated. 
Bottom panel: Fork progression measured by tract lengths of CldU (red) in micrometers (μM) is depicted for 
HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where indicated, in untreated conditions (left) or 
2 hours after 4 J/m2 UV-C (right). n≥300 tracts from three independent experiments. (F) Number of 53BP1 
foci in HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where indicated, in untreated conditions or 
the indicated time after UV-C (8 J/m2). Red lines indicate average number of foci ± SEM. n≥200 cells from 
two independent experiments. (G) Left panel: Quantitation of chromosomal aberrations per cell in HCT116 
Wt and ELOF1 -/-A cells 48 or 72 hours after irradiation with 4 J/m2 UV-C or mock treatment (NT). At least 
60 metaphases were analyzed. Right panel: Representative images of metaphase spreads. Arrows indicate 
chromosomal aberrations. (H) Model showing function of ELOF1. Top panel: wildtype conditions: ELOF1 is 
an integral part of the elongation complex and binds near the DNA entry tunnel and ubiquitylation site of Pol 
II to promote TC-NER and subsequent transcription restart. Cells do not have replication problems. Bottom 
panel: in the absence of ELOF1 are CSA and CSB still recruited to lesion-stalled Pol II, however, UVSSA, TFIIH, 
and Pol II ubiquitylation are absent. The incomplete assembly of the TC-NER complex prevents functional 
TC-NER and subsequent transcription restart. In addition, there is an increase in transcription-mediated 
replication stress leading to genome instability. *p≤0.05, **≤0.01, ****p≤0.0001.
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suggests that more control steps are needed to recruit or stably incorporate UVSSA, 
and that this is not only mediated via a direct interaction with CSA, which is in line with 
the previously observed CSA-independent UVSSA recruitment57,63. Such tight regulation 
will control the subsequent TFIIH recruitment and assembly of the incision complex and 
may represent an important proof-reading step that prevents build-up of the incision 
complex on non-lesion stalled Pol II. An example of such a regulatory mechanism is the 
recently discovered TBL-induced ubiquitylation of a single lysine residue (K1268) of Pol 
II, that is crucial for Pol II stability and TFIIH recruitment18,19. Interestingly, based on 
recent structural analysis of the elongation complex in yeast32, the K1268 ubiquitylation 
site is in close proximity of ELOF1 (Suppl. Fig. 10). In the absence of ELOF1, Pol II ubiqui-
tylation is reduced. We hypothesize that ELOF1 might either stimulate this ubiquitylation 
by facilitating a correct orientation of the elongation complex, or is involved in recruiting 
E3 ligases or repair factors that promote Pol II ubiquitylation. As UVSSA was shown to be 
important for the K1268 ubiquitylation18 and its recruitment is promoted by ELOF1, this 
might argue for the latter. 
Our data, together with recent cryo-EM studies, indicate that TC-NER factors embrace 
the complete elongation complex, with CSB binding to upstream DNA extruding from 
Pol II13 and ELOF1 binding to downstream DNA entering Pol II32 (Suppl. Fig. 10). As CSB 
promotes the forward translocation of Pol II, thereby sensing for a TBL13, it is tempting 
to speculate that the presence of ELOF1 at the opposite site of Pol II might promote Pol 
II backtracking upon DNA damage, thereby facilitating repair factors to access the TBL. 
Since TFIIH might be involved in this backtracking process1, this could explain why TFIIH 
recruitment is reduced upon ELOF1 depletion.
In addition to its role in TC-NER, our data show that ELOF1 plays an important role 
in preserving genome stability upon DNA damage, likely by preventing transcription- 
mediated replication stress (Fig. 5). The chromatin binding of the transcription machinery 
and the inability to clear Pol II from the DNA is assumed to play an important role in the 
onset of transcription-replication conflicts8,61,64. Even though CSB and ELOF1 depletion 
had similar effects on the prolonged binding of Pol II upon DNA damage (Fig. 4A), 
only ELOF1 KO resulted in a clear replication defect and increased genome instability 
(Fig. 5E,F). This suggests that Pol II is differently processed in the absence of ELOF1 
compared to what happens in CSB-deficient cells. This is most likely not caused by 
Pol II degradation, as loss of ubiquitylation is observed in the absence of both ELOF1 
and CSB (Fig. 4I and Suppl. Fig. 8J). This implies that ELOF1 either has a function in Pol 
II release upon stalling at a lesion or that, in the absence of ELOF1, Pol II cannot be 
properly released from the DNA by incoming replication forks, resulting in an increase 
in transcription-replication conflicts (Fig. 5H). Together, our results show that ELOF1 is 
an important guardian of elongating Pol II by protecting transcription from the severe 
consequences of TBLs via two mechanisms; stimulating repair and preventing transcrip-
tion-replication conflicts. 




We thank the Optical Imaging Centre and the proteomics center of the Erasmus Medical 
Center for support with microscopes and mass spectrometry analysis. We thank the 
Advanced Sequencing Facility of the Francis Crick Institute’s for technical assistance on 
the DRB/TTchem-seq. 
Funding
This work is part of the Oncode Institute which is partly financed by the Dutch Cancer 
Society and was funded by a grant from the Dutch Cancer Society (KWF grant 10506). This 
work was further funded by the Dutch organization for Scientific Research (NWO-ALW) 
which awarded a VIDI (864.13.004) and VICI (VI.C.182.025) grant to J.A.M. A.R.C. is 
supported by the Dutch Cancer Society (KWF grant 11008). S.L. is funded by the National 
Science Foundation (MCB-1615550). J.J.W. is funded by the National Institute of Environ-
mental Health Sciences (grants R01ES028698, R21ES029655, and R21ES029302). H.L. is 
funded by The Netherlands Organization for Scientific Research (project nr 711.018.007) 
and Cancergenomics.nl. J.Q.S. was supported by the Francis Crick Institute (FCI receives 
funding from Cancer Research UK [FC001166], the UK Medical Research Council 
[FC001166], and the Wellcome Trust [FC001166]) and by a grant from the European 
Research Council (Agreement 693327).
Author contributions
M.E.G. performed the majority of the experiments and generated ELOF1 and CSB KO 
cell lines and ELOF1- and RPB1-KI cell lines. D.Z. generated CSB- and UVSSA-KI cells and 
performed live-cell imaging experiments and the TCR-UDS. K.S., D.A.P., W.G, S.L, and J.J.W. 
performed and supervised all experiments in S.cerevisiae. B.S. and M.E.G. performed 
the CRISPR/cas9 screen, and B.E. and R.B. analyzed and supervised the screen. C.M. 
and A.R.C. performed and supervised the metaphase spread and DNA fiber analysis. 
S.C., R.M., and J.Q.S. performed and supervised the DRB/TTchem-seq. M.v.T. performed 
the alamar blue cell viability assay. M.v.d.W. and H.L. performed and supervised the 
experiments in C. elegans. R.J. provided experimental support. J.L. generated images 
of Pol II structure. B.G. performed Monte-Carlo based-modeling and was supervised 
by A.H.. K.B. and J.A.A.D. performed and supervised mass spectrometry analysis. A.R. 
performed UDS experiments and A.F.T. performed FACS sorting, both supervised by 
W.V.. J.A.M. conceived and supervised the project and together with M.E.G. wrote the 
manuscript with input from all authors.
Competing interests 
Authors declare no competing interests.
Data and materials availability 
All DRB/TTchem-seq data used in this study is available under GEO accession: GSE148844. 
All CPD-seq data is available under GEO accession: GSE149082. Raw mass spectrometry 




Cell lines and cell culture
MRC-5 (SV40) immortalized human lung fibroblast cells and HCT116 colorectal cancer 
cells were cultured in a 1:1 mixture of DMEM (Gibco) and Ham’s F10 (Invitrogen) 
supplemented with 10% fetal calf serum (FCS, Biowest) and 1% penicillin-streptomycin 
in a humidified incubator at 37oC and 5% CO2. C5RO fibroblasts (hTert), CS3BE (CS-A, 
SV40), XP186LV (XPC-/-) and CS216LV (CS-A, hTert) cells were maintained in Ham’s F10 
with 15% FCS and antibiotics. 
For stable isotope labeling of amino acids in culture (SILAC), cells were grown for two weeks 
(>10 cell doublings) in arginine/lysine-free SILAC DMEM (Thermofisher) supplemented 
with 15% dialyzed FCS (Gibco), 1% penicillin-streptomycin, 200 µg/ml proline (Sigma), 
and either 73 μg/mL light [12C6]-lysine and 42 μg/mL [
12C6, 
14N4]-arginine (Sigma) or 
heavy [13C6]-lysine and [
13C6, 
15N4]-arginine (Cambridge Isotope Laboratories).
HCT116 knock-out cells were generated by transiently transfecting HCT116 cells with 
a pLentiCRISPR.v2 plasmid23 containing appropriate sgRNAs. Transfected cells were 
selected using 1 µg/ml puromycin (Invitrogen) for 2 days and single cells were seeded to 
allow expansion. Genotyping of single-cell clones was performed by immunoblotting or 
genomic PCR as indicated. sgRNAs sequences can be found in table 1, see below. 
Table 1. Primers
Name Sequence function Gene
sgRNA1 CACGGTACAAGAGATGACTC sgRNA ELOF1 -/- B ELOF1
sgRNA2 TCGTCTATAAAACAGAGACA sgRNA ELOF1 -/- A ELOF1
sgRNA3 GGGCAGGATGGAGAACAGCG sgRNA ELOF1 -/- A ELOF1
sgRNA4 GGTGATGACGCCTTCACCAA sgRNA ELOF1 -/- A ELOF1
sgRNA5 AATGAGGGAATCCCCCACTC sgRNA CSB -/- CSB
sgRNA6 CACCGGCCAATCAGTAGCGACACAG sgRNA ELOF1 KI ELOF1
sgRNA7 CACCGAATGTTGTTTAGCAGTATTC sgRNA CSB KI CSB
sgRNA8 CACCGCTACGCACTGAACTAGAGAG sgRNA UVSSA KI UVSSA
fw1 GCCTCACTATGTTGCCCAGG Genotype KO ELOF1
rv1 TCCTCTAGGCACACGGTACA Genotype KO ELOF1
fw2 CCCTGGTGCAGGGCCAAAGC Genotype front of KI and complete KI ELOF1
rv2 GGGCCACCGCTTGATTTTTGGC Genotype front of KI ELOF1
fw3 GGTTGACGGCAATTTCGATG Genotype back of KI ELOF1
rv3 GACCCCTGGAATGTCTCTGG Genotype back of KI ELOF1
rv4 CGGCTGTGACAGCCCAGGACC Genotype complete KI ELOF1
fw5 CACCTGCAGGAAGCTTCTGC Genotype front of KI (front, in CSB) CSB
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rv5 CAATCCAAGTATTTTCTCCTTTAGC Genotype CSB KI (reverse, in CSB) CSB
fw6 CACCACAGAACACGATGACC Genotype CSB KI (front, in CSB) CSB
rv6 TCCATGTGCACCTTGAACCG Genotype CSB KI (front, in HR 
template)
CSB
fw7 CATCCGGAGCTTGCAGGATCG Genotype CSB KI (back, in HR 
template)
CSB
rv7 TCTCCTTTAGCTAGCATTATTA Genotype CSB KI (back, in CSB) CSB
fw8 ACGCGGATTTCGGCTCCAAC Genotype UVSSA KI (back, in HR 
template)
UVSSA
rv8 TTCTGCGAGGCCAGACCCAT Genotype UVSSA KI (reverse, in 
UVSSA)
UVSSA
fw9 ATCCTGCTCCCCGGAATGCC Genotype UVSSA KI (front, in UVSSA) UVSSA






















Adaptor PCR Screen 
PCR2
Barcode 1 ACATCG Wt 0J, barcode 1 Screen 
PCR1
Barcode 2 TCAAGT Wt 0J, barcode 2 Screen 
PCR1
Barcode 3 TGGTCA Wt 6.8J, barcode 3 Screen 
PCR1
Barcode 4 AAGCTA Wt 6.8J, barcode 5 Screen 
PCR1
ELOF1 complemented cell lines were generated by lentiviral transduction in ELOF1 -/- 
cells. Therefore, full-length expression constructs with ELOF1-Flag-GFP, or Wt or mutated 
ELOF1-Flag were synthesized (Genscript) and inserted in a pLenti-CMV-puro-DEST 
plasmid65. After transduction, cells were selected with 1 µg/ml puromycin.
HCT116 osTIR1 knock-in (KI) cells66 were generated by transiently transfecting cells with 
an sgRNA-containing pLentiCRISPR.v2 plasmid (sgRNA sequences in table 1, see below) 
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targeting the stop codon of ELOF1, CSB or UVSSA and co-transfecting a homology- 
directed repair template, which included an Auxin-inducible Degron, fluorescent 
mScarletI-tag, HA-tag, hygromycin resistance cassette and homology arms (140 bp for 
ELOF1, 200 bp for CSB and UVSSA, sequence upon request)67. Subsequently, cells were 
seeded in a low density to allow expansion and were kept in presence of 100 µg/ml 
hygromycin for two weeks to select for successful recombination. Single-cell clones were 
genotyped and homozygous KI clones were selected for further analysis. A GFP-RPB1 KI 
was generated in HCT116 Wt or ELOF1-KI cells as previously described by Steurer et al.68. 
MRC-5 GFP-RPB1 KI cells68 expressing CPD-PL-mCherry were generated as described 
previously69.
Genotyping PCR was performed on genomic DNA (isolated using a PureLinkTM Genomic 
DNA Mini Kit according to manufacturer’s protocol) with Phusion (NEB) or taq (Invitrogen) 
polymerases according to manufacturer’s protocol. Primer sequences can be found in 
table 1, see below. If necessary for assessing genomic alterations, PCR fragments were 
sequenced with forward primers and indels were analyzed using TIDE analysis70. 
siRNA transfections were performed 2 or 3 days before each experiment using 
Lipofectamine RNAiMax (Invitrogen) according to manufacturer’s protocol. siRNAs were 
purchased from Dharmacon: siELOF1 #1: 5’-CCGUGUGCCUAGAGGAAUUUU-3’, siELOF1 
#2: 5’- GAAAUCCUGUGAUGUGAAAUU-3’, siCSB: 5’-GCAUGUGUCUUACGAGAUAUU-3’, 
siXPF: M-019946-00, siSPT4: L-012602-00-0005, siSPT5: L-016234-00-0005, siCSA: 
L-011008-00-0005. Knock-down efficiency was determined by immunoblot or RT-qPCR.
For UV-C irradiation, cells were washed with PBS, and placed under a 254 nm germicidal 
UV-C lamp (Philips). Duration of irradiation was controlled with an air-pressured 
shutter connected to a timer and cells were irradiated with doses as indicated. Cells 
were treated with VCP inhibitor (Seleck Chemicals, 5 µM) directly after UV irradiation 
or pre-treated 1 hour before irradiation with proteasome inhibitor MG132 (Enzo, 50 
µM) or NEDD8 E1 Activating Enzyme Inhibitor (NAEi) MLN4924 (R&D systems, 10 µM) 
where indicated. Cell were treated for 1 hour with the following chemicals: Actinomycin 
D (Sigma, 1 µg/ml), Flavopiridol (Sigma, 1 µM), THZ1 (Xcessbio, 2 µM), Mitomycin C 
(Sigma, 10 µg/ml unless indicated differently), or potassium bromate (KBrO3, Sigma). 
Cells were exposed continuously to camptothecin or treated for 24 hours with cisplatin, 
illudin S, or hydroxyurea (all Sigma). Final concentrations of all inhibitors were diluted 
in culture media and cells were washed once with PBS before putting fresh media after 
removing damaging agent when necessary. For ionizing radiation, plates were irradiated 
using an RS320 X-ray cabinet (X-Strahl). For photoreactivation, cells were washed with 
PBS and covered with a thin layer of HBSS (Thermofisher) before exposing them to 
white-light tubes (General Electric Lighting Polylux LX F36W/840) for 10 minutes at 37 
°C69. Mock-treated samples were covered with tinfoil during photo-reactivation.
GeCKO v2 lentiviral library production and transduction
We used the lentiCRISPRv2 human library designed by Shalem et al.71 and obtained from 
Addgene. The sgRNA library was synthesized using array synthesis as previously described71 
and cloned as a pool into the lentiCRISPR transfer plasmid for virus production.
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To produce the pooled lentiviral library, twelve T-225 flasks of HEK293T cells were seeded 
at ~40% confluency the day before transfection. Per flask 10 µg of pVSVg, and 15 µg of 
psPAX2 (Addgene) packaging plasmids and 20 µg of lentiCRISPR plasmid library were 
transfected using Lipofectamine 2000 and Plus reagent (Life Technologies), according 
to manufacturer’s instructions. After 6 hours the medium was changed, and after 60 
hours the medium was collected and centrifuged at 3,000 rpm for 10 minutes at 4 °C to 
pellet cell debris. The supernatant was filtered through a 0.45 µm low protein-binding 
membrane (Millipore Steriflip HV/PVDF). To achieve a 300 times concentration of the 
GeCKO pooled library, the virus was ultracentrifuged (Sorvall) at 24,000 rpm for 2 hours 
at 4 °C and then resuspended overnight at 4 °C in D10 supplemented with 1% BSA. 
Aliquots were stored at –80°C. 
Per condition 20 million MRC-5 cells were transduced at 75% confluency in 145 cm2 
dishes with concentrated lentivirus diluted in 18 ml of culture medium supplemented 
with 12 µg/mL polybrene (Sigma). The virus titer was determined to achieve a multiplicity 
of infection of <0.25. The next day, cells were re-seeded at 25% confluency in culture 
medium containing 2 µg/ml Puromycin. Cells were expanded for 1 week in puromycin- 
containing medium. Culture medium was refreshed every other day. 
Genome-wide CRISPR screen
For UV irradiation or mock treatment 30 million transduced and puromycin-selected 
cells were seeded per condition at 40% confluency in 145 cm2 dishes (2.25 million cells 
per dish) in medium without puromycin. The next day (day 0) dishes were mock-treated 
or irradiated with 6.8 J/m2 UV-C. Control cells (mock-treated) and UV irradiated cells 
were washed with PBS and (mock) irradiated every day for 10 consecutive days. The 
culture medium was refreshed after each irradiation. Mock-treated cells were reseeded 
to 40% confluency when they reached a confluency > 90%. After the last irradiation cells 
were given 24 hours to recover and gDNA was isolated using the Blood & Cell Culture 
DNA Midi Kit (Qiagen) according the manufacturers protocol (DNA content of MRC-5 
cells was estimated at 10 pg per cell, genomic DNA of max 15 million cells was loaded 
per column). The screen was performed in duplicate. 
PCR and next-generation sequencing
Per condition, sgRNA sequences of at least 300 µg of DNA (of ~30 million cells) were 
amplified by PCR (PCR1) using barcoded forward primers to be able to deconvolute 
multiplexed samples after next-generation sequencing (primers and barcodes are 
listed in table 1, see below). PCR1 was performed on 3 µg of gDNA in a total volume of 
50 µl per reaction. Each PCR1 reaction contained 1 U of Phusion Hot Start II Polymerase 
(Thermo Fisher Scientific), 1x reaction buffer, 200 nm of each dNTP, 0.5 µM of both 
forward and reverse primer, and 3% DMSO. The following PCR program was used: initial 
denaturation for 3 minutes at 98°C; 35 cycles of denaturation for 1 sec at 98°C, primer 
annealing for 30 sec at 60°C, extension for 30 sec at 72°C, and final extension of 10 
minutes at 72°C. Individual PCR reaction products were pooled per condition and 2 
µl of pooled PCR product was used for a second PCR (PCR2) using primers containing 
adapters for next-generation sequencing (table 1, see below). The same PCR program 
was used as for PCR1, except that only 15 cycles were applied. 30 µl of PCR2 product was 
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cleaned up to remove primer pairs using the NucleoSpin Gel & PCR clean up kit (Bioké). 
Equal DNA content between conditions was checked by gel electrophoresis and samples 
were equimolarly pooled and subjected to Illumina next-generation sequencing as 
described before24. Mapped read-counts were subsequently used as input for the 
Model-based Analysis of Genome-wide CRISPR-Cas9 Knockout (MAGeCK) analysis 
software package, using version 0.5. For each condition, two biological replicates were 
performed. All conditions were sequenced simultaneously. To determine which genes 
showed a significant negative selection after 10 days of UV treatment, the sequencing 
data were analyzed with the MAGeCK tool25. Gene ontology (GO) term enrichment 
analysis was performed using the g:Profiler website. Genes with a FDR<0.1 were analyzed 
and the top 10 biological processes affected by UV were identified.
Survival assays
For clonogenic survival assay, 200-300 cells were seeded per well in triplicate in a 
6-well plate. The following day, cells were treated with different DNA damaging agents. 
Following treatment, colonies were grown for 7 to 10 days after which they were fixed 
and stained using Coomassie blue (50% methanol, 7% acetic acid and 0.1% coomassie 
blue (all Sigma)). To assess the growth speed of siRNA-transfected cells, 10,000 (HCT116) 
or 20,000 (ELOF1 -/-A) cells were seeded in a 6-well plate and grown for 10 days after 
transfection. Colony numbers were counted using GelCount (Oxford Optronix Ltd.). 
Relative colony number was plotted of at least 2 independent experiments, each 
performed in triplicate. Levels were normalized to mock-treated, set to 100 and plotted 
with SEM. Statistics was performed using independent T-test. 
For AlamarBlue survival assay, siRNA-transfected cells were seeded to confluency 
in presence of 0.5% serum in triplicate in 96-well plates to arrest cells in G0, and UV- 
irradiated after 30 hours. 72 hours after UV irradiation, AlamarBlue® (Invitrogen) was 
added for 4 hours and fluorescence was measured at 570 nm using a SpectraMax iD3 
reader. Data were background corrected and normalized to mock-treated conditions.
RNA isolation, cDNA synthesis and RT-qPCR
To determine ELOF1 expression levels, RNA was isolated using the RNeasy mini kit 
(Qiagen) and cDNA was synthesized using the SuperScriptTM II Reverse Transcriptase 
(Invitrogen), both according to the manufacturer’s protocol. The generated cDNA was 
amplified using 1x taqman assay (ELOF1: Hs00361088_g1, GAPDH: 4333764T, both 
Thermofisher) and 1x taqman gene expression master mix (Thermofisher) by activating 
UNG for 2 minutes at 50°C, activating the polymerase for 10 minute at 95°C, followed by 
40 cycles of 15 seconds of denaturing at 95°C and 1 minute of annealing and extending 
at 60°C in a CFX96 Touch Real-Time PCR Detection System. mRNA expression levels were 
normalized to GAPDH using the 2-ΔΔCt method72.
Cell lysis and immunoblotting
Cells were directly lysed in SDS Page loading buffer (0.125M Tris pH 6.8, 2% SDS, 0.005% 
bromophenol blue, 21% glycerol, 4% β-mercaptoethanol) or, for assessing the chromatin 
fraction, one confluent 9.6 cm2 dish was lysed for 30 minutes at 4°C in buffer containing 
30 mM HEPES pH 7.5, 130 mM NaCl, 1 mM MgCl2, 0.5% Triton X-100, cOmplete
TM 
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EDTA-free protease inhibitors (Roche), Phosphatase inhibitor cocktail 2 (Sigma), 
 N-ethylmaleimide (Sigma), and 50 µM MG132i. Chromatin was pelleted at 15,000 for 10 
minutes at 4°C and washed once. Finally, the chromatin was digested for 30 minutes at 
4°C in presence of 50 U of benzonase (Millipore) before adding SDS Page loading buffer 
and incubating 5 minutes at 95°C. Chromatin fractions or cell lysates were separated on 
4-15% Mini-PROTEAN TGXTM Precast Protein Gels (BioRad). Proteins were transferred 
onto PVDF membranes (0.45µm, Merck Millipore) at 4°C, either 1.5h at 90V with 1x 
transfer buffer (25mM TRIS, 190mM Glycine, 10% methanol) or overnight at 25V in 2x 
transfer buffer (50mM TRIS, 380mM Glycine). Membranes were blocked with 5% BSA 
(Sigma) in PBS-tween (0.05%) and probed with primary antibodies (Table 2, see below). 
Subsequently, membranes were extensively washed with PBS-tween and incubated with 
secondary antibodies coupled to IRDyes (LI-COR, table 3, see below) to visualize proteins 
using an Odyssey CLx infrared scanner (LI-COR). 
Table 2. primary antibodies.
Dilutions
Antibody Host Source WB IF
53BP1 Rb Santa Cruz, sc-22760 N.A. 1/1000
BrdU (CldU) Rat Abcam, ab6326 N.A. 1/500
BrdU (IdU) Ms BD Biosciences, B44, 347580 N.A. 1/100
CSA/ERCC8 Ms Santa Cruz, sc376981 1/250 N.A.
CSB/ERCC6 G Santa Cruz, sc10459 1/500 N.A.
CSB/ERCC6 Rb Antibodies-online, ABIN2855858 1/1000 N.A.
GFP Ms Roche, 14314500 1/1000 N.A.
GFP Rb Abcam, Ab290 1/1000 N.A.
HA R Roche, 11867423001 1/1000 N.A.
Lamin B1 Rb Abcam, 1/1000 N.A.
p62/GTF2H1 Ms Sigma Aldrich, WH0002965M1 1/1000 N.A.
RPB1 (Pol II) Rb Cell signalling, D8L4Y 1/1000 N.A.
RPB3 Rb Abcam, ab138436 1/1000 N.A.
RPB9 Rb Abcam, ab192407 1/500 N.A.
Ser2 R Chromotek, 3E10 1/1000 N.A.
SPT4/SUPT4H1 Rb Cell signalling, D3P2W 1/1000 N.A.
SPT5/SUPT5H Rb Bethyl, A300-869A 1/500 N.A.
SSRP1 Ms Biolegend, 609701 1/1000 N.A.
Tubulin Ms Sigma Aldrich, B512 1/5000 N.A.
XPD Ms Abcam, ab54676 1/1000 N.A.
XPF Ms Santa Cruz, sc-136153 1/500 N.A.
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Table 3. secondary antibodies.
Dilutions
Antibody Host Source WB IRDye
Rabbit goat Sigma, sab4600215 1/10000 770
Rabbit goat Sigma, sab4600200 1/10000 680
Mouse goat Sigma, sab4600199 1/10000 680
Mouse goat Sigma, sab4600214 1/10000 770
Goat donkey Sigma, sab4600375 1/10000 770
Rat goat Sigma, sab4600479 1/10000 770
Antibody Host Source IF AlexaFluor
Rabbit donkey Invitrogen, A21207 1/1000 594
Mouse goat Invitrogen, A11001 1/300 488
Rat donkey Jackson Immuno-Research lab., 
712-166-153
1/150 Cy3
Fluorescence Recovery After Photobleaching (FRAP)
For FRAP, a Leica TCS SP5 microscope (LAS AF software, Leica) equipped with a HCX PL 
APO CS 63x 1.40 NA oil immersion lens (ELOF1, RPB1, CSB) or Leica TCS SP8 microscope 
(LAS AF software, Leica) equipped with a HC PL APO CS2 63x 1.40 NA oil immersion lens 
(UVSSA) was used. Cells were maintained at 37°C and at 5% CO2 during imaging. A narrow 
strip of 512 x 32 pixels (for ELOF1 and RPB1) or 512x16 (for CSB and UVSSA) spanning the 
nucleus was imaged every 400 ms (200 ms for UVSSA during pre-bleach) at 400 Hz using 
a 488 nm laser (RPB1) or 561 nm laser (ELOF1, CSB, UVSSA). 25 (RPB1), 40 (ELOF1), or 5 
(CSB, UVSSA) frames were measured to reach steady state levels before photobleaching 
(1 frame 100% laser power for RPB1 and ELOF1, 2 frames for CSB and UVSSA). After 
photobleaching, the recovery of fluorescence was measured with 600 (ELOF1 and RPB1), 
40 (CSB) or 20 (UVSSA) frames until steady-state was reached. Fluorescence intensity was 
measured inside and outside of the nucleus and recovery was determined by correcting 
for background signal and normalizing the values to the average pre-bleach fluorescence 
intensities. Relative fluorescence intensity levels were calculated using the pre-bleach 
intensities corrected for background. Immobile fractions (Fimm) were calculated using the 
individual and average (indicated by <brackets>) fluorescence intensities after bleaching 
(Ibleach) and fluorescence intensities after recovery from the bleaching (Irecovery): 
𝐹imm= 1 −(𝐼𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦,𝑈𝑉 − < 𝐼𝑏𝑙𝑒𝑎𝑐ℎ >)/(< 𝐼𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦,𝑢𝑛𝑐 > − < 𝐼𝑏𝑙𝑒𝑎𝑐ℎ >)
Experimental FRAP curves of Pol II were simulated using Monte-Carlo-based computa-
tional modeling as described previously68 to determine the residence time of elongating 
Pol II and the fraction size of promoter-bound and elongating Pol II. 




Cells were mock-treated or irradiated with 16 J/m2 UV-C 1 hour prior to cell harvest. Cell 
pellets were prepared from 3 confluent 145 cm2 dishes per condition for IP followed 
by immunoblot or 8 confluent 145 cm2 dishes per condition for mass spectrometry. 
Cells were collected by trypsinization and pelleted in cold PBS using centrifugation for 
5 minutes at 1500 rpm. After one wash with cold PBS, cell pellets were stored at -80°C 
until immunoprecipitation. 
For immunoprecipitation, pellets were thawed on ice and lysed for 20 minutes at 4°C 
in HEPES buffer containing 30 mM HEPES pH 7.6, 1 mM MgCl2, 150 mM NaCl, 0.5% 
NP-40, and 1x cOmpleteTM EDTA-free Protease Inhibitor Cocktail (Roche). Chromatin 
was pelleted by spinning 5 minutes at 10,000 g at 4°C and subsequently incubated for 1 
hour at 4°C in HEPES buffer containing 500 units of Benzonase (Millipore) and 2 µg Pol 
II antibody (ab5095, abcam) or IgG (sc2027, Santacruz) to digest the chromatin. After 1 
hour, the NaCl was increased to 300 mM to inactivate benzonase and antibody-binding 
was continued for another 30 minutes. The undigested fraction was pelleted at 13,200 
rpm for 10 minutes at 4°C and the soluble, antibody-bound fraction was immunopre-
cipitated for 90 minutes at 4°C using 25 µL slurry salmon sperm protein A agarose 
beads (Millipore). Unbound proteins were removed by washing the beads 5 times in 
wash buffer (30 mM HEPES pH 7.6, 150 mM NaCl, 1mM EDTA, 0.5% NP-40, and 0.2x 
cOmpleteTM EDTA-free Protease Inhibitor Cocktail). Bound proteins were eluted in SDS 
page loading buffer and separated on 4-15% Mini-PROTEAN TGXTM Precast Protein Gels 
(BioRad). Samples were processed for immunoblotting or fixed and stained for mass 
spectrometry using Imperial protein stain (Pierce) according to manufacturer’s protocol.
For ELOF1 IP, the same protocol was followed but instead of adding antibody during 
chromatin digestion, precipitation was performed using RFP-Trap® agarose beads 
(Chromotek) and binding control agarose beads (Chromotek).
Cross-linked immunoprecipitation
Cells were mock-treated or irradiated with 16 J/m2 UV-C one hour prior to cell harvest. 
Cell pellets were prepared from 8 confluent 145 cm2 dishes per condition for mass 
spectrometry. MRC-5 GFP-RPB1 KI cells were used for Pol II IP (Flag-beads) and HCT116 
ELOF1-KI cells were used for ELOF1 IP (HA-beads). 
Crosslinked IP was performed as described previously73 with modifications as indicated. 
Cells were cross-linked with 1% paraformaldehyde (PFA) in serum-free DMEM for 7 
minutes with constant shaking before quenching the reaction for 5 minutes with glycine 
(final concentration of 0.125 M). Cells were collected by scraping in PBS with 10% glycerol 
and 1 mM PMSF and pelleted for 15 minutes at maximum speed at 4°C. Consequently, 
chromatin was purified by washing the cell pellets for 30 minutes at 4°C in buffer 1 (50 
mM HEPES, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.25% Trition X-100, 0.5% NP-40, 
10% glycerol), pelleting the cells 10 minutes at 1300 rpm, washing the pellet twice with 
buffer 2 (10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) and finally pelleting 
the chromatin, all at 4°C. Chromatin was sonicated in RIPA buffer (10 mM Tris pH 7.5, 
150 mM NaCl, 5 mM EDTA, 0.1% SDS, 1% Sodium Deoxycholate and 0.5 mM EGTA) using 
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the Bioruptor Sonicator (Diagenode) with 14 cycles of 15s on/15s off using the highest 
amplitude. Extracted chromatin was collected by spinning 15 minutes at maximum 
speed and pre-cleared for 30 minutes with Protein G agarose beads (Pierce) at 4°C. IP 
was performed by incubating 4 hours at 4°C with Flag M2 agarose beads (Sigma). Finally, 
aspecific interactors were removed by washing five times with RIPA buffer and proteins 
were eluted and crosslinking was reversed by incubating 30 minutes at 95°C in SDS Page 
loading buffer. Samples were separated on 4-15% Mini-PROTEAN TGXTM Precast Protein 
Gels (BioRad) and fixed and stained using imperial protein stain in preparation of mass 
spectrometry. To all buffers, 1 mM PMSF, 0.5 mM Na2VO4, 5 mM NaF, 5 mM NaPPi, 10 
mM β-glycerol and cOmpleteTM EDTA-free Protease Inhibitor Cocktail were added. 
For ELOF1 IP, the same protocol was followed with minor alterations. Cells were 
crosslinked in 1 mM dithiobis(succinimidyl propionate) (DSP) in PBS for 30 minutes and 
quenched by adding Tris pH 7.5 to a final concentration of 25 mM for 10 minutes. IP was 
performed using HA-agarose beads (Sigma) and beads were incubated for 5 minutes at 
95°C to elute and reverse cross-linked immunocomplexes. 
Mass spectrometry
SDS-PAGE gel lanes were cut into slices and subjected to in-gel reduction with dithioth-
reitol (Sigma, D8255), alkylation with iodoacetamide (Sigma, I6125) and digestion with 
trypsin (sequencing grade; Promega) as previously described57. Nanoflow liquid chroma-
tography tandem mass spectrometry (nLC-MS/MS) was performed on an EASY-nLC 
1200 coupled to a Lumos Tribid Orbitrap mass spectrometer (ThermoFisher Scientific) 
operating in positive mode. Peptide mixtures were trapped on a 2 cm x 100 μm Pepmap 
C18 column (Thermo Fisher 164564) and then separated on an in-house packed 50 cm 
x 75 μm capillary column with 1.9 μm Reprosil-Pur C18 beads (Dr. Maisch) at a flowrate 
of 250 nL/min, using a linear gradient of 0–32% acetonitrile (in 0.1% formic acid) during 
90 min. The eluate was directly sprayed into the electrospray ionization (ESI) source of 
the mass spectrometer. Spectra were acquired in continuum mode; fragmentation of 
the peptides was performed in data-dependent mode by HCD. Mass spectrometry data 
were analyzed using the MaxQuant software (version 1.6.3.3). The false discovery rate 
(FDR) of both PSM and protein was set to 0.01 and the minimum ratio count was set 
to 1. The Andromeda search engine was used to search the MS/MS spectra against the 
UniProt database (taxonomy: Homo sapiens, release June 2017), concatenated with the 
reversed versions of all sequences. A maximum of two missed cleavages was allowed. 
In case the identified peptides of two proteins were the same or the identified peptides 
of one protein included all peptides of another protein, these proteins were combined 
by MaxQuant and reported as one protein group. Before further analysis, known 
contaminants and reverse hits were removed. Gene ontology (GO) term enrichment 
analysis was performed using the g:Profiler website. Genes with an average SILAC ratio 
of >2.5 were analyzed and the top 10 biological processes affected by UV were identified.
DRB/TTchem-seq method
The DRB/TTchem-seq was carried out as described in Gregersen et al.
40 in two biological 
replicates. Briefly, 8 × 106 cells were incubated in 100 µM DRB (Sigma-Aldrich) for 
3.5 hours. The cells were then washed twice in PBS and fresh, DRB-free medium was 
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added to restart transcription. The RNA was labelled in vivo with 1 mM 4SU (Glentham 
Life Sciences) for 10 minutes prior to the addition of TRIzol (Thermo Fisher Scientific), 
which was used to stop the reaction at the desired time point. Following extraction, 
100 µg of RNA was spiked-in with 1 µg 4-thiouracile labelled S. cerevisiae RNA (strain 
BY4741, MATa, his3D1, leu2D0, met15D0, ura3D0), and then fragmented with NaOH 
and biotinylated with MTSEA biotin-XXlinker (Biotium). The biotinylated RNA was then 
purified using µMACS Streptavidine MicroBeads (Miltenyi Biotec) and used for library 
preparation. The libraries were amplified using the KAPA RNA HyperPrep kit (Roche) 
with modifications as described in19.The fragmentation step was omitted and the RNA, 
resuspended in FPE Buffer, was denatured at 65°C for 5 min. Two SPRI bead purifica-
tions were carried out, with a bead-to-sample volume ratio of 0.95x and 1x, respectively. 
The libraries were then sequenced with single end 75bp reads on the Hiseq4000, with 
~50,000,000 reads per sample.
Computational Analysis
DRB/TTchem-seq data were processed using previously published protocol
40. Briefly, 
reads were aligned to human GRCh38 Ensembl 86. Read depth coverage was normalized 
to account for differences between samples using a scale factor derived from a yeast 
spike-in aligned and counted against Saccharomyces cerevisiae R64-1-1 Ensembl 
86.74Biological replicate alignments were combined for the purpose of visualization and 
wave-peak analysis in order to increase read-depth coverage.
A set of non-overlapping protein-coding genes (200kb+) were selected for wave-peak 
analysis. A meta-gene profile was calculated by taking a trimmed mean of each basepairs 
coverage in the region -2kb:+200kb around the TSS. This was further smoothened 
using a spline. Wave peaks were called at the maximum points on the spline, with the 
stipulation that the peak must advance with time before being subjected to manual 
review. Elongation rates (kb/min) were calculated by fitting a linear model to the wave 
peak positions as a function of time.
EU incorporation
Cells were grown on coverslips and transcription levels were measured by pulse labeling 
with 5’ethynyl uridine (EU, Jena Bioscience) in Ham’s F10 medium supplemented with 
10% dialyzed FCS and 20 mM HEPES buffer (both Gibco). Cells were labeled for 30 minutes 
using 400 µM EU (MRC-5 cells) or for 1 hour with 200 µM EU (HCT116 cells) before 
fixation with 3.7% formaldehyde (FA, Sigma) in PBS for 15 minutes at room temperature 
(RT). After permeabilisation with 0.1% Triton X-100 in PBS for 10 minutes and blocking in 
1.5% BSA in PBS for 10 minutes, Click-it chemistry-based azide coupling was performed by 
incubation for 1 hour with 60 µM Atto594 Azide (Attotec, Germany) in 50 mM Tris buffer 
(pH 8) with 4 mM CuSO4 (Sigma), and 10 mM freshly prepared ascorbic acid (Sigma). 
DAPI (Brunschwieg Chemie) was added to visualize the nuclei. Coverslips were washed 
with 0.1% Triton in PBS and PBS only and mounted with Aqua-Poly/Mount (Polysciences). 
Cells were imaged with a Zeiss LSM 700 Axio Imager Z2 upright microscope equipped 
with a 40x Plan-apochromat 1.3 NA oil immersion lens or 63x Plan-apochromat 1.4 NA 
oil immersion lens (Carl Zeiss Micro Imaging Inc.). Integrated density of the EU signal 
in the nuclei was quantified using ImageJ. Therefore, the surface of each nucleus was 
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determined based on the DAPI signal and mean fluorescence intensity was determined, 
corrected for the background signal. With these values, the integrated density was 
calculated, and plotted as single cell point with the average and SEM.
For assessing recovery of transcription after UV, cells were mock-treated or irradiated 
with 8 J/m2 UV-C 2 or 18 hours before EU incorporation. For recovery after mitomycin C, 
cells were mock-treated or incubated for 2 hours with 10 µg/ml Mitomycin C followed by 
a recovery period of 2 or 22 hours in normal medium. Integrated density was normalized 
to mock-treated. 
TC-NER-specific UDS
Amplified UDS was performed as described previously43. Briefly, siRNA transfected 
primary XP186LV (XP-C patient cells) were serum-deprived for at least 24 hours in Ham’s 
F10 (Lonza) containing 0.5% FCS and antibiotics to arrest cells in G0. Cells were irradiated 
using 8 J/m2 UV and labelled for 7 hours with 20 µM 5-Ethynyl-2´-deoxyuridin (EdU) 
and 1 µM Floxouridine (Sigma). Subsequently, a 15-minute chase was performed with 
normal medium (0.5% FCS) supplemented with 10 µM thymidine (Sigma) to remove 
unincorporated EdU and cells were fixed and permeabilized with 3.7% FA and 0.5% 
Triton X-100 for 15 minutes. After permeabilizing the cells for 20 minutes with 0.5% 
Trition in PBS and washing with 3% BSA in PBS, endogenous peroxidase activity was 
quenched using 2% hydrogen peroxide (Sigma) for 15 minutes and incubated with PBS+ 
(0.5% BSA + 0.15 % glycine). Click-it chemistry was performed using the Click-it reaction 
cocktail containing Azide-PEG3-Biotin Conjugate (20 μM, Jena Bioscience), 1× Click-it 
reaction buffer (ThermoFisher Scientific), copper(III) sulfate (0.1 M) and 10× reaction 
buffer additive (ThermoFisher Scientific) for 1 hour and washed with PBS. To amplify the 
signal, coverslips were incubated for 1 hour using HRP-streptavidin conjugate (500 μg/
ml), followed by PBS washes and a 10-minute incubation with Alexa-Fluor 488 labeled 
tyramide (100x stock, Thermofisher Scientific). Coverslips were washed with PBS and 
PBS+ and the nuclei were stained with DAPI in 0.1% triton. DAPI was washed away with 
0.1% triton and slides were mounted using Aqua-Poly/Mount.
Unscheduled DNA Synthesis (UDS) 
Cells were grown to confluency on coverslips and serum-deprived (0.5%) for 2 days 
to arrest cells in G0. Cells were irradiated with 16 J/m
2 and labeled with 20 µM EdU 
(Invitrogen) in Ham’s F10 supplemented with 10% dialyzed FCS and 20 mM HEPES buffer 
(both Gibco) for 3 hours before fixation for 15 minutes (3.7% FA and 0.5% triton X-100). 
Background signal was blocked by washing twice with 3% BSA in PBS for 10 minutes and 
nuclei were permeabilized for 20 minutes using 0.5% triton in PBS. EdU incorporation was 
visualized using Click-it chemistry, imaged and analyzed as described in the section EU 
incorporation with the adjustment that click-it reaction was performed for 30 minutes. 
Yeast strains
Yeast deletion strains used in this study are derivatives of the wild type strain BY4741 
(MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and Y452 (MATα, ura3-52, his3–1, leu2-3, 
leu2-112, cir°). The gene deletions were made by transformation of yeast cells with PCR 
products bracketing selection markers75 or following published methods76. 
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Yeast UV sensitivity assay
Yeast cells were grown in YPD medium to mid-log phase. For spotting assay, cells were 
serially 10-fold diluted in fresh YPD medium and spotted on YPD plates. After exposure 
to different doses of UV-C light (254 nm), plates were incubated at 30°C in the dark 
and images were taken after 3-5 days of incubation. For quantitative UV survival assay, 
diluted yeast cells were plated on YPD plates and exposed to the indicated UV doses. The 
number of colonies on each plate was counted after incubating for 3 days at 30°C in the 
dark. The survival graph depicts the mean and SEM of three independent experiments. 
CPD-seq library preparation and sequencing
CPD-seq analysis of repair in Wt and elf1∆ mutant strains was performed as previously 
described49. Briefly, yeast cells were grown to mid-log phase, pelleted, re-suspended 
in dH2O, and irradiated with 125 J/m
2 UV-C light (254 nm). After UV treatment, cells 
were incubated in the dark in pre-warmed, fresh YPD medium for repair. Cells were 
collected before UV irradiation (No UV), immediately after UV (0 hours), and following a 
2-hour repair incubation. The cells were pelleted and stored at -80°C until genomic DNA 
isolation. 
Genomic DNA extraction, CPD-seq library preparation and quality control, sequencing 
with an Ion Proton sequencer, and data processing were performed as previously 
described49. The resulting sequencing reads were aligned to the yeast genome (saccer3) 
using Bowtie 277. Only CPD-seq reads associated with lesions at dipyrimidine sequences 
(i.e., TT, TC, CT, CC) were retained for further analysis. 
Bin analysis for CPD repair along the transcribed strand (TS) and non-transcribed strand 
(NTS) of ~4500 yeast genes was performed as previously described78, using transcription 
start site (TSS) and polyadenylation site (PAS, also referred to as transcription termination 
site, TTS) coordinates from Park et al.79. A similar gene bin analysis was displayed for each 
yeast gene using the Java Treeview program80,81. Genes were sorted by transcription 
rate82. Single nucleotide resolution repair analysis adjacent to the TSS was performed 
as previously described78,83. Nucleosome dyad coverage from MNase-seq experiments 
were obtained from Weiner et al.,84 as reference. CPD-seq data for elf1∆ and Wt yeast 
was normalized using the fraction of CPDs remaining determined for bulk genomic DNA 
by T4 endonuclease V digestion and alkaline gel electrophoresis (see below).
Analysis of bulk CPD repair in UV irradiated yeast 
Alkaline gel electrophoresis to assay global DNA repair of bulk DNA was conducted as 
previously described85. Yeast cell cultures were grown to mid-log phase in YPD media. 
Yeast cell cultures were briefly centrifuged to pellet, resuspended in dH2O, and exposed 
to 100 J/m2 UV-C light or left unirradiated for the “No UV” sample. Following irradiation, 
yeast cells were resuspended in YPD and incubated at 30C̊. Aliquots were taken at each 
repair time point, briefly centrifuging to discard media supernatant prior to storing yeast 
cells at -80C̊. Genomic DNA was isolated by bead beating the yeast cell pellets in 250 µL 
lysis buffer (2% Triton-X 100, 1% SDS, 100 mM NaCl, 10 mM Tris-Cl pH 8, 1 mM Na2EDTA) 
and 300 µL Phenol-Chloroform-Isoamyl alcohol (25:24:1). 300 µL TE pH 8 was added to 
each tube, briefly vortexing to mix. Samples were centrifuged and the DNA-containing 
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aqueous layer was transferred to a fresh tube for ethanol precipitation. DNA pellets 
were resuspended in TE pH 8 containing 0.2 mg/mL RNase A, incubating at 37C̊ for 15 
minutes prior to enzymatic digestion. Equal amounts of DNA were then treated with 
T4 endonuclease V (T4 PDG; NEB) and resolved by electrophoresis on a 1.2% alkaline 
agarose gel. Following neutralization and staining with SYBR Gold (Invitrogen), alkaline 
gels were imaged using the Typhoon FLA 7000 (GE Healthcare) and analyzed using 
ImageQuant TL 8.2 (GE Healthcare). The number of CPD lesions per kb was estimated 
using the ensemble average pixel density of each lane, corrected by the no enzyme 
control lane. Percent repair was calculated by normalizing the number of CPDs per kb to 
the no repair time point. Graphs represent the mean and SEM of at least 3 independent 
experiments.
Repair analysis of UV induced CPDs in RPB2 locus
Yeast cells were grown in synthetic dextrose (SD) medium at 30°C to late log phase 
(A600 ≈ 1.0), irradiated with 120 J/m
2 of UV-C and incubated in YPD medium at 30°C in 
the dark. At different times of the repair incubation, aliquots were removed, and the 
genomic DNA was isolated. To map the induction and repair of UV-induced CPDs at the 
nucleotide resolution in a specific gene, libraries of DNA fragments adjoining the lesions 
were created by using the LAF-Seq (Lesion-Adjoining Fragment Sequencing) strategy86 
with some modifications. Briefly, the isolated genomic DNA was restricted with HincII and 
NruI to release a 553 bp RPB2 gene fragment (168 bp upstream and 385 bp downstream 
of the transcription start site) and incised at the CPDs with T4 endonuclease V and 
treated E. coli endonuclease IV (New England Biolabs). The 3’ ends of the restricted 
and CPD-incised DNA fragments were ligated to Illumina sequencing adapters by using 
Circligase (Lucigen). After PCR amplification, the libraries were sequenced by using an 
Illumina HiSeq platform. 
The sequencing reads were aligned to the RPB2 gene by using Bowtie 277. The numbers 
of reads from the UV-irradiated samples were normalized to those from the control 
(unirradiated) samples. Reads corresponding to CPDs at individual sites along the 
RPB2 gene fragment were counted after subtraction of the background counts (in the 
unirradiated samples) by using codes in R. To more directly ‘visualize’ the CPD induction 
and repair profiles, images with band intensities corresponding to counts of aligned 
sequencing reads were created by using codes in R and MATLAB.
C. elegans strains and UV sensitivity assays
C. elegans strains were cultured according to standard methods and outcrossed 
against Bristol N2, which was used as wild type. Mutant alleles were xpc-1(tm3886), 
csb-1(ok2335), and elof-1(emc203). The loss of function elof-1(emc203) (Suppl. Fig. 6I) 
mutant strain was generated by injection of Cas9 protein together with tracrRNA and two 
crRNAs targeting elof-1 (CAGTTGAATTGGGTGTCGAG and AGACGTCGATTGGCTCGGAG; 
Integrated DNA Technologies). Deletion animals were selected by genotyping PCR and 
sequencing. UV survival experiments were performed as described previously52. Animals 
were irradiated at the indicated dose using two Philips TL-12 (40W) tubes emitting UV-B 
light. Briefly, ‘germ cell and embryo UV survival’ was determined by allowing UV-irra-
diated staged young adults to lay eggs on plates for 3 hours. To calculate the survival 
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percentage, the total number of hatched and unhatched eggs was counted after 24 
hours. For the ‘L1 larvae UV survival’, staged L1 larvae were UV irradiated and grown 
for 48 hours. Survival percentage was calculated by counting surviving animals that 
developed beyond the L2 stage and arrested animals as L1/L2 larvae.
Metaphase spreads and chromosomal aberrations
Metaphase spreads were carried out as described previously87. Briefly, cells were 
irradiated with 4 J/m2 or mock-treated 48 or 72 hours before preparing metaphase 
spreads (final confluence of 50-80%). Cells were arrested at metaphase by incubating with 
colcemid (N-methyl-N-deacetyl-colchicine, Roche, 10295892001) for the last 14 hours 
before harvesting the cells. Collected cells were treated with hypotonic solution (KCl 
0.075 M) for 30 minutes at 37 °C and fixed with methanol:acetic acid 3:1. Telomere-FISH 
was further carried out to study chromosomal aberrations. Metaphases were hybridized 
with telomere-repeat specific peptide nucleic acid (PNA) probes (Applied Biosystems) as 
described to label telomeres88. A minimum 60 metaphase images were obtained using 
Carl Zeiss Axio Imager D2 microscope using 63x Plan Apo 1.4 NA oil immersion objective 
and analyzed with ImageJ software for chromosomal aberrations. 
DNA fiber analysis
DNA fiber analysis was carried out as described previously87,89. Briefly, cells were 
sequentially pulse-labeled with 30 μM CldU (c6891, Sigma-Aldrich) and 250 μM IdU 
(I0050000, European Pharmacopoeia) for 15 min. For assessing fork progression after 
DNA damage, cells were irradiated with 4 J/m2 UV and incubated for 2 hours before 
pulse-labeling. After labeling, cells were collected and resuspended in PBS at 2.5 × 105 
cells per ml. The labeled cells were mixed 1:1 with unlabeled cells, and 2.5 µl of cells was 
added to 7.5 µl of lysis buffer (200 mM Tris-HCl, pH 7.5, 50 mM EDTA, and 0.5% (w/v) 
SDS) on a glass slide. After 8 min, the slides were tilted at 15–45°, and the resulting 
DNA spreads were air dried, fixed in 3:1 methanol/acetic acid overnight at 4 °C. The 
fibers were denatured with 2.5 M HCl for 1 hour, washed with PBS and blocked with 
0.2% Tween-20 in 1% BSA/PBS for 40 min. The newly replicated CldU and IdU tracks were 
incubated (for 2.5 hours in the dark, at RT with anti-BrdU antibodies recognizing CldU and 
IdU (Table 2, see below), followed by a 1-hour incubation with secondary antibodies at 
RT in the dark: anti–mouse Alexa Fluor 488 and anti–rat Cy3 (Table 3, see below). Fibers 
were visualized and imaged by Carl Zeiss Axio Imager D2 microscope using 63X Plan 
Apo 1.4 NA oil immersion objective. Data analysis was carried out with ImageJ software. 
A one-way ANOVA was applied for statistical analysis using the GraphPad Prism Software.
Immunofluorescence 
Immunofluorescence was carried out as described previously90. Cells were grown on 
24-mm glass coverslips and mock-treated or irradiated with 8 J/m2 48, 24 or 6 hours 
prior to fixation for 15 minutes in PBS with 3.7% FA. Subsequently, cells were permea-
bilized with 0.1% Triton X-100 in PBS and washed with PBS+ (0.15% BSA and 0.15% 
glycine in PBS). Cells were incubated for 2 hours at RT with rabbit anti-53BP1 antibody 
(table 2, see below) in PBS+. Thereafter, cells were washed with PBS+, 0.1% Triton and 
PBS+ before incubating 2 hours at RT with donkey anti-rabbit Alexa Fluor 594 conjugated 
antibody (table 3, see below) and DAPI. After washes with PBS+ and 0.1% Triton, 
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coverslips were mounted with Aqua-Poly/Mount. Images were acquired with a Zeiss 
LSM700 Axio Imager Z2 upright microscope equipped with a 63x Plan-apochromat 1.4 
NA oil immersion lens (Carl Zeiss Micro Imaging Inc.). Number of foci per nucleus was 
counted by using ImageJ.
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Allele 1: 181 GGACCGTG  - - - - - - - - - - - - - - - - - - - - - - - - - TA - - - - - - - - - - - - - - - - - - - - - - - - - - CCCATAAC 249 25bp + 26bp deletion
Wildtype: 181 GGACCGTGCCCGCAACACCGGAGTCATCTCTTGTACCGTGTGCCTAGAGGAATTCCAGACGCCCATAAC 249
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 Supplemental figure 1. (A) Brightfield images of MRC-5 cells irradiated with indicated doses of UV-C for 10 
consecutive days. Images were taken every other day. (B) Schematic of the genomic ELOF1 locus. Scissors 
indicate target regions of the sgRNAs used to generated ELOF1 KO (-/-) cells, half arrows indicate primers 
used for genotyping as shown in (C). (C+D) Genotyping of ELOF1 KO (-/-) cells, both originating from a single 
cell clone. (C) Genotyping PCR of loss of exon 2 in ELOF1 -/-A cells. (D) Top panel: Sequencing results showing 
frameshift mutations in the targeted genomic locus of ELOF1 -/-B. Bottom panel: Amino acid sequence of 
ELOF1 in ELOF1 -/-B cells. (E) Relative ELOF1 levels in indicated HCT116 Wt and ELOF1 KO (-/-) cells, with 
ELOF1 re-expression where indicated, as determined by RT-qPCR. Relative ELOF1 mRNA expression was 
normalized to GAPDH signal and levels in Wt cells were set to 1. Error bars indicate SEM. (F) Immunoblot of 
indicated HCT116 cell lines showing CSB or ELOF1-GFP expression. Tubulin was used as loading control. (G) 
Relative ELOF1 levels in HCT116 cells transfected with indicated siRNAs as determined by RT-qPCR. Relative 
ELOF1 expression was normalized to GAPDH signal and siCTRL levels were set to 1. Error bars indicate SEM. 
(H) Immunoblot showing endogenous ELOF1 and XPF levels in ELOF1-mScarletI-HA KI cells (suppl. fig. 2A) 
transfected with indicated siRNAs. Tubulin was used as loading control. (I) Immunoblot showing expression 
of Flag-tagged Wt or indicated ELOF1 mutants in HCT116 ELOF1 -/-A cells. (J) Relative colony survival of CPD 
photolyase cells transfected with indicated siRNAs. PR indicates CPD removal by photoreactivation. Plotted 
curves represent averages of 2 independent experiments ± SEM. 
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Supplemental figure 2. (A) Left panel: Schematic of the genomic locus of ELOF1 for generating ELOF1-
mScarletI-HA KI cell line. Half arrows indicate primer locations. Middle and right panel: Genotyping PCR 
and immunoblot for ELOF1-KI cell line. LaminB1 was used as loading control. (B) Immunoblot of HCT116 
GFP-RPB1 KI. Tubulin was used as loading control. (C) Histograms showing intensities of GFP and mScarletI 
measured over the indicated dotted line in HCT116 double KI cells. (D) Native immunoprecipitation of P-Ser2-
modified Pol II in HCT116 cells followed by immunoblotting for indicated proteins. Cells were harvested 1 
hour after mock treated or irradiation with 16 J/m2 UV-C. IgG was used as binding control. (E) Interaction 
heat map based on the SILAC ratios of MRC-5 GFP-RPB1-interacting proteins as determined by quantitative 
interaction proteomics. Average SILAC ratios of duplicate experiments are plotted and represent RPB1-
interactors relative to empty beads. SILAC ratio >1 indicates increase in interaction. * indicates proteins 
quantified in one experiment. (F) Top 10 enriched GO terms (biological processes) identified using g:Profiler 































ELOF1 KI Intron mAID mScarletI HygromycinR
KI1: 293bp KI2: 302bp
HA
ELOF1 Intron Last exon
Wt: 298bp
STOP
GO biological processes. Top 10 terms of n=55 genes (SILAC ratio ≥ 2.5)
Pathway description Gene count Adjusted p-value
RNA processing 34 out of 941 2.99E-29
transcription elongation from RNA 
polymerase II promoter 18 out of 83 3.18E-27
DNA-templated transcription, elongation 18 out of 111 9.67E-25
RNA metabolic process 44 out of 4714 2.68E-17
nucleic acid metabolic process 45 out of 5207 8.10E-17
mRNA processing 21 out of 523 1.67E-16
snRNA transcription by RNA polymerase II 12 out of 71 1.06E-15
snRNA transcription 12 out of 72 1.27E-15
ncRNA transcription 13 out of 108 3.31E-15














































































































































Supplemental figure 3. (A) Browser tracks from DRB/TTchem-seq experiment at ATM, TAF3 and UBR5. 
Results are shown 10, 20, 30 or 40 minutes after DRB release. (B) Transcription levels as determined by 
relative EU incorporation in HCT116 cells transfected with indicated siRNAs. Red lines indicate average 
integrated density ± SEM. n≥200 cells from two independent experiments. (C) Representative images of 
EU incorporation in HCT116 cells transfected with indicated siRNAs. Scale bar: 20 µm. (D) Immunoblot for 
indicated proteins in HCT116 cells transfected with indicated siRNAs. Tubulin was used as loading control. 
(E) Images of HCT116 Wt and ELOF1 -/-A cells transfected with indicated siRNAs, stained with coomassie 
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 Supplemental figure 4. (A+B) Representative immunofluorescence images of EU incorporation in (A) 
indicated HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where indicated, or (B) HCT116 cells 
transfected with indicated siRNAs, 2 or 18 hours after 8 J/m2 UV-C or mock treatment (NT). Scale bar: 
20 µm. (C) Transcription restart after UV damage as determined by relative EU incorporation in HCT116 
cells transfected with indicated siRNAs, 2 or 18 hours after 8 J/m2 UV-C or mock treatment (NT). Relative 
integrated density of UV-irradiated samples are normalized to mock-treated and set to 100%. Red lines 
indicate average integrated density ± SEM. n≥300 cells from three independent experiments. (D) Represent-
ative immunofluorescence images of amplified EdU signal in XP186LV fibroblasts (XP-C) transfected with 
indicated siRNAs, 7 hours after exposure to 8 J/m2 UV-C. Scalebar: 20 µm. (E) Relative ELOF1 mRNA levels 
in XP186LV fibroblasts (XP-C) following transfection with indicated siRNAs as determined by RT-qPCR. 
ELOF1 expression was normalized to GAPDH expression and siCTRL levels were set to 1. Error bars indicate 
SEM. (F) Representative fluorescence images of EdU incorporation 3 hours after irradiation with 16 J/m2 
UV-C in C5RO (hTert) cells transfected with indicated siRNAs. Scale bar: 20 µm. (G) Relative ELOF1 mRNA 
levels in C5RO (hTert) cells following transfection with indicated siRNAs as determined by RT-qPCR. ELOF1 
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Supplemental figure 5. (A-D) Relative colony survival of indicated HCT116 Wt and KO (-/-) cells, with ELOF1 
re-expression where indicated, continuously exposed to indicated concentrations of (A) camptothecin 
(CPT) or (B) potassium bromate (KBrO3), or irradiated with indicated doses of (C) ionizing radiation (IR), 
or exposed (D) to indicated concentrations of hydroxyurea (HU). Plotted curves represent averages of at 
least two independent experiments ± SEM. (E) Relative colony survival of HCT116 cells transfected with 
indicated siRNAs following exposure to indicated doses of UV-C. Plotted curves represent averages of three 
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 Supplemental figure 6. (A) Indicated mutant yeast strains were serially 10-fold diluted, spotted, and 
exposed to indicated UV-C doses. (B) Schematic showing the CPD-seq method. Isolated DNA is sonicated 
and adaptors are ligated. Subsequently, CPDs are cleaved by T4 endonuclease V and APE1 nuclease to 
generate 3’ ends. Following denaturing of the DNA, the ends are ligated to a second adaptor that allows 
sequencing of CPDs. (C) Gene plot analysis of CPD-seq data following 2-hour repair for ~4500 yeast genes, 
ordered by transcription frequency. Plots depict fraction of unrepaired CPDs following 2-hour repair relative 
to no repair for both the transcribed strand (TS) and non-transcribed strand (NTS) for gene coding regions, 
regions upstream of the transcription start site (TSS), and downstream of the transcription termination site 
(TTS). Each row represents approximately 10 genes to display the plot in a compact manner. (D) Analysis of 
bulk repair of UV-induced CPD lesions in Wt and elf1∆ mutant yeast. The repair of CPD lesions at various 
time points was measured by T4 endonuclease V digestion and alkaline gel electrophoresis of genomic 
DNA isolated from UV-irradiated yeast (100 J/m2 UV-C light). A representative gel is shown on the left. The 
right panel depicts the quantification of CPD repair at each time point from at least three independent 
experiments ±SEM. *P≤0.05. (E) Single nucleotide resolution analysis of CPD-seq data downstream of 
the TTS of ~4500 yeast genes. Plots depict fraction of unrepaired CPDs following 2-hour repair relative to 
no repair for both TS and NTS. Nucleosome positioning data is shown for reference. (F) Controls for UV 
spotting assays shown in Fig. 3I. (G) Image showing repair of CPDs in the TS of the RPB2 gene for indicated 
yeast strains. The image was generated by converting counts of sequencing reads aligned to the sites of 
the RPB2 fragment into bands. ‘U’ indicates samples from unirradiated cells. Nucleotide positions relative 
to the TSS (+1) of the RPB2 gene are indicated on the left. (H) Left panel: Relative percentage of CPDs 
remaining in the short region (within 54 bp) immediately downstream of the transcription start site of the 
RPB2 gene. Right panel: Relative percentage of CPDs remaining in the more downstream region (from 69 to 
353 bp) of the RPB2 gene. Error bars (S.D.) are shown only for most relevant strains for clarity. (I) Schematic 
representation of the C. elegans elof-1 genomic organization, depicting the 180 bp emc203 deletion allele 
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 Supplemental figure 7. (A) FRAP analysis of GFP-RPB1 mobility after depletion of indicated factors. 
Mock-treated curves corresponding to figure 4A. n≥14 cells. (B) Left panel: Residence time of elongating Pol 
II or right panel: relative fraction size of promoter-bound or elongating Pol II as determined by Monte-Car-
lo-based modeling of RPB1 mobility as shown in (A). (C) Relative ELOF1 mRNA levels in GFP-RPB1 KI cells 
transfected with indicated siRNAs as determined by RT-qPCR. ELOF1 expression was normalized to GAPDH 
signal and levels of control cells were set to 1. Error bars indicate SEM. (D) Native immunoprecipitation of 
Pol II in Wt and ELOF -/-A cells followed by immunoblotting for indicated proteins. Cells were harvested 1 
hour after mock treatment or irradiation with 16 J/m2 UV-C. MG132: treatment with 50 µM proteasome 
inhibitor MG132, 1 hour before UV irradiation. (E) Native immunoprecipitation of Pol II in Wt and ELOF -/-A 
cells followed by immunoblotting for indicated proteins. Cells were harvested 1 hour after mock treatment 
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 Supplemental figure 8. (A) Left panel: Schematic of the genomic locus of CSB and used strategy for 
generating the homozygous CSB-mScarletI-HA KI cell line. Half arrows indicate primer locations. Middle and 
right panel: Genotyping PCR and immunoblot for CSB-KI cell line. (B) Left panel: Schematic of the genomic 
locus of UVSSA and used strategy for generating the homozygous UVSSA- mScarletI-HA KI cell line. Half 
arrows indicate primer locations. Middle and right panel: Genotyping PCR and immunoblot for UVSSA-KI 
cell line. (C) Left panel: CSB mobility was determined by FRAP analysis of CSB-mScarletI after the indicated 
treatments. THZ1: 1 hour treatment (2 µM) before UV-C irradiation (4 J/m2) or mock treatment. Right 
panel: Relative immobile fraction of CSB as determined by FRAP analysis. Plotted values represent mean 
± SEM and are normalized to mock treated. n≥15 cells. (D) Same as C but for UVSSA-mScarletI. n≥10 cells. 
(E+F) FRAP analyses of CSB-mScarletI (E) or UVSSA-mScarletI (F) mobility after transfection with indicated 
siRNAs in individual graphs. Cells were mock treated (NT) or analyzed directly (UV) or 5 hours (5hr UV) after 
irradiation with 4 J/m2 UV-C. (G) Relative fluorescence intensity of UVSSA in UVSSA-KI cells transfected with 
indicated siRNAs as determined by live-cell imaging. Plotted values represent mean ± SEM. n≥16 cells. (H) 
FRAP analysis of CSB in CSB-KI cells transfected with indicated siRNAs 2 hours after UV. VCPi: VCP inhibitor 
(5 µM) was directly added after UV-C (4 J/m2). (I) Immunoblot of chromatin fraction of indicated cell lines 1 
hour after 12 J/m2 UV-C or mock treatment. NAEi = 1 hour treatment with NEDDylation inhibitor (10 µM). 
SSRP1 is shown as loading control. (J) Immunoblot of chromatin fraction of HCT116 cells transfected with 
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 Supplemental figure 9. (A) Top panel: Representative immunofluorescence images of EU incorporation 
in indicated HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression where indicated, 2 or 22 hours 
after a 2-hour exposure to 10 µg/ml mitomycin C or mock treatment. Scale bar: 20 µm. Bottom panel: 
Transcription restart after mitomycin C as determined by relative EU incorporation in the indicated HCT116 
cells. Mitomycin C-treated samples are normalized to mock treated levels and set to 100%. Red lines 
indicate average integrated density ± SEM. n≥300 cells from four independent experiments. (B) Relative 
colony survival of indicated cell lines with siRNA transfection following exposure to indicated doses of UV-C. 
Plotted curves represent averages of three independent experiments ± SEM. (C) Representative immuno-
fluorescence images of 53BP1 foci in indicated HCT116 Wt and KO (-/-) cells, with ELOF1 re-expression 





















Supplemental figure 10. (A) S.cerevisiae Pol II (5vvr.pdb) with Rpb1 in green, Rpb2 in cyan, DNA in 
orange and Rad26 (CSB) in pink. The P.pastoris Pol II in complex with elongation factors (5xog.pdb) was 
superimposed onto this structure (Rpb1 subunits aligned onto each other), and all subunits except Elf1 
(ELOF1; purple) were omitted for clarity. Conserved lysine K1246 (K1268 in mammalian Pol II) is indicated 
in dark red. (B) Close up of Elf1 (ELOF1) binding region.
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Supplemental table 1. Table showing negatively regulated genes from the CRISPR/cas9 screen resulting 
from MaGecK analysis of the change in abundance of sgRNAs in UV-treated over mock-treated samples. 
Experiment was performed in duplicate.  
https://1drv.ms/x/s!AvEm1Jm7uzqFnnZDvTykqJWZQwIa?e=p6Yi3E 
Supplemental table 2. Table with SILAC ratios and peptide numbers as determined using quantitative 
interaction proteomics. Each tab represents a different experiment as indicated.  
https://1drv.ms/x/s!AvEm1Jm7uzqFnnX9wYHxxC9rEOfV?e=h18Zoc 
4
DNA damage-induced replication 
stress results in PA200-proteasome 
mediated degradation of acetylated 
histones
I.K. Mandemaker1,#, M.E. Geijer1, I. Kik1, K. Bezstarosti2,  
E. Rijkers2, A. Raams1, R.C Jansssens1, H. Lans1,  
J.H. Hoeijmakers1 J.A. Demmers2, W. Vermeulen1 and  
J.A. Marteijn1 
1 Department of Molecular Genetics, Oncode Institute, Erasmus University Medical 
Center, Rotterdam, The Netherlands
2 Proteomics Center, Erasmus University Medical Center, Rotterdam, The Netherlands
#  Current address: Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-
Universität München, Germany
Published in EMBO reports, 2018; 19 (10)
156
Abstract
Histone acetylation influences protein interactions and chromatin accessibility and 
plays an important role in the regulation of transcription, replication and DNA repair. 
Conversely, DNA damage affects these crucial cellular processes and induces changes in 
histone acetylation. However, a comprehensive overview of the effects of DNA damage 
on the histone acetylation landscape is currently lacking. To quantify changes in histone 
acetylation we developed an unbiased quantitative mass spectrometry analysis on affinity 
purified acetylated histone peptides, generated by differential parallel proteolysis. We 
identify a large number of histone acetylation sites and observe an overall reduction of 
acetylated histone residues in response to DNA damage, indicative of a histone-wide 
loss of acetyl-modifications. This decrease is mainly caused by DNA damage-induced 
replication stress coupled to specific proteasome-dependent loss of acetylated histones. 
Strikingly, this degradation of acetylated histones is independent of ubiquitylation but 
requires the PA200-proteasome activator, a complex that specifically targets acetylated 
histones for degradation. The uncovered replication stress-induced degradation of 
acetylated histones represents an important chromatin-modifying response to cope 
with replication stress.




DNA transacting processes such as transcription, replication and DNA repair take place 
in the context of chromatin. Chromatin is a highly organized structure in which DNA is 
wound around histone octamers to form nucleosomes. The histone octamer consists 
of a histone H3-H4 heterotetramer flanked by two histone H2A-H2B heterodimers. The 
linker histone H1 binds linker DNA entering and exiting nucleosomes, thereby regulating 
chromatin compaction1. Histones are a target for many post-translational  modifications 
(PTMs), like methylation, phosphorylation, ubiquitylation and acetylation, that are 
predominantly located at histone tails protruding from the nucleosome2. Histone PTMs 
can directly influence the strength of the histone interactions with each other and 
with the DNA2. Furthermore, several PTMs provide a docking site for specific readers, 
like chromatin remodeling complexes containing bromodomains that have affinity for 
acetylated histones3. Together this interplay of histone PTMs and chromatin remodeling 
proteins controls the accessibility of the chromatin thereby playing an important role in 
transcription, replication and DNA repair. 
For example, histone PTMs play a crucial role during DNA repair and DNA damage 
signaling2,4,5. Histone acetylation was one of the first histone PTMs, shown to be involved 
in DNA repair. More than 3 decades ago it was found that after UV irradiation histones 
undergo a wave of rapid hyperacetylation followed by a hypoacetylation phase6. UV 
light causes helix-distorting lesions such as 6-4 photoproducts (6-4PP) and cyclobutane 
pyrimidine dimers (CPD), which block transcription and interfere with replication. These 
lesions can be removed by a specific DNA repair mechanism called nucleotide excision 
repair (NER)7. The fact that hyperacetylated nucleosomes both increased chromatin 
accessibility in vivo and stimulated repair efficiency8, led to the formulation of the 
access-repair-restore concept9. This model proposed that chromatin is remodeled by 
ATP-dependent chromatin remodelers, histone chaperones and modifying enzymes 
to provide access of repair proteins to damaged sites. After repair, the chromatin 
conformation is restored to pre-damage conditions to preserve epigenetic information 
and inhibit DNA damage signaling9,10. Over the years, several histone acetyltransferases 
(HATs) have been implicated in the response to UV damage11-14. For instance, p300 
interacts with PCNA and is associated with newly synthesized DNA after UV irradiation14. 
UV-induced H3K9/K14 acetylation by GCN5 increases nucleosome  accessibility at the 
repressed MFA2 locus in yeast11,15 through binding of the RSC remodeling complex, 
which stimulated CPD repair16. In human cells, GCN5 is necessary for efficient recruitment 
of NER factors and repair17. In addition to H3 acetylation, also histone H4 is rapidly 
acetylated after UV by ING2 leading to the recruitment of XPA to the lesion13. Notably, 
besides acetylation also deacetylation plays an important role during the UV-DDR. For 
instance, histone deacetylase enzymes (HDACs) 1 and 2 are recruited to damaged sites 
by the DNA damage recognition proteins, DDB1 and DDB2, resulting in H3K56 deacetyl-
ation18.
Although these studies underscore the crucial interplay of histone acetylation and 
DNA repair, thus far a comprehensive overview of UV-induced histone acetylation 
and deacetylation events during repair, but also caused by UV-induced replication or 
transcription blocks is missing. Changes in histone modifications are often studied using 
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modification-specific antibodies15,19. However, these techniques rely on the specificity 
and availability of antibodies and unknown modification sites can therefore not be 
identified. Especially the acetylation status of histone H2A and H2B after UV irradiation 
remains largely unclear. In this study we used a quantitative mass spectrometry approach 
to identify histone acetylation changes in response to UV irradiation in an unbiased 
manner. Surprisingly, we found that UV damage induces a histone-wide reduction 
in acetylation levels. This loss of acetylated histones was not dependent on active 
transcription or NER. Instead, we show that it is the result of replication stress-induced 
histone degradation by a specific type of proteasome, containing the PA200 subunit, 
which recognizes acetylated proteins.
Results
Isolation of acetylated histone peptides
To identify the effects of UV-induced DNA damage on histone acetylation in an unbiased 
and quantitative manner we used a stable isotope labeling by amino acids in cell culture 
(SILAC) MS based approach. Cells labelled with light-isotope-containing amino acids 
(K0R0) were mock treated and cells labelled with heavy-isotope-containing amino acids 
(K6R10) were UV irradiated (16 J/m2) 1 hour before harvesting. In order to increase 
detection and quantification of histone acetylation sites, including less abundant ones, 
we established an isolation procedure to enrich for acetylated histone peptides. To this 
end we combined histone acid extraction20,21 with recently developed  acetyl-lysine 
immunoprecipitation (Ac-IP) procedures22,23 (Fig 1A). Histones were isolated by a 
two-step histone acid extraction protocol: extracting first linker histone H1 and the 
high mobility group proteins, followed by isolation of the core histones. Specificity of 
the histone extraction was confirmed by comparing the pellet fraction containing the 
precipitated non-acid-soluble proteins with the histone H1 and the core histone fractions 
using Coomassie staining (Fig 1B). Protein bands of the expected sizes of H1 (21 kDa) and 
the core histones (10-15 kDa) could be detected in the designated lanes. The presence 
of histone H1.2 in the histone H1 fraction and histone H2B in the core histone fraction 
was confirmed by western blot analysis. Furthermore, the induction of yH2AX following 
UV irradiation24,25 indicates that histone PTMs are preserved during the acid extraction 
procedure (Fig 1C). Prior to digestion the isolated H1 and core histone fractions were 
pooled. To obtain peptide sizes that are compatible with MS analysis to ensure a high 
coverage of all histone proteins, we split our sample in fractions, each digested with 
a different protease; trypsin, pepsin or GluC (Fig 1A). The trypsin fraction was further 
split in four and digested for different durations. After pooling these differential digested 
fractions, this approach led to the detection of many different unique and overlapping 
peptides, covering 74-98% of the core histone sequences and 27-62% of the different 
histone H1 variants (Fig 1D and Dataset EV1).
Acetylated peptides were isolated by Ac-IP and measured on LC-MS/MS. While several 
acetylated histone peptides could already be identified without the specific isolation 
procedure (Dataset EV1), the Ac-IP resulted in a 4-fold increase in the number of 
identified unique acetylated histone peptides. We identified 301 different acetylated 
histone peptides in total, 75% of which carry more than one acetyl-group (Dataset 
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EV2). Of note, when we performed additional MaxQuant analysis for the presence of 
phosphorylation, methylation and diGLY modifications, we found that about 19% of the 
peptides carried additional histone PTMs (Fig EV1). This suggests that the affinity of the 
antibody used for the acetylation enrichments is not negatively affected by the presence 
of additional PTMs on the same peptide.
Within this set of peptides, 40 unique histone acetylation sites were identified, including 
many previously described sites, like histone H3 acetylation on lysine 9, 14, 18, 23, 27 
and 6426,27. Interestingly, we found H2B to have most unique acetylation sites (Fig 1E). 
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Figure 1. Isolation of acetylated histone peptides. (A) Schematic overview of the experimental set up to 
isolate and identify acetylated histone peptides following UV irradiation. SILAC labeled cells are mock or 
UV (16 J/m2) treated one hour before harvesting. Heavy and light labelled cells are mixed in a 1:1 ratio 
followed by acid extraction to isolate histones. Histones are separated in 3 fractions each digested with 
either pepsin, trypsin or GluC. The limited digestion with trypsin is performed for 2, 10, 30 and 120 min. The 
different fractions of digested peptides are combined and followed by acetyl-lysine immunopurification. 
The acetylated-lysine enriched histone peptides are analyzed by LC-MS/MS. (B) Histones were isolated 
by acid extraction from HeLa cells one hour after UV (16 J/m2) or mock treatment and were loaded on a 
4-15% gradient SDS-PAGE gel and stained with Coomassie Brilliant Blue. The different fractions originate 
from the same amount of cells and contain the non-acid-soluble proteins (pellet), histone H1 and high 
mobility group proteins (H1 fraction) or the core histones (core histone fraction). * indicates 21 kDa protein 
band, most likely representing histone H1. ** indicates several protein bands ranging between 10-15 kDa 
most likely representing core histones. (C) Western blot of isolated histone fractions from HeLa cells one 
hour after UV (16 J/m2) or mock treatment. Western blots were stained with α-histone H1.2 (top panel), 
α-histone H2B (middle panel) and α-yH2AX (bottom panel). (D) Table listing the coverage of the histone 
sequences using our peptide digestion procedure by LC-MS/MS analysis. (E) Table listing the number of 
acetylation sites on core histones identified by MS after acetylated peptide enrichment.
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As expected, acetylated sites of core histones were mainly found in the tails28 whereas 
lysine 64 of histone H3 was the only acetylated residue found within the globular 
domains (Dataset EV3). In contrast to the core histones, the majority of acetyl modified 
lysines of the linker histone H1 were located in the globular domain29. 
Histone acetylation levels are decreased after UV-irradiation
After validating our approach to identify histone acetylation sites efficiently, we analyzed 
differences in the extent of histone acetylation one hour after UV-induced DNA damage. To 
visualize UV-induced changes in the acetylation status, all unique acetyl-modified histone 
peptides were plotted against their SILAC based UV/mock log2 ratio (Fig 2A). Surprisingly, 
the vast majority of the acetylated histone peptides had a negative normalized SILAC 
ratio following UV treatment (61% had a UV/mock log2 ratio < -0.5), indicative of an 
overall reduction in acetylation level of histones one hour after UV-induced DNA damage 
(Fig 2B and Dataset EV2). This is in contrast to previously observed UV-induced acetylation 
at chromatin locations nearby DNA lesions, like H3K9/14Ac, which was observed using 
site specific antibodies combined with a ChIP procedure11,15. Our mass spectrometry 
approach, which quantifies all histones in the cell, showed a loss of histone H3 peptides 
that were acetylated at lysine 9 or 14 (Dataset EV3). In addition to these 2 acetylation 
sites on histone H3, we found several other H3 acetylation sites to be reduced after UV 
damage. All core histones displayed lower acetylation levels for most quantified acetyl 
modifications after UV-induced DNA damage, however histone H2B and H2A were 
affected the most (Fig 2B, Fig EV2A and Dataset EV2&3). Most acetylated peptides we 
identified, showed multiple acetyl- modifications on different residues, which were all 
reduced following DNA damage. Together this data indicates a non-site specific, general 
loss of acetylated histones. This loss can be either caused by deacetylation of histones, 
reduced activity of histone acetylases or by degradation of acetylated histones. Of note, 
only for histone H2A variant H2AZ sites with increased acetylation after UV irradiation 
(UV/mock log2 ratio>0.5) were observed, while its unmodified peptides are not changed 
(Dataset EV2&3).
To confirm this striking histone-wide reduction of acetylation detected by MS, we 
quantified overall histone acetylation levels on western blot using the α-acetyl-
lysine antibody. Western blotting of sonicated whole cell extract (WCE), obtained by 
lysing HeLa cells directly in Laemmli buffer, showed that the vast majority of the 
signal from the α-acetyl-lysine antibody is confined in two bands around 10-15 kDa 
(Fig 2C). This α-acetyl-lysine signal fully overlapped with bands obtained by staining 
against the different core histones, the lower band mainly representing acetylated 
H4, while the upper band represent acetylated histones H2A, H2B and H3 (Fig EV2B). 
A similar α-acetyl-lysine signal was obtained from an acid extracted histone fraction 
(Fig 2C and Fig EV2C). This strongly suggests that these low molecular weight acetyl-
lysine signals represent acetylated histones and that the majority of lysine  modifications 
with acetyl within the cell take place at the highly expressed and heavily modified 
core histones. This was further corroborated by the reduction in acetylation signal 
following incubation with HAT inhibitors and the increase in signal after HDACs 
were inhibited (Fig 2C). Together this shows that the overall histone acetylation status 
can be assessed in a quantitative manner by western blot using α-acetyl-lysine staining. 
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In line with our MS results, we observed a UV-induced decrease in acetylated histones 
1 hour after UV (Fig 2D-E). Interestingly, the histone acetylation levels decreased 
even further over time. Quantification of the histone acetylation levels normalized 
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H2A 26 2 (8%) 16 (62%)
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Figure 2. UV-induced decrease in acetylated histones. (A) Identified acetylated histone peptides plotted 
against their log2 SILAC ratio (1h after 16 J/m
2 UV/mock), ranked by SILAC ratio. (B) Table listing the number 
of identified peptides per histone using MS following enrichment of acetylated peptides, and the number 
of peptides identified that are decreased (UV/mock log2<-0.5) or increased (UV/mock log2>0.5) one hour 
after UV irradiation (16 J/m2). (C) Western blot of acid extracted histones and WCE from HeLa cells, treated 
with HATi (CTK7A, 100 μM and CPTH2, 50 μM) or HDACi (TSA, 1 μM) for 4h or mock treated as indicated. 
(D) A representative western blot of histone acetylation levels of HeLa cells lysed at indicated time points 
after UV-irradiation (16 J/m2). Blots were stained with α-acetyl-lysine (top panels, high and low exposure), 
α-histone H4 (middle panel) and α-tubulin (bottom panel). (E) Quantification of histone acetylation levels, 
normalized against either the histone H4 levels (red bars) or tubulin levels (blue bars). Error bars represent 
SEM. N=5 independent experiments. Significant differences between UV treated and mock treated 
conditions were calculated using a T-test and are indicated with * (p<0.1), ** (p<0.05) and *** (p<0.01). 
(F) Representative western blots of HeLa WCE from different time points after UV-C irradiation (16J/m2) 
using the indicated histone modification specific antibodies. Histone H4 and tubulin were used as loading 
controls. (G) Quantification of specific histone acetylation marks normalized to tubulin levels. Significant 




hours following UV exposure (Fig 2D-E). Our MS results were further confirmed using 
western blot in combination with antibodies recognizing specific histone acetylation 
marks (H3K9, H3K14, H3K27 and H4K12) that were identified to be decreased in 
our MS experiments (Fig 2F-G). In addition, using another acetyl-lysine antibody22, 
we confirmed the UV-induced reduction in overall histone acetylation levels by both MS 
(Dataset EV4) and western blotting experiments (Fig EV2D-E), excluding the possibility 
that our results were due to preferred recognition motifs or other biases of the used 
antibodies. 
Recovery of acetylation levels 16 hours after UV is dependent on NER
To study the temporal behavior of histone acetylation levels after UV irradiation in 
more detail, western blot experiments were performed with WCE obtained at later time 
points after UV irradiation. While the acetylation signal was still reduced 8 h after UV, it 
recovered to levels similar as mock treated cells 16 h after irradiation (Fig 3A (left panel) 
and B), a time point when most DNA repair is finished30,31. This suggests that repair of 
UV-induced damage by NER might be necessary for the recovery of histone acetylation 
levels. Indeed, the recovery of the histone acetylation signal is abolished in cell lines 
deficient for NER proteins XPC or XPA, indicating that repair of UV-induced DNA damage 
is crucial for recovery of histone acetylation levels and that the persistent presence of 
DNA damage prevents this (Fig 3). Interestingly, in NER-deficient cells a similar loss of 
acetylated histones was observed compared to NER-proficient cells in the first 8 h after 
UV, showing that the UV-induced decrease in acetylated histones is not dependent on Figure 3
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Figure 3. The recovery of histone acetylation levels at later time points after UV is dependent on NER. 
(A) Representative western blots of WCE from NER-proficient HeLa cells and NER-deficient XP4PA (XP-C) 
and XP2OS (XP-A) cells obtained at indicated time points after UV irradiation (16 J/m2) and stained with the 
indicated antibodies. (B) Quantification of histone acetylation levels of NER-proficient cells (HeLa) and NER-
deficient (XP-A and XP-C) patient cells at the indicated time points after UV-irradiation (16 J/m2). Histone 
acetylation levels are normalized against histone H4 levels. Average of at least 5 independent experiments 
and error bars represent SEM. Significant differences (T-test) are indicated with * (p<0.1), ** (p<0.05) and 
*** (p<0.01).
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DNA damage recognition or on repair by NER (Fig 3). Together these data suggest that 
the trigger for the observed decrease in histone acetylation levels and occurs upstream 
or in parallel of the damage recognition step of NER.
Transcription does not influence the decrease in acetylated histones after 
UV-irradiation
Persistent UV-induced DNA lesions severely impede transcription and replication32,33. 
As active transcription is highly associated with increased levels of histone acetylation2 
we tested whether transcription inhibition, in the absence of DNA damage, affects the 
acetylation status of histones. Transcription was impeded by THZ1 and flavopiridol, which 
both inhibit transcription preceding productive elongation, and α-amanitin that blocks 
elongating RNAPII34. In contrast to UV, the histone acetylation levels remain rather stable 
after transcription inhibition, indicating that transcription inhibition is not the main cause 
of the UV-induced loss of acetylated histones (Fig 4A-B). However, even though chemical 
transcription inhibition did not result in a decrease in acetylated histones, we could not 
exclude that active transcription or lesion stalled RNAPII might initiate this UV-induced 
process. To test this, cells were pre-treated with the transcription inhibitors THZ1 or 
flavopiridol to deplete cells of elongating RNAPII before UV irradiation. This, however, 
did not affect the decrease in histone acetylation levels after UV irradiation (Fig 4C-D), 
indicating that the UV-induced loss of acetylated histones is a process independent of 
transcription.
Decrease in histone acetylation levels is the result of UV-induced replication 
stress
In addition to transcription inhibition, UV induced DNA lesions also cause replication 
stress, by slowing down or stalling replication forks. To test whether the loss of acetylated 
histones is caused by UV-induced replication stress, we also induced replication stress 
by exposing cells to a combination of hydroxyurea (HU) and arabinofuranosyl cytidine 
(AraC) or by mitomycin C (MMC). These experiments showed that induction of 
replication stress results in a similar loss of acetylated histones as after UV irradiation 
(Fig 5A-B). This indicates that replication stress itself can indeed induce a general 
decrease in histone acetylation levels and suggests that the loss of acetylated histones 
following DNA damage might be the direct consequence of UV-induced replication 
stress. To test whether the loss of acetylated histones following UV exposure could be 
attributed to replication stress, we studied UV-induced effects on histone acetylation in 
non-replicating cells. To this end, HeLa cells were blocked in S-phase using the Cdc7/
CDK9 inhibitor PHA 767491 hydrochloride (Fig EV3A). These cells displayed lower 
histone acetylation levels under unperturbed conditions (Fig 5C and Fig EV3B), which 
suggests that the high histone acetylation levels in cycling cells are mainly induced 
by replication related events. However, no additional UV-induced decrease was 
observed in these cells (Fig 5C-D). Similar results were obtained in contact inhibited 
non-replicating VH10 cells, which showed less reduction in histone acetylation levels 
compared to cycling VH10 cells following UV-exposure (Fig EV3C-E). Together these 
results indicate that the loss of acetylated histones after UV irradiation is mainly the 
result of replication stress.
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Figure 4. Loss of acetylated histones is independent of transcription inhibition. (A) Representative western 
blots of histone acetylation levels of HeLa cells lysed at indicated time points after UV irradiation (16 J/m2, 
left panel), α-amanitin (second panel, 100 µg/ml), THZ1 (third panel, 1 μM) or flavopiridol (right panel, 
1 μM) treatment. Blots were stained with α-acetyl-lysine (top panel), α-histone H4 (middle panel) and 
α-tubulin (bottom panel). (B) Quantified histone acetylation levels, normalized against histone H4 levels for 
quantification. Average of at least 3 experiments. Error bars represent SEM. Significant differences between 
UV-irradiated and inhibitor treated conditions are indicated with * (p<0.1). (C) Representative western 
blots of histone acetylation levels of HeLa cells pre-treated with transcription inhibitors (mock (left), THZ1 
(middle, 1 μM) or flavopiridol (right, 1 μM) an hour before UV irradiation and lysed at the indicated time 
points after UV (16J/m2). Blots were stained with the indicated antibodies. (D) Quantification of α-acetyl-
lysine signal, normalized against histone H4 levels. Average of 5 experiments. Error bars represent SEM. 
Significant differences, calculated by T-test, between UV treated and mock treated conditions are indicated 
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Figure 5. Replication stress induces loss of acetylated histones. (A) Representative western blots of histone 
acetylation levels of HeLa cells obtained at the indicated time points after UV irradiation (16 J/m2), HU/AraC 
treatment (100 mM/10 μM) or MMC treatment (10 µg/ml). Blots were stained with α-acetyl-lysine (top 
panel), α-histone H4 (middle panel) and α-tubulin (bottom panel). (B) Quantification of average histone 
acetylation signal, normalized to loading control. N≥3. Error bars represent SEM. Significant differences, 
calculated with T-test, between treated and mock conditions are indicated with * (p<0.1), ** (p<0.05) and 
*** (p<0.01). (C) Representative Western blots, stained with the indicated antibodies of HeLa cells pre-
treated o/n with an S-phase inhibitor (PHA 767491 hydrochloride, 10 μM) and lysed at indicated time 
points after UV (16 J/m2). (D) Quantification of the α-acetyl-lysine signals, normalized against histone H4 
levels, N= 5, error bars represent SEM. Significant differences, calculated with T-test, between UV-irradiated 
and inhibitor treated conditions are indicated with ** (p<0.05).
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Although ATR and ATM signaling pathways play an important role following DNA damage 
and replication stress35,36, the replication stress-induced loss of acetylated histones was 
not dependent on the activity of these kinases as histone acetylation was still reduced in 
the presence of both ATM and ATR inhibitors (Fig EV3F-G).
Chromatin bound acetylated histones are degraded
Besides the reduction in histone acetylation levels, we observed a concomitant subtle 
decrease in the histone H4 levels after UV irradiation, which was more pronounced 
at later time points (Fig 6A-B), however to a lesser extent than the loss of acetylated 
histones (Fig 6C). This suggests that the observed UV-induced decrease in histone 
acetylation levels could be caused by degradation of a specific subset of acetylated 
histones. Accordingly, we observed that the decrease in histone acetylation after UV 
was larger when normalized to tubulin compared to normalization to H4 levels (Fig 2E). 
To test this hypothesis, cells were pre-treated with the proteasome inhibitor MG132 one 
hour before UV irradiation. Proteasome inhibition completely rescued the UV-induced 
loss of both acetylated histones and histone H4 (Fig 6A-C). Of note, this loss of H4 is, like 
the loss of histone acetylation, dependent on replication (Fig EV3I).
During replication, the levels of soluble histones are increased. In addition, it has 
previously been shown that newly synthesized histone H3/H4 dimers are acetylated to 
stimulate incorporation into chromatin37-39. Therefore, we hypothesized that this pool 
of newly synthesized, yet unincorporated acetylated histones might be degraded upon 
replication stress, thereby preventing an excess of non-incorporated histones. To test 
this, we performed cell fractionation experiments to separate newly synthesized, free 
histones from chromatin bound histones. Compared to chromatin-bound histones, the 
levels of soluble histones is, as expected, very low and often hardly detectable on blots 
(Fig 6D). Most importantly, the acetylation signal is almost completely restricted to the 
chromatin fraction. This suggests that the observed 30-50% decrease in acetylation levels 
can only be explained by degradation of chromatin-bound histones. Indeed, after UV 
irradiation the acetylation levels in the chromatin fraction are decreasing over time, to a 
similar extend as was observed in whole cell extract (Fig 6D-E). This replication stress-in-
duced decrease in acetylation levels of chromatin-bound histones was confirmed by 
additional stainings using acetylation site specific histone antibodies (Fig 6D, F-G).
Acetylated histones are degraded by PA200-proteasome complexes
Interestingly, inhibition of the ubiquitin-activating enzyme (E1) using PYR-41, did not 
rescue the decrease in acetylated histones (Fig 7A-B). This indicates, in contrast to 
most proteasome dependent protein degradation, that the proteasomal degradation 
of acetylated histones is independent of protein ubiquitylation. It has been shown that 
acetylated histones can be recognized and degraded by a specific proteasome complex 
independent of protein ubiquitylation40. This specific proteasome complex consists 
of the 20S core complex and the nuclear proteasome activator PA20040. In contrast 
to the 26S proteasome, in which the 19S regulatory cap recognizes  ubiquitylated 
proteins, the PA200-proteasome complex does not recognize poly-ubiquitin chains 
but binds to acetylated proteins and targets them for degradation40. Therefore, we 
tested the involvement of PA200 in the UV-induced decrease in histone H4 and histone 
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Figure 6. Proteasomal degradation of acetylated histones following replication stress. (A) Western blots of 
HeLa cells treated with proteasome inhibitor MG132 one hour before UV irradiation and lysed at different 
time points after UV (16 J/m2). Blots were stained with α-acetyl-lysine (top panel), α-histone H4 (middle 
panel) and α-tubulin (bottom panel). Quantifications of (B) histone H4 levels and (C) acetylation levels, 
normalized against tubulin levels. Average of 6 experiments and error bars represent SEM. Representative 
blots are shown in panel A. (D) Fractionation experiments comparing histone and acetylation levels in 
chromatin and soluble fractions at the indicated time points after UV irradiation (16J/m2). HP1y was used as 
loading control for chromatin fraction, tubulin for soluble fraction. (E) Quantification of histone acetylation 
and H2B levels in chromatin fraction. Non-irradiated samples were set as 1. N≥4, error bars indicate SEM. (F) 
Representative western blots of fractionated cell extracts of HeLa cells at indicated time after UV irradiation 
(16J/m2) using histone modification specific antibodies. Loading controls for H3K9 and H3K27 are depicted 
in figure F. (G) Quantification of the signal of the indicated histone modification specific antibodies stanings 
in the chromatin fraction. N≥4 and error bars represent SEM. Significant differences were calculated with 








































Time after UV (16 J/m2)
Mock
PYR41
1h 1h/2h/4h 1h 1h/2h/4h
- 1h         2h       4h 
α-acetyl-lysine                          
α-histone H4
α-tubulin














































- 1h         2h       4h 
α-acetyl-lysine                          
α-histone H4
α-tubulin
- 1h         2h        4h Time after UV (16 J/m2)
siControl siPA200 a
- 1h        2h        4h 
siPA200 b



































Figure 7. PA200-proteasome degrades acetylated histones. (A) Western blots of HeLa cells pre-treated 
with the E1 enzyme inhibitor PYR-41 (10 μM) one hour before UV irradiation and lysed at different time 
points after UV (16 J/m2). Blots were stained with the indicated antibodies and representative blots are 
shown. (B) Quantification of histone acetylation levels, normalized against histone H4 levels, average 
of 5 experiments. Error bars represent SEM. (C) Representative western blots of siControl or siPA200 
(2 independent siRNAs, a and b) transfected cells, lysed at indicated time points after UV-irradiation 
(16 J/m2). (D) Quantification of histone H4 and (E) histone acetylation levels, normalized against tubulin 
and non-treated levels are set as 1. The average of at least 9 independent experiments and SEM is shown. 
Significant differences were calculated by T-test and are indicated with * (p<0.1), ** (p<0.05) and *** 
(p<0.01). (F) Clonogenic survival of HeLa cells treated with different doses of UV-C. Relative survival (in 
percentage) is plotted against UV-C dose. N≥2, error bars represent SEM. Significant differences, calculated 
by T-test are indicated with * (p<0.1), ** (p<0.05) and *** (p<0.01). (G) Unscheduled DNA synthesis in non-
cycling C5RO cells measured by the incorporation of EdU (20 µM) after UV irradiation (16J/m2) visualized 
by ATTO594 labelling using Click-chemistry. Levels in siControl cells were set as 1. N=2, >200 cells analyzed, 
error bars represent SEM. 
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acetylation levels. siRNA mediated knockdown of PA200 (Fig EV3A) inhibited the 
UV-induced proteasomal degradation of acetylated histones (Fig 7C-E). Together these 
results show that following replication stress, for example induced by UV-induced DNA 
damage, acetylated histones are degraded by the PA200-20S proteasome complex in an 
ubiquitin independent manner. To address the biological relevance of the degradation 
of acetylated histones we performed cellular survival assays following UV-induced DNA 
damage. Interestingly, PA200 depleted cells were more sensitive to UV-induced DNA 
damage compared to control transfected cells (Fig 7F, Fig EV3C), suggesting that the 
degradation of acetylated histones play a crucial role during the cellular responses to 
replication stress. Of note, this UV-sensitivity following PA200 depletion is not caused 
by an effect on NER-mediated repair rate, since knockdown of PA200 did not affect NER 
efficiency as shown by unscheduled DNA synthesis (UDS) experiments, which quantifies 
the gap filling DNA synthesis step NER (Fig 7G). Together these data indicate that the 
replication stress-induced degradation of acetylated histones is important for cells to 
cope with replication stress.
Discussion
To study the effects of UV-induced DNA damage on histone acetylation in an unbiased 
manner, we established a protocol to efficiently isolate acetyl-modified histone peptides. 
This stepwise purification approach, consisting of an acid extraction of histones, 
combined with proteolytic digestion with different proteases in parallel and followed 
by immuno-purification of acetylated peptides and analysis by mass spectrometry, 
resulted in the identification of 40 histone acetylation sites originating from over 300 
unique acetylated peptides. Using this procedure, we uncovered a striking UV-induced 
reduction of the vast majority of detected acetylated residues originating from all 
histones, except for variant H2AZ. Western blot experiments confirmed this UV-induced 
overall loss of acetylated histones and showed a loss of overall histone acetylation levels 
up to 40% 4 hours after UV exposure. Thus far most research on histone acetylation was 
focused on H3 and H4, for example on the role of H4K16Ac in chromatin compaction41 
and H3K9/14Ac in transcription42 and during the UV-DDR15-17. Our data shows that 
acetylation levels of H2A and H2B are more reduced in response to UV than H3 and 
H4 acetylation levels (Fig 2B, Fig EV2A and Dataset EV2&3), suggesting an important 
role for the regulation of H2A and H2B acetylation levels in the UV-DDR or in the 
extensive chromatin remodeling processes observed following DNA damage43,44. In 
striking contrast to the here described global decrease of histone acetylation, multiple 
other studies have observed an increase in acetylation in response to UV irradiation11-
13,15-17,45. For example, the UV-induced histone acetylation on H3K9/14 was shown to 
stimulate efficient NER17 by opening the chromatin structure as a result of recruitment 
of the chromatin remodeling complex RSC16. This UV-induced acetylation is mediated by 
histone acetyltransferases GCN5 and p300, which are both found at UV lesions and 
interact with the UV-DDB complex11,12,15,17,46,47. Our MS results show a reduction in H3K9 
and K14 acetylation an hour after UV damage. In addition, western blot analysis using 
antibodies specifically recognizing H3K9 and K14 acetylation shows a further decrease 
in the levels of these acetylation marks at later time points after damage (Fig 2F-G). 
This apparent discrepancy may be explained by the fact that the observed UV-induced 
increase of these marks may specifically happen in close vicinity of UV-induced DNA 
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lesions17. It is thus likely that this local increase of acetylated histones is masked by 
the overall  replication-stress-derived loss of acetylated Histones. In addition, in our MS 
dataset we do not find any peptides that only carry H3K9Ac or only H3K14Ac, but all 
peptides containing these modifications carry at least one other additional acetylation 
mark. Additionally, this discrepancy could also be due to differences in cell cycle or 
caused by the fact that following replication stress a specific subset of hyperacetylated 
histones is degraded, while histones in the vicinity of UV-induced lesions carry a single 
H3K9 or H3K14 acetylation mark. 
We propose that our observed overall loss of histone acetylation is a separate event, 
that acts independent of the reported histone acetylation events during NER11-13,15-
17,45. First, the large 40% decrease in total histone acetylation levels occurs on all 
core histones and includes multiple lysines, suggesting a chromatin-wide effect in 
contrast to the reported histone acetylation events that are often lysine specific and 
are mainly locally observed centered around the DNA lesion11,15,17. Furthermore, NER- 
stimulating acetylation was proposed to be facilitated by the recruitment of HATs to 
the site of DNA damage14,17,46-48, while the here described replication stress-associated 
loss of acetylated histones is due to proteasomal degradation rather than caused by 
changes in HATs or HDACs activity. In addition, the degradation of acetylated histones 
is only observed in cycling cells (Fig. 5C-D), while NER and the previously described 
histone acetylation events are expected to take place throughout the cell cycle. 
Finally, we found that the loss of acetylated histones after UV irradiation is completely 
independent on NER; it is still observed in NER deficient cells (Fig 3) and the degradation 
of acetylated histones does not affect NER efficiency (Fig 7G). These observations 
suggest that the overall decrease in histone acetylation in response to UV is not directly 
associated with DNA repair of UV lesions, but more likely a consequence of UV-induced 
replication stress. Indeed, induction of replication stress by other mechanism, treatment 
with MMC or HU/AraC, resulted in a similar loss of acetylated histones (Fig 5A-B). In 
line with this, it was previously observed, using acetyl-histone specific antibodies, 
that H3K9Ac and H3K56Ac are reduced after hydroxyurea treatment19. The fact that 
mainly an overall loss of histone acetylation was observed, despite the existence 
of independent and opposing UV-induced histone acetylation influencing events, 
indicates that in dividing cells the replication stress-induced loss of acetylated histones 
is much more abundant than the DNA damage-localized, site-specific acetylation 
that regulates NER. To specifically investigate acetylation events that are induced 
by UV-lesions or associated with NER, it is thus important to execute experiments in 
non-replicating cells.
Of note, unlike the loss of acetylated histones, the recovery of histone acetylation levels 
after UV-induced replication stress is dependent on NER. Since NER is the mammalian 
DNA repair system capable of removing UV-induced lesions7, its absence will prohibit 
repair of replication stress inducing UV-lesions. The recovery of histone acetylation 
levels is likely the result of synthesis of new histones required for the resumption of 
replication, which are subsequently acetylated, to replace the acetylated histones that 
were degraded in response to DNA damage. 
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The decrease in histone acetylation levels following replication stress is proteasome 
dependent and is likely explained by the degradation of a specific subset of histones, 
i.e. acetylated histones, as the histone acetylation levels are more reduced than the 
histone levels in response to UV irradiation (Fig 6A-C). Surprisingly, the observed 
histone degradation is not dependent on ubiquitylation, but instead it depends on 
the PA200-proteasome that specifically targets acetylated proteins for degradation 
(Fig 7A-E)40. It is not known whether or how PA200 can discriminate between differ-
entially acetylated histones. For example, it is not expected that histones in transcrip-
tionally active regions, which also carry acetylation marks49, are constantly targeted by 
the PA200-proteasome. We observed a reduction in almost all acetylated peptides, many 
of which carried multiple acetyl groups (Dataset EV2). This might suggest that PA200 may 
not recognize specific histone marks, but rather targets hyperacetylated histones for 
degradation. Future studies should uncover if and how PA200 can discriminate between 
different subsets of acetylated histones, or that for example the activity of the PA200 
complex itself is regulated to control histone degradation following replication stress. 
It is also not clear yet whether incorporated histones can be degraded by the PA200 
proteasome or whether histones need to be evicted by a specific histone chaperone 
from chromatin prior to degradation.
An important question that remains to be answered is why histones are degraded in 
response to replication stress. In response to DNA damage, chromatin is remodeled to 
a more accessible conformation to enable efficient repair and this might be facilitated 
by the degradation of histones. In line with this, histone degradation in response to 
zeocin treatment was recently observed in yeast. This degradation was shown to lead to 
enhanced chromatin dynamics and recombination rates50. We have shown that PA200 
dependent histone degradation does not affect nucleotide excision repair, however 
it might be necessary to efficiently overcome stalled replication forks. In accordance 
with this hypothesis, PA200 was found to localize to chromatin in response to DNA 
damage51, which suggests that it might degrade nucleosomal histones. Previously, it was 
shown that an excess of histones interferes with homologous recombination in yeast52. 
It is thus plausible that the observed histone degradation in response to replication 
stress is required to prevent an excess of histones to resolve stalled replication forks 
efficiently. Degradation of chromatin-bound histones around stalled forks might make 
space for the proteins involved in resolving stalled forks for example by facilitating 
reversal of the replication fork followed by template switching to allow resumption 
of replication53. Additionally, this mechanism might be involved in the repair of DNA 
breaks, caused by the collapse of stalled replication forks. As degradation of acetylated 
histones is much more abundant as the UV-induced histone acetylation, this suggest 
that chromatin remodeling by histone degradation around stalled replication forks 
possibly involves longer stretches of chromatin than remodeling around UV-induced 
lesions that are resolved by NER. However, it is currently not known whether histones 
are indeed hyperacetylated near stalled replication forks. Interestingly, in yeast all core 
histones, except H2AZ, are degraded in response to DNA damage50. The only two sites 
that in our study were identified to be more acetylated in response to UV irradiation 
are both located on this histone variant (Dataset EV3), which was previously described 
to be important for UV survival and CPD repair in yeast16. This might imply that also in 
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human cells H2AZ might not be degraded in response to replication stress. However, the 
function of this UV-induced H2AZ acetylation16 and why the PA200-proteasome would 
not recognize this specific histone variant remains unclear.
In summary, our data indicates that in response to replication stress acetylated histones 
are specifically degraded by the PA200-proteasome in an ubiquitin independent manner. 
This degradation most likely represents an important chromatin-modifying mechanism 
for cells to cope with stalled replication forks.
Materials and methods
Cell culture and treatments
HeLa and VH10, SV40 or hTert immortalized, cells were cultured in DMEM/F10 (Lonza) 
supplemented with 10% fetal calf serum (FCS) and 1% penicillin-streptomycin (PS, 
P0781 Sigma) at 37oC in a humidified incubator containing 5% CO2. For stable isotope 
labeling by amino acids in cell culture (SILAC), HeLa cells were cultured for at least 10 cell 
doublings in lysine, arginine and L-glutamine (PAA) deficient DMEM with 10% dialyzed 
FCS (Invitrogen), 1% PS and 1% ultraglutamine (200mM Lonza), supplemented with 
either 73 μg/mL light [12C6]lysine and 42 μg/mL light [12C6, 14N4]arginine (Sigma) or 
similar concentrations of heavy [13C6]lysine and heavy [13C6, 15N4]arginine (Cambridge 
Isotope Laboratories). If not stated otherwise in the figure legends, cells were at 70-80% 
confluency when treated. For UV treatments cells were washed with phosphate-buffered 
saline (PBS) and irradiated with 16 J/m2 (254nm, Philips TUV lamp). To induce replication 
stress a combination of hydroxyurea (100 mM) and AraC (10µM) or mitomycin C (10 µg/
ml) was used. Transcription was inhibited using; α-amanitin (0.1mg/ml), THZ1 (1 µM) and 
flavopiridol (1 µM). To inhibit cell cycle PHA 767491 hydrochloride (10 μM) was added 
o/n to the culture medium. MG132 (50 10 µM) and PYR41 (10 μM) were added to inhibit 
the proteasome or ubiquitylation respectively. DNA damage signaling was inhibited by 
the addition of ATM (Ku55933, 10 µM) and ATR (VE-821, 10 µM) inhibitors. Sequences 
of siRNAs used: siControl UGGUUUACAUGUCGACUAA, siXPF (Dharmacon smartpool), 
siPA200 a GAAAAGAGAUGCAAAGUUA, siPA200 b AGAAAUAAGGCUCAGCAAA and 
siPA200 c GCUUCAACUUAGUAAAGAA.
Histone isolation and protein digestion
Cells were washed twice with cold PBS, scraped and mixed in a 1:1 ratio based on cell 
pellet size (UV:mock). The cell pellet was resuspended in 1 volume 5% perchloric acid. 
After incubating for 10 min, the solution was centrifuged for 10 min at 13,000 rpm. 
The supernatant containing histone H1 was collected and the procedure was repeated 
twice. The pellet was then resuspended in 2 volumes 0.4N hydrochloric acid (HCl) and 
incubated for 15 min before spinning down (10 min 13.000 rpm). This procedure was 
repeated twice and all supernatants containing the core histones were collected. The 
histone containing supernatants were precipitated by the addition of trichloric acid to 
25% and incubated on ice for 30 min and centrifuged for 20 min at 13,000 rpm. Pellets 
were washed in acetone with 0.006%HCl and subsequently in acetone and finally the 
histone pellets were dissolved in 50 mM ammonium bicarbonate. Digestions were 
performed with proteomics-grade trypsin (Roche, 1:100, 30oC, 2/10/30/120 min) (50% of 
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sample), GluC (100x, o/n, room temperature (RT)) (25% of sample) or on an immobilized 
pepsin (Pierce) column (in 0.5% trifluoracetic acid (TFA)) (25% of sample). Tryptic and 
GluC digestion was stopped by acidification to 0.5% TFA. The digested peptides were 
mixed and subsequently purified using 200 mg tC18 SEP-PAK SPE cartridges (Waters) 
and eluted with 40% acetonitrile (ACN) containing 0.1% TFA. The peptides were then 
lyophilized for 48 h (Scanvac CoolSafe 110-4, Scala Scientific). 
Ac-K peptide enrichment 
Lyophilized peptides were dissolved in 1.4 mL of IAP buffer (PTMscan, cell signaling) 
and incubated with anti-Ac-K antibody beads (PTMscan, cell signaling) for 2 h at 4oC 
on a rotating unit. Beads were washed three times in IAP buffer followed by two 
washes in H2O and subsequently the peptides were eluted using 0.1% of TFA in H2O. 
The enrichments with the anti-Ac-K antibody from Immunechem were performed as 
described previously22. In short, peptides were dissolved in 1.4 ml IP buffer (50 mM 
MOPS pH7.2, 10 mM sodium phosphate, 50 mM NaCl) and incubated o/n with 62,5 µg 
anti-Ac-K antibody conjugated to 12 µl protein A beads (GE Healthcare). Beads were 
washed 3 times in IP buffer and two times with water before peptide elution with 0.15% 
TFA. Eluted peptides were purified with C18 stage tips (Millipore). 
Mass spectrometry
Digested histone peptides, not enriched for acetyl-lysines, were analyzed with an 
Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific) or a quadrupole 
Orbitrap (Q-Exactive, Thermo Fisher Scientific) and samples enriched for acetylated 
peptides were analyzed with the Orbitrap Fusion Tribrid mass spectrometer according 
to protocols below.
Mass spectra were acquired on an Orbitrap Fusion Tribrid mass spectrometer (Thermo 
Fisher Scientific) coupled to an EASY-nLC 1000 system (Thermo Fisher Scientific). 
Peptide samples were loaded onto a ReproSil C18 reversed phase column (20 cm x 75 
μm ID) and eluted with a gradient of 5-80% (acetonitrile containing 0.1% formic acid) 
over 90 min at 300 nl/min. For all experiments, the instrument was operated in data- 
dependent acquisition (DDA) mode. MS1 spectra were collected at a resolution of 120,000, 
with an automated gain control (AGC) target of 2E5 and a max injection time of 50 ms 
in the scan range from 375-1500 m/z. The most intense ions were selected for MS/
MS, top speed method with a 3 second cycle time. The normalized collision energy was 
optimized at 30% for HCD. Precursors were filtered according to charge state (2-7z), and 
monoisotopic peak assignment. Previously interrogated precursors were dynamically 
excluded for 70 s. Peptide precursors were isolated with a quadrupole mass filter set to 
a width of 0.7 Th. 
For ETD and EThcD fragmentation experiments a decision tree was applied in the 
Orbitrap Tune software for instrument control. For precursor ions with charges 2-3 
EThcD was used for fragmentation, while for precursors with charges 4-8 ETD was 
used. Calibrated charge dependent ETD parameters were applied and fragment ions 
were measured in the ion trap. Alternatively, peptides were analyzed on a quadrupole 
Orbitrap (Q-Exactive, Thermo Fisher Scientific) mass spectrometer equipped with an 
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EASY-nLC 1000 (Thermo Fisher Scientific). Peptide samples were loaded onto a ReproSil 
C18 reversed phase column (20 cm x 75 μm ID) and eluted with a gradient of 5-80% 
(acetonitrile containing 0.1% formic acid) over 70 min at 300 nl/min. Fragmentation of 
the peptides was performed in DDA mode. MS1 spectra were collected at a resolution 
of 70,000, with an automated gain control (AGC) target of 1E6 and a max injection 
time of 50 ms. The 10 most intense ions were selected for MS/MS. Precursors were 
filtered according to charge state (2-7z) and monoisotopic peak assignment. Previously 
interrogated precursors were dynamically excluded for 30 sec and peptide precursors 
were isolated witha quadrupole mass filter set to a width of 2.0 Th.
Peptide identification 
Raw data files were analyzed using MaxQuant software (version 1.5.2.8). MS/MS 
spectra were searched against a histone database, containing all uniprot entries of 
which the protein name contains the string “histone” and organism “Homo sapiens”, 
using the Andromeda search engine. The protease specificity was set to nonspecific 
cleavage. Cysteine carbamidomethylation was included as a fixed modification, whereas 
methionine oxidation, N-terminal protein acetylation and lysine acetylation were set as 
variable modifications. To check for the presence of additional histone modifications, 
as shown in Figure EV1, dedicated MaxQuant searches were performed in which also 
ubiquitylation, phosphorylation, methylation, dimethylation and trimethylation were 
set as variable modifications. A false discovery rate of 0.05 for peptides and a minimum 
peptide length of 7 were set. Before further data analysis, known contaminants and 
reverse hits were removed from the modification-specific peptides list. 
Cell fractionations
To separate chromatin-bound proteins from soluble proteins, cells (80% confluent, 3 
cm2 dishes) were washed 2x with PBS and scraped from the plates. Cells were lysed 
for 1h in buffer A (30 mM HEPES pH7.5, 250 mM NaCl, 1 mM MgCl2, 0.5% Triton X-100, 
protease inhibitor) on ice and centrifuged for 15 min at full speed at 4oC. Supernatants 
containing soluble proteins were taken and pellets, containing chromatin, were washed 
1x with 1ml buffer A. Two both the soluble and chromatin fractions 2x SDS sample 
buffer was added and samples were boiled for 5 min at 95oC prior to loading on 14% 
SDS-PAGE gels.
Western blotting 
Cell lysates were made in 2x Laemmli buffer. Lysates were boiled and sonicated with 
a Diagenode Bioruptor (30 sec on; 30 sec off for 10min) to shear the DNA. Lysates 
were separated on a 6 or 14% SDS-PAGE acrylamide gel and transferred to a PVDF 
membrane (0.45 μm, Merck Millipore ltd). Membranes were blocked with 5% milk in 
PBS for 1 hour at RT and incubated with primary antibody for 2 hours at RT or overnight 
at 4oC. Secondary Alexa Fluor 795 donkey anti-mouse antibodies and Alexa Fluor 
680 donkey anti-rabbit antibodies (Sigma) were used to visualize the proteins using 
an infrared imaging system (Odyssey; LI-COR Biosciences). Primary antibodies were: 
rabbit-α-histone H2B ((1:2000, Cat # ab64039 abcam), mouse-α-phospho-H2A.X 
(SER139) (1:1000, Cat # 05-636, Millipore), rabbit-α-histone H1.2 (1:1000, Abcam), 
rabbit-α-histone H2A (1:200, ab13923, Abcam), goat-α-histone H2B (1:100, Cat # 
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SC-8650, Santacruz), goat-α-histone H3 (1:1000, Cat # CS-8654, Santacruz), mouse-α-
histone H4 (1:1000, Cat # ab31830, Abcam), rabbit-α-Acetyl-lysine (1:2000, Ac-K-100, 
Cat # 9814S, PTMscan), rabbit-α-Acetyl-lysine (1:1000, Cat # ICP0380, Immunechem), 
rabbit-α-Acetyl histone H3 Lys9 (1:1000, Cat # 06-942, Millipore), rabbit-α-Acetyl histone 
H3 Lys14 (1:2000, Cat # 07-353, Millipore), rabbit-α-Acetyl histone H3 Lys27 (1:2000, Cat 
# ab4729, Abcam), rabbit-α-Acetyl histone H4 Lys12 (1:2000, Cat # ab46983, Abcam), 
mouse-anti-HP1y (1:1000, Cat # ab56978, Abcam) and mouse-α-tubulin (1:5000, Cat # 
T5168, Sigma Aldrich). 
For western blots the rabbit-α-Acetyl-lysine from PTMscan was used, except when 
stated otherwise. Quantifications were performed using the Odyssey software (LI-COR 
Biosciences). The intensity of the acetyl-lysine signal was normalized against the histone 
H4 or tubulin signals and the mock treated time point was set as 1. Each experiment 
was performed at least three times and mean values and standard error of the means 
(SEM) are shown. A two-tailed t-test was performed and P-values <0.1 (*), <0.05 (**) and 
<0.005 (***) are depicted.
EdU incorporation
Cells were incubated with 20 μM 5-ethynyl-2’-dexoyuridine (EdU, Invitrogen) and 1 
μM 5-Fluoro-2′-deoxyuridine for 2 hours. Cells were fixed in 3.6% formaldehyde in PBS 
and permeabilized in 0.5% Triton-X in PBS. EdU was visualized with a click-it reaction 
using Alexa fluorophore 488 nm according to manufactures protocol (Invitrogen). For 
Unscheduled DNA synthesis experiments, cells were labeled with 20 μM EdU in medium 
containing 20 mM Hepes buffer (Lonza) directly after UV irradiation (16J/m2). After 3h of 
labeling a chase with 10 μM thymidine was performed after which the cells were fixed in 
3.7% formaldehyde and 0.5% Trition in PBS. Cells were shorlty washed twice in PBS and 
blocked 2x in 3% BSA in PBS for 10 min. Permeabilization was performed in 0.5% Triton 
in PBS for 20 min. Click-it reaction was performed using a 594 nm azide (Atto Tec) for 30 
min. Images were obtained using a LSM700 microscope (Carl Zeiss Microimaging Inc.) 
and analyzed using ImageJ software54.
Clonogenic survival assays
HeLa cells were seeded in 6-well plates (400 cells/well) a day before treatment with 
a single doses of UV-C. Each experiment was performed in triplicate. After 6 days the 
colonies were fixed and stained with 50% methanol, 43% H2O, 7% acetic acid and 0.1% 
Brilliant blue R (Sigma). Number of colonies was counted using a GelCountTM (Oxford 
Optronix, version 1.1.2.0). The survival was plotted as the relative amount of colonies 
after treatment compared to the non-treated samples.
Immunofluorescence
Cells were grown on coverslips until 70-80% confluency, washed in PBS and fixed in 2% 
paraformaldehyde in PBS containing 0.1% triton-X. Cells were permeabilized for 20 min 
in 0,5% Triton-X in PBS and washed in PBS containing 0.5% bovine serum albumin (BSA) 
and 0.15% glycine prior to primary antibody mouse-α-phospho-H2A.X (SER139) (1:1000, 
Cat # 05-636, Millipore) staining for 1 h at RT. Coverslips were washed three times short 
and twice for 10 min in 0.1% triton-X in PBS and once in PBS with BSA and glycine and 
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subsequently stained with secondary antibodies labeled with alexa fluorochromes 555 
(Invitrogen) and DAPI (0.1 μg/ml) for 1 h at RT. Images were obtained using a Leica 
DM4000B microscope.
Data availability
The mass spectrometry data from this publication have been deposited to the PeptideAtlas 
database (http://www.peptideatlas.org) and assigned the identifier PASS01209 
(http://www.peptideatlas.org/PASS/PASS01209).
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Extended View Figure 1
Histone peptide Modifications
(H2B) KGSKKAVTKAQKKDGKKR 4 Acetyl (K)
4 Acetyl (K);Dimethyl (KR)
(H3) QTARKSTGGKAPRKQLATKAAR Acetyl (K);Methyl (KR)
2 Acetyl (K)
2 Acetyl (K);Phospho (STY)
2 Acetyl (K);Methyl (KR)
2 Acetyl (K);Dimethyl (KR)
3 Acetyl (K)
3 Acetyl (K);Phospho (STY)
3 Acetyl (K);Methyl (KR)
3 Acetyl (K);Dimethyl (KR)
4 Acetyl (K)
(H4) KGLGKGGAKR 3 Acetyl (K)
Acetyl (K);GlyGly (K)
Figure EV1. Isolation of acetylated histone peptides. Table listing three representative examples of 
acetylated histone peptides from H2B, H3 and H4, isolated by acetyl-IP and identified with MS followed 
by MaxQuant analysis. In addition to acetylation marks, these peptides can be modified with additional 
histone PTMs.
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Extended View Figure 2
A
- 1h        2h         4h 
α-acetyl-lysine (ImmuneChem)                         
α-histone H4
α-tubulin
































































































































Figure EV2. UV-induced decrease in acetylated histones. (A) Identified acetylated peptides per histone 
plotted against their log2 SILAC ratio (1h after 16 J/m
2 UV/mock), ranked by SILAC ratio. Green dots 
represent the identified peptides from histone variant H2AZ. The percentage of peptides with a SILAC ratio 
< -0.5 are indicated in red. (B) Western blots of WCE from HeLa cells stained with α-histone H2A, α-histone 
H2B, α-histone H3 α-histone H4 (depicted in green) and α-acetyl-lysine (depicted in red) indicating that 
the strong acetyl-lysine signal of the low molecular weight bands originates from acetylated core histones. 
H2A and acetyl-lysine antibodies were raised in the same species and therefore did not allow an overlay. 
(C) Coomassie staining of extracted histones and WCE from the same number of HeLa cells, treated with 
HATi (CTK7A, 100 μM and CPTH2, 50 μM) or HDACi (TSA, 1 μM) or mock treated. (D) Western blots of HeLa 
cells lysed at different time points after irradiation with UV (16J/m2). Blots were stained with α-acetyl-lysine 
(Immunechem, top panel), α-histone H4 (middle panel) and α-tubulin (bottom panel). (E) Quantification 
of the α-acetyl-lysine signal normalized against either the histone H4 levels (red bars) or tubulin levels 
(blue bars). Error bars represent SEM. N= 7 and SEM is shown. Significant differences between UV treated 
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Figure EV3. Loss of acetylated histones is caused by replication stress. (A) Relative amount of HeLa cells 
positively stained for EdU incorporation (2h, 20 μM), quantified from immunofluorescence images (>120 
cells analyzed). (B) Quantification of histone acetylation levels, normalized against histone H4 levels of 
HeLa cells that are cultured with S-phase inhibitor (10 μM, o/n) or mock treated. Error bars represent SEM. 
(C) Relative amount of EdU positive, cycling or contact inhibited (confluent) VH10 cells, quantified from 
immunofluorescence images (>100 cells analyzed). (D) Western blots of WCE from confluent (right panel) 
or cycling (left panel) VH10 cells lysed at different time points after UV (16J/m2). Blots were stained with 
α-acetyl-lysine (top panel), α-histone H4 (middle panel) and α-tubulin (bottom panel). (E) Quantification 
of histone acetylation levels in confluent or cycling VH10 cells at different time points in which the histone 
acetylation levels are normalized against histone H4 levels after UV (16J/m2). N= 3, error bars represent 
SEM. Significance of differences between cycling and confluent cells are indicated with * (p<0.1) and 
** (p<0.05). (F) Western blot of WCE, made at different time points after UV irradiation (16J/m2) from 
HeLa cells pre-treated for 1 hr with a combination of ATM (Ku55933, 10 µM) and ATR (VE-821, 10 µM) 
inhibitors. (G) Quantification of histone acetylation levels in cells treated with ATM and ATR inhibitors an 
hour before UV irradiation (16J/m2). Bar graph represent mean, dots represent individual data points. 
N=2 (H) Representative immunofluorescence images of yH2AX staining following, mock treatment, UV-
induced DNA damage (4 J/m2) with or without ATM and ATR inhibitors as indicated. Scale bar 10 µm. (I) 
Quantification of histone H4 levels in HeLa cells pre-treated o/n with an S-phase inhibitor (PHA 767491 
hydrochloride, 10 μM) and lysed at indicated time points after UV (16 J/m2). N= 5, error bars represent 
SEM, data is normalized against tubulin levels. Significant differences, calculated with T-test, between UV-
irradiated and inhibitor treated conditions are indicated with * (P<0.1), ** (p<0.05) and *** (p<0.01).
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Extended View Figure 4
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Figure EV4. Histone degradation does not affect repair of UV-lesions. (A) Western blot showing the knock 
down efficiency of the siRNAs targeting PA200. (B) Representative images of non-cycling C5RO cells treated 
with EdU (20 µM) for 3h after UV irradiation (16J/m2) visualized by ATTO594 labelling using Click-chemistry. 
Scale bar 50 µm. (C) Western blot showing the knock down efficiency of the siRNAs targeting PA200 and 
XPF. 
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The genetic code for all organisms is stored in the nucleotide sequence of their DNA. 
Protecting the genetic code is essential to faithfully transcribe the genetic information of 
our DNA into RNA. Progression of RNA polymerase II (Pol II), the protein involved in RNA 
transcription, is regularly impeded by DNA damage. Such transcription-blocking lesions 
(TBLs) can be induced by endogenously produced reactive oxygen species formed as 
side products from metabolic processes, or by exogenous sources such as UV irradiation 
and chemicals. Elongating Pol II that encounters a TBL can cause reduced transcription 
fidelity that eventually can result in mutant RNA transcripts or can even completely 
block the synthesis of new mRNAs. This transcriptional burdens can lead to reduced 
cell function and eventually induce DNA damage-induced aging. Moreover, if stalling of 
Pol II is persistent, this can induce the formation of R-loops and induce transcription- 
replication conflicts that can lead to genome instability and eventually can induce cancer. 
Collectively, these transcriptional impediments and consequences are referred to as the 
DNA damage-induced transcription stress response.
To prevent these detrimental effects of prolonged stalling, cells have a dedicated repair 
mechanism called transcription-coupled nucleotide excision repair (TC-NER) that repairs 
TBLs and is initiated upon stalling of Pol II at a lesion. Lesion-stalled Pol II results in the 
recruitment of TC-NER factors that help to recognize and verify the lesion and excise the 
damaged part of the DNA. Eventually, new DNA is synthesized and the DNA is ligated 
after which transcription can be resumed. During the repair reaction, Pol II needs to 
be displaced to allow repair factors to access the lesion. Moreover, in addition to the 
direct consequences of stochastic Pol II stalling, transcription is also highly regulated at 
a genome-wide level, as part of the DNA damage-induced transcription stress response. 
These include complex activation and subsequent inhibition of transcription initiation, 
a release of promoter-paused Pol II into the gene body and changes in alternative 
splicing. These events are all important for cells to cope with TBLs and contribute to 
recognizing the lesions, initiating repair and maintaining transcription fidelity. In Chapter 
1, the different direct and indirect consequence of TBLs on Pol II and genome-wide 
transcription regulation have been reviewed. In addition, we described the factors that 
have thus far been identified in regulating this cellular response to DNA damage-induced 
transcription stress including the TC-NER reaction. 
Although several factors have been identified to be involved in regulating the cellular 
response to DNA damage-induced transcription stress, the exact mechanisms of this 
pathway have yet to be determined. To identify new proteins involved in regulating Pol II 
in response to UV-induced DNA damage, we used quantitative interaction proteomics. In 
Chapter 2, we described different approaches to extract and immunoprecipitate Pol II and 
its interactors. First, we used a native extraction protocol to isolate both the initiating and 
elongation fraction of Pol II. Subsequently, we used these fractions to successfully immuno-
precipitate Pol II and used SILAC-based interaction proteomics to identify its basal and 
UV-induced interactors. We identified several Pol II complex components and regulatory 
factors but, surprisingly, only a few known and no new UV-specific interactors. Therefore, 
we switched to a protocol that includes chemical crosslinking to stabilize loosely associated 




to identify transient interactors. Both agents successfully identified Pol II interactors but 
again only a few UV-specific interactors, besides the known UV-induced interactor CSB, 
were identified. Even inhibiting degradation of proteins using VCP segragase inhibition, 
which extracts ubiquitylated Pol II from the chromatin to allow proteasomal degradation, 
or accumulating NER-intermediates, using NER-deficient XPA knock out cells, did not 
improve identification of UV-induced interactors of Pol II and left just a few interesting 
new candidates. Alternatively, we used two independent proximity labeling methods to 
covalently biotin-tag proteins that are in close proximity of Pol II. Both approaches identified 
basal complex interactors but again few new UV-induced interactors were identified. Finally, 
we used a native fractionation method to isolate Pol II and focused on immunoprecipi-
tating elongating Pol II to enrich for lesion-stalled complexes. This procedure successfully 
identified multiple of the known UV-induced Pol II interactors but also identified only a few 
additional interactors. Finally, we combined the mass spectrometry results of the different 
extraction methods and discuss the putative implications of UV-specific Pol II interactors 
that were identified in four or more experiments. 
To further identify new factors involved in regulating the cellular response to transcription 
stress, we performed a genome-wide CRISPR/Cas9 loss-of-function screen to identify 
genes involved in the UV-induced DNA damage response, Chapter 3. In this screen, we 
identified many known TC-NER factors such as CSB, CSA and UVSSA and additionally 
identified Elongation Factor 1 Homolog (ELOF1) as a new UV-sensitive gene. During 
basal conditions, ELOF1 is an integral part of the transcription elongation complex. In 
the absence of ELOF1, transcription resumption in response to UV was severely impaired 
due to impaired TC-NER. We also showed that this repair function was highly conserved 
between species. Further studying the function of ELOF1 in TC-NER revealed that 
without ELOF1, UVSSA and thus the downstream repair factors, like the TFIIH complex, 
could not be recruited. This is likely a result of the absence of Pol II ubiquitylation, which 
suggests that ELOF1 is important for facilitating this ubiquitylation. Interestingly, we 
showed that there is an additive sensitivity when both ELOF1 and CSB were knocked 
out, suggesting an additional role for ELOF1 outside of TC-NER. We finally showed that 
this supplementary function was linked to preventing transcription-replication conflicts.
In Chapter 4, we described another regulatory mechanism implicated in the UV-induced 
DNA damage response. Here, using a SILAC-based mass spectrometry approach to 
specifically study changes in histone PTMs, we show that there is a genome-wide loss 
of acetylated histones. This loss of acetylation is independent of transcription but can 
be induced by different types of DNA damage that induce replication-stress. We showed 
that the histone-wide deacetylation is a result of degradation of acetylated histones 
by the PA200 proteasome via a ubiquitin-independent mechanism. This uncovered 
replication stress-induced degradation of acetylated histones represents an important 
chromatin-modifying response to cope with replication stress. 
Finally, in Chapter 5, we summarized the main findings of the in this thesis described 
experimental work and discussed their implications. We propose future experiments 





De genetische code voor alle organisme ligt opgeslagen in de nucleotide volgorde 
van hun DNA en vormt de basis voor alle eiwitten. Het beschermen van deze code is 
essentieel om de genetische informatie van ons DNA foutloos over te schrijven in RNA, 
dit proces wordt transcriptie genoemd. RNA polymerase II (Pol II) is het eiwitcomplex 
dat verantwoordelijk is voor het overschrijven van de genetische informatie van het 
DNA in RNA. Echter, de voortgang van Pol II wordt regelmatig verstoord door schades in 
het DNA. Deze zogenoemde transcriptie-blokkerende laesies (TBLs) kunnen veroorzaakt 
worden door schadelijke stoffen die gevormd worden in ons lichaam als bijproduct van 
ons metabolisme of door stoffen van buiten ons lichaam zoals chemicaliën of UV-straling 
in zonlicht. Wanneer Pol II tijdens het aflezen van het DNA een TBL tegen komt kan dit 
de betrouwbaarheid van het overschrijven van het DNA verminderen of zelfs helemaal 
blokkeren. Dit kan uiteindelijk leiden tot het foutief kopiëren van het DNA of de volledige 
afwezigheid van nieuwe RNA-kopieën. Deze problemen met het overschrijven van 
het DNA kunnen leiden tot een verminderde cel functie en uiteindelijk tot versnelde 
veroudering. Als Pol II langdurig geblokkeerd blijft, kan dit leiden tot botsingen met de 
eiwitten die het DNA kopiëren, het replicatie mechanisme. Deze zogenoemde transcrip-
tie-replicatie conflicten (TRCs) kunnen instabiliteit van het genoom veroorzaken wat 
uiteindelijk kan bijdragen aan het ontstaan van kanker. De cel heeft verschillende 
systemen ontwikkeld om met DNA-schade om te kunnen gaan die het overschrijven 
van ons DNA belemmeren. Deze verschillende mechanismen worden gezamenlijk de 
DNA-schade geïnduceerde transcriptie stress reactie genoemd. 
Om de schadelijke effecten van Pol II wat vastgelopen is op DNA-schade te voorkomen, 
hebben cellen een herstel mechanisme genaamd transcriptie-gekoppeld nucleotide 
excisie herstel (TC-NER). TC-NER herstelt TBLs en dit proces wordt gestart zodra Pol II 
vastloopt op een schade. Vastgelopen Pol II wordt herkend door de TC-NER factoren CSA 
en CSB, waarna UVSSA en het eiwitcomplex TFIIH worden gerekruteerd welke helpen 
met het in gang zetten van de reparatie reactie. Vervolgens wordt het beschadigde deel 
van het DNA eruit geknipt en vervangen door nieuw DNA zodat het overschrijven van 
dit stukje DNA kan worden hervat. Daarnaast wordt transcriptie op vele verschillende 
manieren gereguleerd na DNA schade. Dit zorgt ervoor dat de TBLs worden herkend, 
opgeruimd, en transcriptie correct kan plaatsvinden wat nodig is voor het overleven van 
de cel. In Hoofdstuk 1 worden de gevolgen van TBLs op Pol II en transcriptie regulatie 
samengevat. 
Ondanks de identificatie van verschillende factoren die betrokken zijn bij het reguleren 
van de cellulaire reactie op DNA-schade geïnduceerde transcriptie stress is het exacte 
mechanisme nog niet duidelijk. Om nieuwe eiwitten te identificeren die betrokken zijn 
bij deze cellulaire reactie, hebben we gebruik gemaakt van methodes om op een kwanti-
tatieve manier eiwit interacties van Pol II te bestuderen. In Hoofdstuk 2 beschrijven 
we verschillende manieren om Pol II te isoleren uit cellen. Als eerste gebruiken we 
een extractie protocol dat gebruikt maakt van milde condities om zowel initiërend als 
elongerend Pol II te isoleren. Vervolgens kunnen we deze fracties gebruiken om Pol II 
te isoleren en daarmee kwantitatieve massa spectrometrie uit te voeren om zo basale 




methode hebben we verschillende componenten en regulerende factoren van het Pol II 
complex geïdentificeerd, maar helaas geen nieuwe UV geïnduceerde interactie partners. 
Daarom zijn we overgestapt naar een protocol wat gebruik maakt van een chemische 
reactie (crosslinken) om kort gebonden of zwakke eiwit interacties te stabiliseren en 
deze zo detecteerbaar te maken. We hebben twee verschillende chemische stoffen 
onderzocht om de eiwit interacties te crosslinken, PFA en DSP. Beide stoffen konden 
succesvol gebruikt worden om Pol II interactie partners te identificeren maar konden, 
naast de al bekende TC-NER factor CSB, weinig UV geïnduceerde interactie partners 
identificeren. Het remmen van afbraak van eiwitten of het halverwege blokkeren van 
de TC-NER reactie, door cellen zonder XPA te gebruiken, leidden niet tot een verrijking 
van de UV geïnduceerde interactie partners van Pol II. Als alternatief hebben we gebruik 
gemaakt van twee verschillende technieken die eiwitten in dichte nabijheid een biotine-
label geven, een zogenoemde nabijheidsmarkering. Beide methodes konden Pol II 
interactie partners identificeren maar weinig nog onbekende UV geïnduceerde factoren. 
Uiteindelijk hebben we gebruik gemaakt van een ander milde extractie techniek die 
de cellen eerst in fracties opdeelt. Daarnaast hebben we ons specifiek gericht op de 
elongerende Pol II complexen om op de manier te verrijken voor schade-gebonden 
Pol II, aangezien dit de complexen zijn die kunnen vastlopen op de DNA-schades. Deze 
methode was van alle geteste methodes het meest succesvol in het identificeren van UV 
verrijkte eiwitten, desondanks resulteerde ook deze methode maar in de identificatie van 
weinig nieuwe factoren. Tot slot hebben we de resultaten van alle hierboven genoemde 
experimenten gecombineerd en op deze manier gekeken naar potentieel interessante 
eiwitten die meerdere keren in verschillende experimenten werden geïdentificeerd. 
Een andere manier om te kijken naar nieuwe factoren die betrokken zijn bij de cellulaire 
reactie op transcriptiestress is door gebruik te maken van een genoom-brede CRISPR/
Cas9 verlies-van-functie analyse om genen te ontdekken die betrokken zijn bij de 
DNA-schade reactie, zoals beschreven in Hoofdstuk 3. Het feit dat deze analyse veel 
reeds bekende TC-NER factoren identificeerde als UV-gevoelige genen, zoals CSB, CSA 
en UVSSA, liet zien dat deze methode goed werkte. Verder werd in deze screen ook een 
eiwit geïdentificeerd waarvan nog geen rol in TC-NER bekend was: Elongatie Factor 1 
Homoloog (ELOF1). We ontdekten dat ELOF1 bindt aan Pol II en een belangrijk onderdeel 
van het transcriptie elongatie complex is in condities zonder DNA-schade. Verder 
hebben we gevonden dat ELOF1 een belangrijke rol speelt in de TC-NER reactie en dat 
het zorgt dat het overschrijven van het DNA na UV weer goed hervat kan worden. We 
laten ook zien dat deze herstel functie van ELOF1 sterk geconserveerd is tussen verschil-
lende soorten. We hebben aangetoond dat ELOF1 er in de TC-NER-reactie voor zorgt 
dat UVSSA en het TFIIH-complex correct naar het op schade vastgelopen Pol II worden 
gerekruteerd. Dit komt waarschijnlijk doordat Pol II niet wordt geubiquityleerd zonder 
ELOF1, wat suggereert dat ELOF1 belangrijk is voor het verzorgen van deze ubiquitine 
modificatie. Interessant genoeg hebben we ook laten zien dat ELOF1 ook een rol heeft in 
de DNA-schade geïnduceerd transcriptie stress reactie, buiten de TC-NER-reactie. Deze 
tweede rol voor ELOF1 is gelinkt aan het voorkomen van TRCs. 
In Hoofdstuk 4 beschrijven we een ander mechanisme dat belangrijk is in de UV 
geïnduceerde DNA-schade reactie waarbij we histonen bestuderen. Histonen zijn eiwitten 
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waar het DNA omheen gewikkeld zit om zo onze genetische code in de cel compact op te 
slaan en te organiseren. In dit hoofdstuk maken we gebruik van massa spectrometrie om 
veranderingen in modificaties van histonen te kunnen bestuderen en laten we zien dat er 
een genoom-breed verlies is van geacetyleerde histonen. Het verlies van deze acetylatie 
is onafhankelijk van transcriptie maar kan worden geïnduceerd door DNA-schades die 
leiden tot replicatie stress. We hebben laten zien dat het verminderen van de acetylatie 
een gevolg is van de afbraak van histonen met een acetylatie modificatie. De histonen 
worden afgebroken door het PA200 proteosoom, onafhankelijk van ubiquitine. Dit leidt 
tot een DNA schade geïnduceerde afbraak van geacetyleerde histonen, een proces wat 
waarschijnlijk een belangrijke rol speelt bij het veranderen van chromatine, zodat cellen 
beter om kunnen gaan met replicatie stress veroorzakende DNA schade. 
Ten slotte vatten we in Hoofdstuk 5 de belangrijkste bevindingen samen van het in dit 
proefschrift beschreven experimentele werk. Daarnaast bespreken we de conclusies 
hiervan en bespreken we tot welke nieuwe inzichten de conclusies hebben geleid. 
Verder stellen we toekomstige experimenten voor die van belang kunnen zijn om onze 
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